{
  "entities": [
    {
      "entity": "妊娠期糖尿病",
      "type": "Disease",
      "description": "女性在怀孕期间首次出现的糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "血糖水平升高",
      "type": "MedicalConcept",
      "description": "怀孕期间激素阻碍胰岛素正常工作导致的血糖异常",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠高血压",
      "type": "Complication",
      "description": "妊娠期糖尿病对母亲的并发症",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "巨大儿",
      "type": "Complication",
      "description": "胎儿体重超过4公斤",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "新生儿低血糖",
      "type": "Complication",
      "description": "新生儿出生后血糖水平过低",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "35岁以上高龄产妇",
      "type": "RiskFactor",
      "description": "年龄超过35岁的孕妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "肥胖",
      "type": "RiskFactor",
      "description": "BMI≥25",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "糖尿病家族史",
      "type": "RiskFactor",
      "description": "家族中有糖尿病患者",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "OGTT",
      "type": "DiagnosticMethod",
      "description": "75g口服葡萄糖耐量试验",
      "attributes": {
        "normal_range": "空腹血糖<5.1mmol/L，1小时血糖<10.0mmol/L，2小时血糖<8.5mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "空腹血糖",
      "type": "DiagnosticMethod",
      "description": "空腹状态下的血糖测量",
      "attributes": {
        "normal_range": "<5.3mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "胰岛素治疗",
      "type": "Treatment",
      "description": "使用胰岛素控制血糖",
      "attributes": {
        "type": "药物治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "饮食控制",
      "type": "Treatment",
      "description": "通过调整饮食结构控制血糖",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "运动疗法",
      "type": "Treatment",
      "description": "通过规律运动改善血糖控制",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "全麦面包",
      "type": "Food",
      "description": "高纤维、低GI的碳水化合物来源",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "低脂牛奶",
      "type": "Food",
      "description": "提供优质蛋白和钙质的低脂肪乳制品",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "高纤维食物",
      "type": "Food",
      "description": "有助于血糖控制的膳食纤维丰富食物",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "什么是妊娠期糖尿病？",
      "type": "Question",
      "description": "关于妊娠期糖尿病定义的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病如何诊断？",
      "type": "Question",
      "description": "关于诊断方法的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病如何治疗？",
      "type": "Question",
      "description": "关于治疗方案的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "胰岛素抵抗",
      "type": "MedicalConcept",
      "description": "机体对胰岛素敏感性降低",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "糖代谢",
      "type": "MedicalConcept",
      "description": "体内葡萄糖的代谢过程",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "多饮",
      "type": "Symptom",
      "description": "异常口渴和大量饮水",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "多尿",
      "type": "Symptom",
      "description": "尿量异常增多",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "体重增加",
      "type": "Symptom",
      "description": "异常体重增长",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "既往妊娠期糖尿病史",
      "type": "RiskFactor",
      "description": "既往怀孕时曾患妊娠期糖尿病",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "多囊卵巢综合征",
      "type": "RiskFactor",
      "description": "内分泌代谢异常疾病",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "糖化血红蛋白",
      "type": "DiagnosticMethod",
      "description": "反映长期血糖控制的指标",
      "attributes": {
        "normal_range": "<6%",
        "confidence": "medium"
      }
    },
    {
      "entity": "血糖监测",
      "type": "Treatment",
      "description": "定期测量血糖水平",
      "attributes": {
        "type": "监测手段",
        "confidence": "high"
      }
    },
    {
      "entity": "产后出血",
      "type": "Complication",
      "description": "分娩后异常大量出血",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "肩难产",
      "type": "Complication",
      "description": "分娩时胎儿肩膀卡住",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "黄疸",
      "type": "Complication",
      "description": "新生儿皮肤和眼白发黄",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "ADA指南",
      "type": "Guideline",
      "description": "美国糖尿病协会发布的临床指南",
      "attributes": {
        "organization": "美国糖尿病协会",
        "confidence": "high"
      }
    },
    {
      "entity": "ACOG推荐",
      "type": "Guideline",
      "description": "美国妇产科医师学会的临床建议",
      "attributes": {
        "organization": "美国妇产科医师学会",
        "confidence": "high"
      }
    },
    {
      "entity": "中华医学会指南",
      "type": "Guideline",
      "description": "中国医学会发布的临床实践指南",
      "attributes": {
        "organization": "中华医学会",
        "confidence": "high"
      }
    },
    {
      "entity": "2型糖尿病",
      "type": "Disease",
      "description": "胰岛素抵抗伴相对胰岛素缺乏的糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "妊高症",
      "type": "Disease",
      "description": "妊娠期高血压疾病",
      "attributes": {
        "icd_code": "O13-O16",
        "confidence": "high"
      }
    },
    {
      "entity": "早产",
      "type": "Complication",
      "description": "妊娠不满37周分娩",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "血糖控制",
      "type": "MedicalConcept",
      "description": "通过干预措施维持血糖在目标范围内",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "剖宫产",
      "type": "Treatment",
      "description": "通过手术方式分娩",
      "attributes": {
        "type": "surgical",
        "confidence": "high"
      }
    },
    {
      "entity": "75g OGTT",
      "type": "DiagnosticMethod",
      "description": "口服75克葡萄糖耐量试验",
      "attributes": {
        "normal_range": "空腹<5.1mmol/L，1小时<10.0mmol/L，2小时<8.5mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "糖耐量受损",
      "type": "MedicalConcept",
      "description": "血糖水平高于正常但未达糖尿病标准",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "母乳喂养",
      "type": "Treatment",
      "description": "通过母亲乳汁哺育婴儿",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "胰岛素敏感性",
      "type": "MedicalConcept",
      "description": "机体对胰岛素降糖效应的反应能力",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "健康体重",
      "type": "RiskFactor",
      "description": "BMI在18.5-24.9kg/m²范围",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "规律运动",
      "type": "Treatment",
      "description": "每周至少150分钟中等强度运动",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "精制碳水化合物",
      "type": "Food",
      "description": "经过加工去除纤维的高升糖指数食物",
      "attributes": {
        "glycemic_index": "≥70",
        "confidence": "high"
      }
    },
    {
      "entity": "添加糖",
      "type": "Food",
      "description": "加工过程中额外添加的游离糖",
      "attributes": {
        "glycemic_index": "high",
        "confidence": "medium"
      }
    },
    {
      "entity": "血糖筛查",
      "type": "DiagnosticMethod",
      "description": "定期检测血糖水平的检查",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "吸烟",
      "type": "RiskFactor",
      "description": "烟草使用行为",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "过量饮酒",
      "type": "RiskFactor",
      "description": "酒精摄入超过推荐量",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病会影响分娩方式吗？",
      "type": "Question",
      "description": "关于疾病对分娩方式影响的常见疑问",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "分娩后血糖会恢复正常吗？",
      "type": "Question",
      "description": "关于产后转归的常见疑问",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "剖宫产率增加",
      "type": "Complication",
      "description": "手术分娩概率上升",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "超重或肥胖(BMI≥25)",
      "type": "RiskFactor",
      "description": "体重相关的代谢风险",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "多囊卵巢综合征",
      "type": "Disease",
      "description": "内分泌代谢异常疾病",
      "attributes": {
        "icd_code": "E28.2",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病有哪些风险？",
      "type": "Question",
      "description": "关于并发症的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病的发病率是多少？",
      "type": "Question",
      "description": "关于流行病学的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "哪些人群容易患妊娠期糖尿病？",
      "type": "Question",
      "description": "关于高危因素的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠高血压疾病",
      "type": "Complication",
      "description": "妊娠期特有的高血压疾病",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "羊水过多",
      "type": "Complication",
      "description": "羊水量异常增多",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "呼吸窘迫综合征",
      "type": "Complication",
      "description": "新生儿因肺表面活性物质缺乏导致的呼吸障碍",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "胎盘早剥",
      "type": "Complication",
      "description": "正常位置的胎盘在胎儿娩出前部分或全部从子宫壁剥离",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病会导致哪些并发症？",
      "type": "Question",
      "description": "患者询问疾病相关并发症",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病会增加胎盘早剥的风险吗？",
      "type": "Question",
      "description": "患者询问特定并发症风险",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "产后抑郁",
      "type": "Complication",
      "description": "分娩后出现的抑郁症状",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "焦虑",
      "type": "Symptom",
      "description": "妊娠期糖尿病诊断后可能出现的情绪反应",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "压力",
      "type": "Symptom",
      "description": "妊娠期糖尿病管理过程中的心理负担",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "血糖波动",
      "type": "MedicalConcept",
      "description": "妊娠期糖尿病患者常见的血糖水平不稳定现象",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "激素变化",
      "type": "MedicalConcept",
      "description": "妊娠期及产后体内激素水平的生理性改变",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "育儿压力",
      "type": "RiskFactor",
      "description": "产后照顾新生儿带来的心理压力",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "社会支持",
      "type": "Treatment",
      "description": "通过家人朋友支持改善心理状态",
      "attributes": {
        "type": "心理干预",
        "confidence": "high"
      }
    },
    {
      "entity": "心理专家咨询",
      "type": "Treatment",
      "description": "专业心理健康服务",
      "attributes": {
        "type": "心理治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "如何应对妊娠期糖尿病的心理压力？",
      "type": "Question",
      "description": "患者关于疾病心理管理的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "患有妊娠期糖尿病会影响产后抑郁的风险吗？",
      "type": "Question",
      "description": "关于疾病与并发症关系的临床问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "血糖监测",
      "type": "DiagnosticMethod",
      "description": "定期检测血糖水平评估控制情况",
      "attributes": {
        "normal_range": "空腹<5.3mmol/L, 餐后1h<7.8mmol/L, 餐后2h<6.7mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "餐后血糖",
      "type": "DiagnosticMethod",
      "description": "进食后特定时间点测量的血糖值",
      "attributes": {
        "normal_range": "1h<7.8mmol/L, 2h<6.7mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "血糖仪",
      "type": "DiagnosticMethod",
      "description": "用于自我监测血糖的便携式设备",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "碳水化合物",
      "type": "Food",
      "description": "主要供能营养素，需控制摄入比例",
      "attributes": {
        "glycemic_index": "依具体种类而异",
        "confidence": "medium"
      }
    },
    {
      "entity": "膳食纤维",
      "type": "Food",
      "description": "有助于血糖控制的食物成分",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "含糖饮料",
      "type": "Food",
      "description": "应避免的高升糖指数饮品",
      "attributes": {
        "glycemic_index": "高",
        "confidence": "high"
      }
    },
    {
      "entity": "散步",
      "type": "Treatment",
      "description": "推荐的低强度有氧运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "孕妇瑜伽",
      "type": "Treatment",
      "description": "适合妊娠期的低强度运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "二甲双胍",
      "type": "Treatment",
      "description": "可能用于特定情况的降糖药物",
      "attributes": {
        "type": "药物治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "口服降糖药可以用于妊娠期糖尿病吗？",
      "type": "Question",
      "description": "关于药物治疗选择的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "健康零食",
      "type": "Food",
      "description": "低升糖指数的营养加餐食品",
      "attributes": {
        "glycemic_index": "<55",
        "confidence": "medium"
      }
    },
    {
      "entity": "规律饮食",
      "type": "Treatment",
      "description": "定时定量进餐的饮食管理方法",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "久坐",
      "type": "RiskFactor",
      "description": "长时间保持坐姿缺乏活动",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "时差影响",
      "type": "RiskFactor",
      "description": "跨时区旅行导致的生物钟紊乱",
      "attributes": {
        "modifiable": false,
        "confidence": "medium"
      }
    },
    {
      "entity": "过度疲劳",
      "type": "RiskFactor",
      "description": "超出身体承受范围的工作强度",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "饮食计划",
      "type": "Treatment",
      "description": "根据营养需求制定的膳食安排",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "75g口服葡萄糖耐量试验(OGTT)",
      "type": "DiagnosticMethod",
      "description": "通过口服葡萄糖后测量血糖水平来诊断糖代谢异常",
      "attributes": {
        "normal_range": "空腹<5.1mmol/L, 1h<10.0mmol/L, 2h<8.5mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "既往GDM史",
      "type": "RiskFactor",
      "description": "既往妊娠期间曾患妊娠期糖尿病",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "BMI≥30",
      "type": "RiskFactor",
      "description": "体重指数达到肥胖标准",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "什么时候需要进行妊娠期糖尿病筛查？",
      "type": "Question",
      "description": "关于GDM筛查时机的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "筛查前需要注意什么？",
      "type": "Question",
      "description": "关于OGTT检查前准备的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "少食多餐",
      "type": "Treatment",
      "description": "饮食控制方法，通过增加餐次减少单次进食量",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "低GI食物",
      "type": "Food",
      "description": "血糖生成指数低于55的食物",
      "attributes": {
        "glycemic_index": "<55",
        "confidence": "high"
      }
    },
    {
      "entity": "坚果",
      "type": "Food",
      "description": "低GI高蛋白植物性食物",
      "attributes": {
        "glycemic_index": "15-25",
        "confidence": "high"
      }
    },
    {
      "entity": "酸奶",
      "type": "Food",
      "description": "发酵乳制品，建议选择无糖型",
      "attributes": {
        "glycemic_index": "30-40",
        "confidence": "high"
      }
    },
    {
      "entity": "高糖食物",
      "type": "Food",
      "description": "含简单碳水化合物为主的食品",
      "attributes": {
        "glycemic_index": ">70",
        "confidence": "high"
      }
    },
    {
      "entity": "全谷物",
      "type": "Food",
      "description": "保留完整谷粒结构的粮食",
      "attributes": {
        "glycemic_index": "40-55",
        "confidence": "high"
      }
    },
    {
      "entity": "低GI水果",
      "type": "Food",
      "description": "血糖生成指数≤55的水果",
      "attributes": {
        "glycemic_index": "≤55",
        "confidence": "high"
      }
    },
    {
      "entity": "如何安排一日三餐？",
      "type": "Question",
      "description": "患者关于饮食分餐制的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "哪些食物应该避免？",
      "type": "Question",
      "description": "患者关于禁忌食物的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "哪些食物可以多吃？",
      "type": "Question",
      "description": "患者关于推荐食物的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "高龄产妇",
      "type": "RiskFactor",
      "description": "年龄≥35岁的孕妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "先兆子痫",
      "type": "Complication",
      "description": "妊娠期高血压伴蛋白尿",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "中国妊娠期糖尿病母儿共同管理指南",
      "type": "Guideline",
      "description": "2024版GDM管理临床指南",
      "attributes": {
        "organization": "中国研究型医院学会糖尿病学专业委员会",
        "confidence": "high"
      }
    },
    {
      "entity": "GDM孕妇是否需要终身监测血糖？",
      "type": "Question",
      "description": "关于产后血糖监测持续时间的常见问题",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "地中海饮食",
      "type": "Food",
      "description": "富含单不饱和脂肪酸和膳食纤维的饮食模式",
      "attributes": {
        "glycemic_index": "整体低GI",
        "confidence": "high"
      }
    },
    {
      "entity": "GDM孕妇是否需要运动？",
      "type": "Question",
      "description": "关于妊娠期糖尿病孕妇运动适应证的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "FPG",
      "type": "DiagnosticMethod",
      "description": "空腹血糖检测",
      "attributes": {
        "normal_range": "<5.1 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "医学营养治疗（MNT）",
      "type": "Treatment",
      "description": "通过个体化饮食方案控制血糖",
      "attributes": {
        "type": "非药物疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "DASH饮食",
      "type": "Food",
      "description": "降压饮食模式，强调低钠高钾",
      "attributes": {
        "glycemic_index": "整体低GI",
        "confidence": "medium"
      }
    },
    {
      "entity": "HbA1c",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白检测",
      "attributes": {
        "normal_range": "<6.0%",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病是否需要胰岛素治疗？",
      "type": "Question",
      "description": "关于妊娠期糖尿病治疗方案的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "GDM孕妇是否需要使用CGM？",
      "type": "Question",
      "description": "关于持续血糖监测在妊娠期糖尿病中的应用问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "TIR",
      "type": "MedicalConcept",
      "description": "目标范围内时间（Time in Range）",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "gestational diabetes mellitus",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin resistance",
      "type": "MedicalConcept",
      "description": "胰岛素抵抗",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "overweight and obese pregnant women",
      "type": "RiskFactor",
      "description": "超重和肥胖孕妇",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "regular exercise",
      "type": "Treatment",
      "description": "规律运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "resistance exercise",
      "type": "Treatment",
      "description": "抗阻运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "structured aerobic and resistance exercise",
      "type": "Treatment",
      "description": "结构化有氧和抗阻运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "glycaemic control",
      "type": "MedicalConcept",
      "description": "血糖控制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "preterm birth",
      "type": "Complication",
      "description": "早产",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "gestational weight gain",
      "type": "MedicalConcept",
      "description": "妊娠期体重增加",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "birth weight",
      "type": "MedicalConcept",
      "description": "出生体重",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "ACOG Committee opinion",
      "type": "Guideline",
      "description": "ACOG委员会意见",
      "attributes": {
        "organization": "ACOG",
        "confidence": "high"
      }
    },
    {
      "entity": "Canadian guideline for physical activity throughout pregnancy",
      "type": "Guideline",
      "description": "加拿大妊娠期体育活动指南",
      "attributes": {
        "organization": "加拿大",
        "confidence": "high"
      }
    },
    {
      "entity": "low-glycemic index diet",
      "type": "Food",
      "description": "低血糖指数饮食",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "higher-complex-carbohydrate",
      "type": "Food",
      "description": "高复合碳水化合物",
      "attributes": {
        "glycemic_index": "medium",
        "confidence": "high"
      }
    },
    {
      "entity": "FIGO initiative on gestational diabetes mellitus",
      "type": "Guideline",
      "description": "FIGO妊娠期糖尿病倡议",
      "attributes": {
        "organization": "FIGO",
        "confidence": "high"
      }
    },
    {
      "entity": "Flemish consensus on screening for gestational diabetes mellitus",
      "type": "Guideline",
      "description": "佛兰芒妊娠期糖尿病筛查共识",
      "attributes": {
        "organization": "佛兰芒",
        "confidence": "high"
      }
    },
    {
      "entity": "Management of gestational diabetes in the community",
      "type": "Guideline",
      "description": "社区妊娠期糖尿病管理",
      "attributes": {
        "organization": "IDF",
        "confidence": "high"
      }
    },
    {
      "entity": "地中海饮食",
      "type": "Treatment",
      "description": "以植物性食物为主的膳食模式",
      "attributes": {
        "type": "营养干预",
        "confidence": "high"
      }
    },
    {
      "entity": "维生素D补充",
      "type": "Treatment",
      "description": "改善糖代谢的辅助治疗",
      "attributes": {
        "type": "营养补充",
        "confidence": "medium"
      }
    },
    {
      "entity": "益生菌",
      "type": "Treatment",
      "description": "调节肠道菌群的微生物制剂",
      "attributes": {
        "type": "微生态调节",
        "confidence": "medium"
      }
    },
    {
      "entity": "胰岛素泵",
      "type": "Treatment",
      "description": "持续皮下胰岛素输注装置",
      "attributes": {
        "type": "器械治疗",
        "confidence": "medium"
      }
    },
    {
      "entity": "DASH饮食",
      "type": "Treatment",
      "description": "防治高血压的膳食模式",
      "attributes": {
        "type": "营养干预",
        "confidence": "medium"
      }
    },
    {
      "entity": "动态血糖监测",
      "type": "DiagnosticMethod",
      "description": "连续监测组织间液葡萄糖浓度",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病会影响胎儿发育吗？",
      "type": "Question",
      "description": "关于妊娠期糖尿病对胎儿影响的常见问题",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Gestational Diabetes Mellitus",
      "type": "Disease",
      "description": "A temporary form of diabetes occurring during pregnancy",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "type 2 diabetes",
      "type": "Disease",
      "description": "A chronic condition affecting the way the body processes blood sugar",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "hyperglycaemia",
      "type": "MedicalConcept",
      "description": "High blood sugar levels",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "high blood pressure",
      "type": "Complication",
      "description": "A condition where the force of the blood against the artery walls is too high",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "large birth weight babies",
      "type": "Complication",
      "description": "Babies born with a weight significantly higher than average",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "obstructed labour",
      "type": "Complication",
      "description": "A complication during childbirth where the baby cannot exit the pelvis",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "caesarean sections",
      "type": "Complication",
      "description": "A surgical procedure to deliver a baby",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "diet",
      "type": "Treatment",
      "description": "Nutritional management to control blood sugar levels",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "exercise",
      "type": "Treatment",
      "description": "Physical activity to improve glucose metabolism",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "WINGS project",
      "type": "Guideline",
      "description": "A project aimed at improving care for women with gestational diabetes in low-resource settings",
      "attributes": {
        "organization": "International Diabetes Federation",
        "confidence": "high"
      }
    },
    {
      "entity": "IDF Model of Care",
      "type": "Guideline",
      "description": "A framework for managing gestational diabetes mellitus",
      "attributes": {
        "organization": "International Diabetes Federation",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetes family history",
      "type": "RiskFactor",
      "description": "A family history of diabetes increases the risk of developing gestational diabetes",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "wheat products",
      "type": "Food",
      "description": "Foods made from wheat, often recommended for their fiber content",
      "attributes": {
        "glycemic_index": "medium",
        "confidence": "medium"
      }
    },
    {
      "entity": "fasting oral glucose tolerance test",
      "type": "DiagnosticMethod",
      "description": "空腹口服葡萄糖耐量试验",
      "attributes": {
        "normal_range": "空腹血糖<5.1mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "non-fasting glucose challenge test",
      "type": "DiagnosticMethod",
      "description": "非空腹葡萄糖负荷试验",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Medical Nutrition therapy (MNT)",
      "type": "Treatment",
      "description": "医学营养治疗",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "Insulin & Oral Hypoglycaemic Agents (OHA)",
      "type": "Treatment",
      "description": "胰岛素和口服降糖药物",
      "attributes": {
        "type": "药物治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "Breastfeeding",
      "type": "Treatment",
      "description": "母乳喂养",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "pre-eclampsia",
      "type": "Complication",
      "description": "子痫前期",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "macrosomia",
      "type": "Complication",
      "description": "巨大儿",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "T2D",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "IDF WINGS MOC",
      "type": "Guideline",
      "description": "IDF WINGS妊娠期糖尿病管理模式",
      "attributes": {
        "organization": "International Diabetes Federation",
        "confidence": "high"
      }
    },
    {
      "entity": "WHO 1999 criteria",
      "type": "Guideline",
      "description": "WHO 1999诊断标准",
      "attributes": {
        "organization": "World Health Organization",
        "confidence": "high"
      }
    },
    {
      "entity": "WHO 2013/IADPSG",
      "type": "Guideline",
      "description": "WHO 2013/IADPSG诊断标准",
      "attributes": {
        "organization": "World Health Organization/International Association of Diabetes and Pregnancy Study Groups",
        "confidence": "high"
      }
    },
    {
      "entity": "meal plan",
      "type": "Treatment",
      "description": "饮食计划",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "physical activity",
      "type": "Treatment",
      "description": "体育活动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "post-natal screening",
      "type": "DiagnosticMethod",
      "description": "产后筛查",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "universal screening",
      "type": "DiagnosticMethod",
      "description": "普遍筛查",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "diagnostic cut-offs",
      "type": "DiagnosticMethod",
      "description": "诊断切点",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "dysglycaemia",
      "type": "MedicalConcept",
      "description": "Abnormal blood glucose levels, including both hyperglycemia and hypoglycemia.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum follow-up",
      "type": "MedicalConcept",
      "description": "Medical monitoring and care provided to women after childbirth to manage and assess health conditions like GDM.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "World Health Organization criteria",
      "type": "Guideline",
      "description": "Diagnostic criteria for GDM established by the WHO.",
      "attributes": {
        "organization": "WHO",
        "confidence": "high"
      }
    },
    {
      "entity": "International Association of Diabetes and Pregnancy Study Groups Criteria",
      "type": "Guideline",
      "description": "Diagnostic criteria for GDM established by the IADPSG.",
      "attributes": {
        "organization": "IADPSG",
        "confidence": "high"
      }
    },
    {
      "entity": "obesity",
      "type": "RiskFactor",
      "description": "A significant risk factor for developing GDM.",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "low birth weight",
      "type": "Complication",
      "description": "A complication where the newborn weighs less than 2.5 kg, associated with maternal conditions like GDM.",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "IDF WINGS Model of Care",
      "type": "Guideline",
      "description": "A model developed by IDF for managing GDM in low and middle income countries.",
      "attributes": {
        "organization": "IDF",
        "confidence": "high"
      }
    },
    {
      "entity": "adverse neonatal outcomes",
      "type": "Complication",
      "description": "Negative health effects on newborns, such as hypoglycemia or macrosomia, associated with GDM.",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "tiredness",
      "type": "Symptom",
      "description": "A common symptom reported by women with GDM.",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "dizziness",
      "type": "Symptom",
      "description": "A symptom that may occur in women with GDM due to fluctuating blood glucose levels.",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "diet control",
      "type": "Treatment",
      "description": "A primary treatment method for managing GDM through regulated food intake.",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "SMBG",
      "type": "DiagnosticMethod",
      "description": "Self-Monitoring of Blood Glucose, a method used by patients to track their blood glucose levels at home.",
      "attributes": {
        "normal_range": "Varies by individual and pregnancy stage",
        "confidence": "high"
      }
    },
    {
      "entity": "Type 2 Diabetes",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "high blood sugar levels",
      "type": "Symptom",
      "description": "高血糖水平",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "weak and tired",
      "type": "Symptom",
      "description": "虚弱和疲劳",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "postpartum screening",
      "type": "DiagnosticMethod",
      "description": "产后筛查",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "follow up rate",
      "type": "MedicalConcept",
      "description": "随访率",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "pregnancy outcomes",
      "type": "MedicalConcept",
      "description": "妊娠结局",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "adverse outcomes",
      "type": "Complication",
      "description": "不良结局",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "local cultural practices",
      "type": "RiskFactor",
      "description": "当地文化习俗",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "community sensitization",
      "type": "Treatment",
      "description": "社区敏感化",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "refresher training sessions",
      "type": "Treatment",
      "description": "进修培训课程",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "food frequency",
      "type": "Treatment",
      "description": "食物频率",
      "attributes": {
        "type": "diet",
        "confidence": "high"
      }
    },
    {
      "entity": "Standards of Care in Diabetes—2023",
      "type": "Guideline",
      "description": "美国糖尿病协会发布的糖尿病护理标准",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "type 1 diabetes",
      "type": "Disease",
      "description": "1型糖尿病",
      "attributes": {
        "icd_code": "E10",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetic retinopathy",
      "type": "Complication",
      "description": "糖尿病视网膜病变",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetic foot ulcers",
      "type": "Complication",
      "description": "糖尿病足溃疡",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "fasting glucose",
      "type": "DiagnosticMethod",
      "description": "空腹血糖",
      "attributes": {
        "normal_range": "<5.1 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin therapy",
      "type": "Treatment",
      "description": "胰岛素治疗",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "exercise therapy",
      "type": "Treatment",
      "description": "运动疗法",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal hypoglycemia",
      "type": "Complication",
      "description": "新生儿低血糖",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum hemorrhage",
      "type": "Complication",
      "description": "产后出血",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "family history of diabetes",
      "type": "RiskFactor",
      "description": "糖尿病家族史",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "advanced maternal age",
      "type": "RiskFactor",
      "description": "高龄产妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "glucose management",
      "type": "MedicalConcept",
      "description": "血糖管理",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycemic index",
      "type": "MedicalConcept",
      "description": "血糖指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "How to manage gestational diabetes during pregnancy?",
      "type": "Question",
      "description": "妊娠期如何管理妊娠期糖尿病？",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "心血管疾病",
      "type": "Disease",
      "description": "影响心脏和血管的疾病",
      "attributes": {
        "icd_code": "I00-I99",
        "confidence": "medium"
      }
    },
    {
      "entity": "风险因素管理",
      "type": "MedicalConcept",
      "description": "对疾病风险因素进行识别和干预的过程",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "利益冲突管理",
      "type": "MedicalConcept",
      "description": "确保医学指南制定过程中避免利益冲突的流程",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "系统文献回顾",
      "type": "DiagnosticMethod",
      "description": "系统性地收集和分析医学文献的方法",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "证据分级",
      "type": "MedicalConcept",
      "description": "对医学证据质量进行评估和分类的系统",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "临床决策",
      "type": "MedicalConcept",
      "description": "基于证据和患者个体情况的治疗选择过程",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "公共评议",
      "type": "MedicalConcept",
      "description": "在指南制定过程中收集公众意见的流程",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Standards of Care",
      "type": "Guideline",
      "description": "ADA发布的糖尿病护理临床实践推荐标准",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "Consensus Report",
      "type": "Guideline",
      "description": "专家小组对糖尿病相关医学或科学问题的集体分析和意见",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "Scientific Review",
      "description": "对糖尿病相关科学或医学文献的平衡分析和综述",
      "type": "Guideline",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "ADA Statement",
      "type": "Guideline",
      "description": "ADA对糖尿病相关问题的官方观点或信念",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "Cardiovascular and Metabolic Risk",
      "type": "MedicalConcept",
      "description": "心血管和代谢风险",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "ADA evidence-grading system",
      "type": "Guideline",
      "description": "ADA用于评估糖尿病护理标准的证据分级系统",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "NICE指南",
      "type": "Guideline",
      "description": "英国国家健康与临床优化研究所发布的妊娠期糖尿病管理指南",
      "attributes": {
        "organization": "NICE",
        "confidence": "high"
      }
    },
    {
      "entity": "先天性畸形",
      "type": "Complication",
      "description": "胎儿发育异常导致的出生缺陷",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "实时连续血糖监测",
      "type": "DiagnosticMethod",
      "description": "通过皮下传感器持续监测组织间液葡萄糖水平",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "hypoglycaemia",
      "type": "Symptom",
      "description": "低血糖症状",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "impaired awareness of hypoglycaemia",
      "type": "Symptom",
      "description": "低血糖意识受损",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "nausea and vomiting in pregnancy",
      "type": "Symptom",
      "description": "妊娠期恶心呕吐",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "large for gestational age",
      "type": "Complication",
      "description": "大于胎龄儿",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "birth trauma",
      "type": "Complication",
      "description": "产伤",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "induction of labour",
      "type": "Treatment",
      "description": "引产",
      "attributes": {
        "type": "obstetric intervention",
        "confidence": "high"
      }
    },
    {
      "entity": "instrumental delivery",
      "type": "Treatment",
      "description": "器械助产",
      "attributes": {
        "type": "obstetric intervention",
        "confidence": "high"
      }
    },
    {
      "entity": "caesarean section",
      "type": "Treatment",
      "description": "剖宫产",
      "attributes": {
        "type": "surgical procedure",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetic nephropathy",
      "type": "Complication",
      "description": "糖尿病肾病",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal hypoglycaemia",
      "type": "Complication",
      "description": "新生儿低血糖",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetes",
      "type": "Disease",
      "description": "糖尿病",
      "attributes": {
        "icd_code": "E11-E14",
        "confidence": "high"
      }
    },
    {
      "entity": "blood glucose meters",
      "type": "DiagnosticMethod",
      "description": "血糖仪",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "blood ketone testing",
      "type": "DiagnosticMethod",
      "description": "血酮检测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "metformin",
      "type": "Treatment",
      "description": "二甲双胍",
      "attributes": {
        "type": "oral hypoglycemic agent",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin",
      "type": "Treatment",
      "description": "胰岛素",
      "attributes": {
        "type": "hormone therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "rapid-acting insulin analogues",
      "type": "Treatment",
      "description": "速效胰岛素类似物",
      "attributes": {
        "type": "insulin therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "isophane insulin",
      "type": "Treatment",
      "description": "中性鱼精蛋白锌胰岛素",
      "attributes": {
        "type": "long-acting insulin",
        "confidence": "high"
      }
    },
    {
      "entity": "long-acting insulin analogues",
      "type": "Treatment",
      "description": "长效胰岛素类似物",
      "attributes": {
        "type": "insulin therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "angiotensin-converting enzyme inhibitors",
      "type": "Treatment",
      "description": "血管紧张素转换酶抑制剂",
      "attributes": {
        "type": "antihypertensive",
        "confidence": "high"
      }
    },
    {
      "entity": "angiotensin-II receptor antagonists",
      "type": "Treatment",
      "description": "血管紧张素II受体拮抗剂",
      "attributes": {
        "type": "antihypertensive",
        "confidence": "high"
      }
    },
    {
      "entity": "statins",
      "type": "Treatment",
      "description": "他汀类药物",
      "attributes": {
        "type": "lipid-lowering agent",
        "confidence": "high"
      }
    },
    {
      "entity": "folic acid",
      "type": "Treatment",
      "description": "叶酸补充",
      "attributes": {
        "type": "nutritional supplement",
        "confidence": "high"
      }
    },
    {
      "entity": "NICE guideline",
      "type": "Guideline",
      "description": "英国国家健康与临床优化研究所指南",
      "attributes": {
        "organization": "NICE",
        "confidence": "high"
      }
    },
    {
      "entity": "preconception blood glucose control",
      "type": "MedicalConcept",
      "description": "孕前血糖控制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "gestational diabetes",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "shoulder dystocia",
      "type": "Complication",
      "description": "肩难产",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "BMI of 30 kg/m2 or over",
      "type": "RiskFactor",
      "description": "BMI≥30 kg/m²",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "75-g 2-hour oral glucose tolerance test (OGTT)",
      "type": "DiagnosticMethod",
      "description": "75克2小时口服葡萄糖耐量试验",
      "attributes": {
        "normal_range": "空腹<5.6 mmol/L, 2小时<7.8 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "How to self-monitor blood glucose?",
      "type": "Question",
      "description": "如何进行血糖自我监测",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "diet and exercise changes",
      "type": "Treatment",
      "description": "饮食和运动调整",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "high"
      }
    },
    {
      "entity": "previous macrosomic baby weighing 4.5 kg or more",
      "type": "RiskFactor",
      "description": "既往巨大儿史(≥4.5kg)",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "fasting plasma glucose level of 5.6 mmol/litre or above",
      "type": "DiagnosticMethod",
      "description": "空腹血糖≥5.6 mmol/L",
      "attributes": {
        "normal_range": "<5.6 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "blood glucose targets",
      "type": "MedicalConcept",
      "description": "目标血糖水平",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fasting plasma glucose level",
      "type": "DiagnosticMethod",
      "description": "空腹血糖水平",
      "attributes": {
        "normal_range": "3.9-5.5 mmol/litre",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin treatment",
      "type": "Treatment",
      "description": "胰岛素治疗",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "hydramnios",
      "type": "Complication",
      "description": "羊水过多",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "hypoglycaemia",
      "type": "Complication",
      "description": "低血糖",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "HbA1c levels",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白水平",
      "attributes": {
        "normal_range": "<6.5%",
        "confidence": "high"
      }
    },
    {
      "entity": "continuous subcutaneous insulin infusion (CSII)",
      "type": "Treatment",
      "description": "持续皮下胰岛素输注",
      "attributes": {
        "type": "device",
        "confidence": "high"
      }
    },
    {
      "entity": "real-time continuous glucose monitoring (rtCGM)",
      "type": "DiagnosticMethod",
      "description": "实时连续血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "intermittently scanned continuous glucose monitoring (isCGM)",
      "type": "DiagnosticMethod",
      "description": "间歇扫描式连续血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "diabetic ketoacidosis",
      "type": "Complication",
      "description": "糖尿病酮症酸中毒",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "Diabetic retinopathy",
      "type": "Disease",
      "description": "糖尿病视网膜病变",
      "attributes": {
        "icd_code": "E11.3",
        "confidence": "high"
      }
    },
    {
      "entity": "blood glucose control",
      "type": "MedicalConcept",
      "description": "血糖控制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "vaginal birth",
      "type": "Treatment",
      "description": "阴道分娩",
      "attributes": {
        "type": "delivery method",
        "confidence": "high"
      }
    },
    {
      "entity": "renal assessment",
      "type": "DiagnosticMethod",
      "description": "肾功能评估",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "serum creatinine",
      "type": "DiagnosticMethod",
      "description": "血清肌酐",
      "attributes": {
        "normal_range": "44-97 μmol/L (female)",
        "confidence": "high"
      }
    },
    {
      "entity": "urinary albumin:creatinine ratio",
      "type": "DiagnosticMethod",
      "description": "尿白蛋白肌酐比",
      "attributes": {
        "normal_range": "<30 mg/mmol",
        "confidence": "high"
      }
    },
    {
      "entity": "nephrotic range proteinuria",
      "type": "Complication",
      "description": "肾病范围蛋白尿",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "thromboprophylaxis",
      "type": "Treatment",
      "description": "血栓预防",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "pre-eclampsia",
      "type": "Disease",
      "description": "子痫前期",
      "attributes": {
        "icd_code": "O14",
        "confidence": "high"
      }
    },
    {
      "entity": "antiplatelet agents",
      "type": "Treatment",
      "description": "抗血小板药物",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "ultrasound scan at 20 weeks",
      "type": "DiagnosticMethod",
      "description": "20周超声检查",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fetal structural abnormalities",
      "type": "Complication",
      "description": "胎儿结构异常",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "fetal growth restriction",
      "type": "Complication",
      "description": "胎儿生长受限",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "fetal umbilical artery doppler",
      "type": "DiagnosticMethod",
      "description": "胎儿脐动脉多普勒",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "biophysical profile testing",
      "type": "DiagnosticMethod",
      "description": "生物物理评分",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "joint diabetes and antenatal clinic",
      "type": "Treatment",
      "description": "糖尿病与产前联合门诊",
      "attributes": {
        "type": "care coordination",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin-treated diabetes",
      "type": "Disease",
      "description": "糖尿病需要胰岛素治疗",
      "attributes": {
        "icd_code": "E10.9",
        "confidence": "high"
      }
    },
    {
      "entity": "steroids for fetal lung maturation",
      "type": "Treatment",
      "description": "用于促进胎儿肺部成熟的类固醇治疗",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "betamimetic medicines for tocolysis",
      "type": "Treatment",
      "description": "用于抑制宫缩的β-拟交感药物",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "elective birth by induced labour",
      "type": "Treatment",
      "description": "通过引产进行的选择性分娩",
      "attributes": {
        "type": "procedure",
        "confidence": "high"
      }
    },
    {
      "entity": "macrosomic fetus",
      "type": "Complication",
      "description": "巨大儿",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "autonomic neuropathy",
      "type": "Complication",
      "description": "自主神经病变",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "monitor blood glucose",
      "type": "DiagnosticMethod",
      "description": "血糖监测",
      "attributes": {
        "normal_range": "4-7 mmol/litre",
        "confidence": "high"
      }
    },
    {
      "entity": "intravenous dextrose and insulin infusion",
      "type": "Treatment",
      "description": "静脉注射葡萄糖和胰岛素",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "polycythaemia",
      "type": "Complication",
      "description": "红细胞增多症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "hyperbilirubinaemia",
      "type": "Complication",
      "description": "高胆红素血症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "hypocalcaemia",
      "type": "Complication",
      "description": "低钙血症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "hypomagnesaemia",
      "type": "Complication",
      "description": "低镁血症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "congenital heart disease",
      "type": "Complication",
      "description": "先天性心脏病",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiomyopathy",
      "type": "Complication",
      "description": "心肌病",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal encephalopathy",
      "type": "Complication",
      "description": "新生儿脑病",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "jaundice",
      "type": "Complication",
      "description": "黄疸",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "NICE",
      "type": "Guideline",
      "description": "英国国家健康与临床优化研究所指南",
      "attributes": {
        "organization": "NICE",
        "confidence": "high"
      }
    },
    {
      "entity": "hyperglycaemia",
      "type": "Symptom",
      "description": "An excess of glucose in the bloodstream, often associated with diabetes.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fasting plasma glucose test",
      "type": "DiagnosticMethod",
      "description": "A test that measures blood glucose levels after a period of fasting.",
      "attributes": {
        "normal_range": "Below 6.0 mmol/litre",
        "confidence": "high"
      }
    },
    {
      "entity": "HbA1c test",
      "type": "DiagnosticMethod",
      "description": "A blood test that measures average blood glucose levels over the past 2-3 months.",
      "attributes": {
        "normal_range": "Below 39 mmol/mol (5.7%)",
        "confidence": "high"
      }
    },
    {
      "entity": "lifestyle advice",
      "type": "Treatment",
      "description": "Recommendations for weight control, diet, and exercise to manage or prevent diabetes.",
      "attributes": {
        "type": "non-pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin pump therapy",
      "type": "Treatment",
      "description": "A device that delivers continuous subcutaneous insulin infusion to manage blood glucose levels.",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "real-time continuous glucose monitoring",
      "type": "Treatment",
      "description": "A technology that provides continuous readings of glucose levels to help manage diabetes.",
      "attributes": {
        "type": "technological",
        "confidence": "high"
      }
    },
    {
      "entity": "congenital malformations",
      "type": "Complication",
      "description": "Physical defects present at birth, which can occur in babies born to women with diabetes.",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "When should testing for gestational diabetes take place – in the first or second trimester?",
      "type": "Question",
      "description": "A research question regarding the optimal timing for gestational diabetes testing.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "maternal hyperglycaemia",
      "type": "MedicalConcept",
      "description": "母体高血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fetal hyperinsulinaemia",
      "type": "Complication",
      "description": "胎儿高胰岛素血症",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "intrauterine death",
      "type": "Complication",
      "description": "宫内死亡",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "maternal age",
      "type": "RiskFactor",
      "description": "高龄产妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "continuous glucose monitoring",
      "type": "DiagnosticMethod",
      "description": "持续血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "diet and exercise",
      "type": "Treatment",
      "description": "饮食和运动疗法",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "NICE NG3",
      "type": "Guideline",
      "description": "NICE妊娠期糖尿病管理指南",
      "attributes": {
        "organization": "NICE",
        "confidence": "high"
      }
    },
    {
      "entity": "How can fetuses at risk of intrauterine death be identified in women with diabetes?",
      "type": "Question",
      "description": "如何识别糖尿病孕妇中宫内死亡高风险胎儿",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Are there effective long-term pharmacological interventions to prevent the onset of type 2 diabetes that can be recommended postnatally for women who have been diagnosed with gestational diabetes?",
      "type": "Question",
      "description": "是否有有效的长期药物干预措施可推荐给妊娠期糖尿病产后妇女以预防2型糖尿病发生",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "continuous glucose monitoring (CGM)",
      "type": "DiagnosticMethod",
      "description": "持续血糖监测技术",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "older women",
      "type": "RiskFactor",
      "description": "高龄产妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "preterm labour",
      "type": "Complication",
      "description": "早产",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "stillbirth",
      "type": "Complication",
      "description": "死产",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "NHS Diabetes Prevention Programme",
      "type": "Treatment",
      "description": "NHS糖尿病预防计划",
      "attributes": {
        "type": "program",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病会增加胎儿畸形风险吗？",
      "type": "Question",
      "description": "关于疾病对胎儿发育影响的常见疑问",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Gestational diabetes mellitus",
      "type": "Disease",
      "description": "A condition in which carbohydrate intolerance develops during pregnancy.",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "preeclampsia",
      "type": "Disease",
      "description": "A pregnancy complication characterized by high blood pressure and signs of damage to another organ system.",
      "attributes": {
        "icd_code": "O14",
        "confidence": "high"
      }
    },
    {
      "entity": "increased age",
      "type": "RiskFactor",
      "description": "Advanced maternal age is a risk factor for gestational diabetes.",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "fasting blood glucose",
      "type": "DiagnosticMethod",
      "description": "A test to measure blood sugar levels after fasting.",
      "attributes": {
        "normal_range": "70-99 mg/dL",
        "confidence": "high"
      }
    },
    {
      "entity": "hemoglobin A1C",
      "type": "DiagnosticMethod",
      "description": "A blood test that measures average blood glucose levels over the past 2-3 months.",
      "attributes": {
        "normal_range": "<5.7%",
        "confidence": "high"
      }
    },
    {
      "entity": "diet-controlled GDM",
      "type": "Treatment",
      "description": "Management of gestational diabetes through dietary modifications.",
      "attributes": {
        "type": "non-pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "cesarean delivery",
      "type": "Complication",
      "description": "Surgical delivery of a baby through incisions in the mother's abdomen and uterus.",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "ADA guidelines",
      "type": "Guideline",
      "description": "Recommendations for the diagnosis and management of diabetes by the American Diabetes Association.",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "ACOG recommendations",
      "type": "Guideline",
      "description": "Clinical management guidelines for obstetrician-gynecologists by the American College of Obstetricians and Gynecologists.",
      "attributes": {
        "organization": "American College of Obstetricians and Gynecologists",
        "confidence": "high"
      }
    },
    {
      "entity": "carbohydrate intolerance",
      "type": "MedicalConcept",
      "description": "Impaired ability to metabolize carbohydrates, leading to elevated blood glucose levels.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycemic control",
      "type": "MedicalConcept",
      "description": "The maintenance of blood glucose levels within a target range.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What is the best test for early GDM or type 2 diabetes screening?",
      "type": "Question",
      "description": "A common question regarding the optimal diagnostic method for early detection of gestational or type 2 diabetes.",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "How is gestational diabetes mellitus diagnosed?",
      "type": "Question",
      "description": "关于GDM诊断标准的临床疑问",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What are the benefits of treating gestational diabetes mellitus?",
      "type": "Question",
      "description": "关于GDM治疗获益的临床疑问",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "blood glucose monitoring",
      "type": "DiagnosticMethod",
      "description": "血糖监测",
      "attributes": {
        "normal_range": "fasting <95 mg/dL, postprandial <140 mg/dL (1h) or <120 mg/dL (2h)",
        "confidence": "high"
      }
    },
    {
      "entity": "nutrition therapy",
      "type": "Treatment",
      "description": "营养治疗",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "large-for-gestational-age neonates",
      "type": "Complication",
      "description": "大于胎龄儿",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal fat mass",
      "type": "Complication",
      "description": "新生儿脂肪量增加",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum weight goals",
      "type": "MedicalConcept",
      "description": "产后体重目标",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "medical nutrition therapy",
      "type": "Treatment",
      "description": "医学营养治疗",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "ketosis",
      "type": "Complication",
      "description": "酮症",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "postprandial hyperglycemia",
      "type": "Symptom",
      "description": "餐后高血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "low-glycemic index nutrition plan",
      "type": "Food",
      "description": "低血糖指数饮食",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "high-fiber diet",
      "type": "Food",
      "description": "高纤维饮食",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "complex carbohydrates",
      "type": "Food",
      "description": "复合碳水化合物",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "simple carbohydrates",
      "type": "Food",
      "description": "简单碳水化合物",
      "attributes": {
        "glycemic_index": "high",
        "confidence": "high"
      }
    },
    {
      "entity": "exercise interventions",
      "type": "Treatment",
      "description": "运动干预",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "ADA",
      "type": "Guideline",
      "description": "美国糖尿病协会指南",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "ACOG",
      "type": "Guideline",
      "description": "美国妇产科医师学会推荐",
      "attributes": {
        "organization": "American College of Obstetricians and Gynecologists",
        "confidence": "high"
      }
    },
    {
      "entity": "How should blood glucose be monitored in a woman with gestational diabetes mellitus?",
      "type": "Question",
      "description": "妊娠期糖尿病女性应如何进行血糖监测？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary modifications",
      "type": "Treatment",
      "description": "饮食调整",
      "attributes": {
        "type": "nonpharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "glucose monitoring",
      "type": "DiagnosticMethod",
      "description": "血糖监测",
      "attributes": {
        "normal_range": "fasting <95 mg/dL, 1-hour <140 mg/dL, 2-hour <120 mg/dL",
        "confidence": "high"
      }
    },
    {
      "entity": "NPH insulin",
      "type": "Treatment",
      "description": "中效胰岛素",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin glargine",
      "type": "Treatment",
      "description": "长效胰岛素类似物",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin detemir",
      "type": "Treatment",
      "description": "长效胰岛素类似物",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin lispro",
      "type": "Treatment",
      "description": "速效胰岛素类似物",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin aspart",
      "type": "Treatment",
      "description": "速效胰岛素类似物",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "glyburide",
      "type": "Treatment",
      "description": "口服降糖药",
      "attributes": {
        "type": "pharmacologic",
        "confidence": "high"
      }
    },
    {
      "entity": "preeclampsia",
      "type": "Complication",
      "description": "子痫前期",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "hyperbilirubinemia",
      "type": "Complication",
      "description": "高胆红素血症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "What nonpharmacologic treatments are effective in managing gestational diabetes mellitus?",
      "type": "Question",
      "description": "非药物治疗妊娠期糖尿病的有效方法",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What pharmacologic treatments are effective in managing gestational diabetes mellitus?",
      "type": "Question",
      "description": "药物治疗妊娠期糖尿病的有效方法",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "GDM",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "type II diabetes mellitus",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "respiratory distress",
      "type": "Complication",
      "description": "呼吸窘迫",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "gestational hypertension",
      "type": "Complication",
      "description": "妊娠期高血压",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "What are delivery considerations in pregnancies complicated by gestational diabetes mellitus?",
      "type": "Question",
      "description": "妊娠期糖尿病孕妇的分娩考虑",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "格列本脲",
      "type": "Treatment",
      "description": "口服降糖药物",
      "attributes": {
        "type": "药物疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "糖代谢异常",
      "type": "MedicalConcept",
      "description": "碳水化合物代谢的病理状态",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Is fetal assessment indicated in pregnancies complicated by gestational diabetes mellitus?",
      "type": "Question",
      "description": "妊娠期糖尿病是否需要进行胎儿评估",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "How should women with a history of gestational diabetes mellitus be screened and counseled postpartum?",
      "type": "Question",
      "description": "有妊娠期糖尿病病史的妇女产后应如何筛查和咨询",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "nutrition and exercise counseling",
      "type": "Treatment",
      "description": "营养和运动咨询",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "IGT",
      "type": "MedicalConcept",
      "description": "糖耐量受损",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "estimated fetal weight",
      "type": "MedicalConcept",
      "description": "估计胎儿体重",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "abnormal glucose metabolism",
      "type": "MedicalConcept",
      "description": "糖代谢异常",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "pre-pregnancy glucose control",
      "type": "MedicalConcept",
      "description": "孕前血糖控制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "infant death",
      "type": "Complication",
      "description": "婴儿死亡",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "Carpenter-Coustan标准",
      "type": "DiagnosticMethod",
      "description": "用于诊断妊娠期糖尿病的特定血糖阈值标准",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "低升糖指数饮食",
      "type": "Treatment",
      "description": "选择升糖指数≤55的食物控制血糖",
      "attributes": {
        "type": "饮食干预",
        "confidence": "high"
      }
    },
    {
      "entity": "higher-complex carbohydrate/low-fat diet",
      "type": "Treatment",
      "description": "高复合碳水化合物/低脂饮食",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiovascular conditioning",
      "type": "Treatment",
      "description": "心血管调节",
      "attributes": {
        "type": "运动疗法",
        "confidence": "medium"
      }
    },
    {
      "entity": "therapeutic exercise",
      "type": "Treatment",
      "description": "治疗性运动",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "home-based exercise training",
      "type": "Treatment",
      "description": "家庭运动训练",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "walking intervention",
      "type": "Treatment",
      "description": "步行干预",
      "attributes": {
        "type": "运动疗法",
        "confidence": "high"
      }
    },
    {
      "entity": "glibenclamide",
      "type": "Treatment",
      "description": "格列本脲",
      "attributes": {
        "type": "口服降糖药",
        "confidence": "high"
      }
    },
    {
      "entity": "polycystic ovary syndrome",
      "type": "Disease",
      "description": "多囊卵巢综合征",
      "attributes": {
        "icd_code": "E28.2",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal adiposity",
      "type": "Complication",
      "description": "新生儿肥胖",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "hypoglycemia",
      "type": "Symptom",
      "description": "低血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "capillary glucose profile",
      "type": "DiagnosticMethod",
      "description": "毛细血管血糖谱",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "AHRQ",
      "type": "Guideline",
      "description": "美国医疗保健研究与质量局指南",
      "attributes": {
        "organization": "Agency for Healthcare Research and Quality",
        "confidence": "high"
      }
    },
    {
      "entity": "ACOG指南",
      "type": "Guideline",
      "description": "美国妇产科医师学会发布的临床实践指南",
      "attributes": {
        "organization": "American College of Obstetricians and Gynecologists",
        "confidence": "high"
      }
    },
    {
      "entity": "第五次国际妊娠期糖尿病研讨会",
      "type": "Guideline",
      "description": "妊娠期糖尿病诊断和管理国际共识",
      "attributes": {
        "organization": "International Workshop-Conference on GDM",
        "confidence": "medium"
      }
    },
    {
      "entity": "选择性剖宫产",
      "type": "Treatment",
      "description": "为预防并发症实施的计划性剖宫产",
      "attributes": {
        "type": "手术干预",
        "confidence": "medium"
      }
    },
    {
      "entity": "产后血糖监测",
      "type": "DiagnosticMethod",
      "description": "产后6-12周进行糖代谢评估",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "National Institutes of Health",
      "type": "Guideline",
      "description": "美国国立卫生研究院发布的指南",
      "attributes": {
        "organization": "National Institutes of Health",
        "confidence": "high"
      }
    },
    {
      "entity": "U.S. Preventive Services Task Force",
      "type": "Guideline",
      "description": "美国预防服务工作组发布的方法学指南",
      "attributes": {
        "organization": "U.S. Preventive Services Task Force",
        "confidence": "high"
      }
    },
    {
      "entity": "randomized controlled trial",
      "type": "MedicalConcept",
      "description": "随机对照试验，用于评估医学干预效果的金标准",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "cohort study",
      "type": "MedicalConcept",
      "description": "队列研究，用于观察暴露因素与结局的关系",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "case-control study",
      "type": "MedicalConcept",
      "description": "病例对照研究，用于比较病例组与对照组的暴露差异",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Level A recommendation",
      "type": "MedicalConcept",
      "description": "基于良好且一致科学证据的推荐等级",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Level B recommendation",
      "type": "MedicalConcept",
      "description": "基于有限或不一致科学证据的推荐等级",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Level C recommendation",
      "type": "MedicalConcept",
      "description": "基于共识和专家意见的推荐等级",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary inflammatory index",
      "type": "MedicalConcept",
      "description": "饮食炎症指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary Approaches to Stop Hypertension",
      "type": "MedicalConcept",
      "description": "停止高血压的饮食方法",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Healthy Eating Index-2015",
      "type": "MedicalConcept",
      "description": "健康饮食指数-2015",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Alternative Healthy Eating Index-2010",
      "type": "MedicalConcept",
      "description": "替代健康饮食指数-2010",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fruits and vegetables",
      "type": "Food",
      "description": "水果和蔬菜",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "low-fat dairy products",
      "type": "Food",
      "description": "低脂乳制品",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "whole grains",
      "type": "Food",
      "description": "全谷物",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "legumes",
      "type": "Food",
      "description": "豆类",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "Which dietary pattern should be adopt by age-appropriate pregnant women to avoid gestational weight gain and gestational diabetes mellitus",
      "type": "Question",
      "description": "适合年龄的孕妇应采用哪种饮食模式以避免妊娠期体重增加和妊娠期糖尿病",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Gestational diabetes",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "self-care interventions",
      "type": "Treatment",
      "description": "自我护理干预",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "glycated haemoglobin",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白",
      "attributes": {
        "normal_range": "4-6%",
        "confidence": "high"
      }
    },
    {
      "entity": "oral glucose tolerance test",
      "type": "DiagnosticMethod",
      "description": "口服葡萄糖耐量试验",
      "attributes": {
        "normal_range": "2小时血糖 <7.8 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "body weight",
      "type": "RiskFactor",
      "description": "体重",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "diet and physical activity",
      "type": "Treatment",
      "description": "饮食和运动疗法",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "GRADE approach",
      "type": "Guideline",
      "description": "证据评价方法",
      "attributes": {
        "organization": "GRADE工作组",
        "confidence": "high"
      }
    },
    {
      "entity": "excessive weight gain",
      "type": "RiskFactor",
      "description": "孕期体重增加过多",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "long-term obesity",
      "type": "Complication",
      "description": "长期肥胖",
      "attributes": {
        "target": "mother/child",
        "confidence": "medium"
      }
    },
    {
      "entity": "healthy weight",
      "type": "MedicalConcept",
      "description": "健康体重",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "nutrient intakes",
      "type": "MedicalConcept",
      "description": "营养素摄入",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "dietary choices",
      "type": "MedicalConcept",
      "description": "饮食选择",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "plant-based diets",
      "type": "Food",
      "description": "植物性饮食",
      "attributes": {
        "glycemic_index": "variable",
        "confidence": "medium"
      }
    },
    {
      "entity": "vitamin B12",
      "type": "Food",
      "description": "维生素B12",
      "attributes": {
        "glycemic_index": "N/A",
        "confidence": "high"
      }
    },
    {
      "entity": "British Nutrition Foundation",
      "type": "Guideline",
      "description": "英国营养基金会",
      "attributes": {
        "organization": "British Nutrition Foundation",
        "confidence": "high"
      }
    },
    {
      "entity": "Ultra-processed foods",
      "type": "Food",
      "description": "高度精制的非营养化合物配方，含有高糖、高脂肪、高钠、食品添加剂和膳食乳化剂",
      "attributes": {
        "glycemic_index": "high",
        "confidence": "high"
      }
    },
    {
      "entity": "hypertensive disorders",
      "type": "Disease",
      "description": "高血压疾病",
      "attributes": {
        "icd_code": "O13-O16",
        "confidence": "high"
      }
    },
    {
      "entity": "obesity",
      "type": "Disease",
      "description": "肥胖",
      "attributes": {
        "icd_code": "E66",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiovascular disease",
      "type": "Disease",
      "description": "心血管疾病",
      "attributes": {
        "icd_code": "I00-I99",
        "confidence": "high"
      }
    },
    {
      "entity": "mental disorders",
      "type": "Disease",
      "description": "精神障碍",
      "attributes": {
        "icd_code": "F00-F99",
        "confidence": "high"
      }
    },
    {
      "entity": "Poor maternal nutrition",
      "type": "RiskFactor",
      "description": "孕妇营养不良",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "high UPF consumption",
      "type": "RiskFactor",
      "description": "高加工食品摄入",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "micronutrient deficiencies",
      "type": "RiskFactor",
      "description": "微量营养素缺乏",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "adverse birth weights",
      "type": "Complication",
      "description": "不良出生体重",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "cognitive deficits",
      "type": "Complication",
      "description": "认知缺陷",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "mental health disorders",
      "type": "Complication",
      "description": "心理健康障碍",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "developmental impairments",
      "type": "Complication",
      "description": "发育障碍",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "cognitive function",
      "type": "MedicalConcept",
      "description": "认知功能",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "neurodevelopment",
      "type": "MedicalConcept",
      "description": "神经发育",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "metabolic health",
      "type": "MedicalConcept",
      "description": "代谢健康",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary interventions",
      "type": "Treatment",
      "description": "饮食干预",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "public health strategies",
      "type": "Treatment",
      "description": "公共卫生策略",
      "attributes": {
        "type": "preventive",
        "confidence": "high"
      }
    },
    {
      "entity": "patient education",
      "type": "Treatment",
      "description": "患者教育干预",
      "attributes": {
        "type": "behavioral",
        "confidence": "high"
      }
    },
    {
      "entity": "glucose control",
      "type": "MedicalConcept",
      "description": "血糖控制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "meta-analysis",
      "type": "MedicalConcept",
      "description": "荟萃分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "randomized controlled trials",
      "type": "MedicalConcept",
      "description": "随机对照试验",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Cochrane risk of bias tool",
      "type": "MedicalConcept",
      "description": "Cochrane偏倚风险评估工具",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "postpartum",
      "type": "MedicalConcept",
      "description": "产后阶段",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "胎儿肺动脉多普勒",
      "type": "DiagnosticMethod",
      "description": "通过超声评估胎儿肺动脉血流动力学",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "APGAR评分",
      "type": "DiagnosticMethod",
      "description": "新生儿出生后1/5分钟的生命体征评估",
      "attributes": {
        "normal_range": "7-10分",
        "confidence": "medium"
      }
    },
    {
      "entity": "血气血参数",
      "type": "DiagnosticMethod",
      "description": "通过血气分析评估酸碱平衡和氧合状态",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Gestational Diabetes Mellitus (GDM)",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "metabolic dysfunction-associated steatotic liver disease (MASLD)",
      "type": "Disease",
      "description": "代谢功能障碍相关脂肪性肝病",
      "attributes": {
        "icd_code": "K76.0",
        "confidence": "high"
      }
    },
    {
      "entity": "hepatic mitochondrial function",
      "type": "MedicalConcept",
      "description": "肝脏线粒体功能",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "high-fat, high-sucrose (HFHS) diet",
      "type": "RiskFactor",
      "description": "高脂高糖饮食",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "liver triglycerides",
      "type": "DiagnosticMethod",
      "description": "肝脏甘油三酯水平",
      "attributes": {
        "normal_range": "通常低于150 mg/dL",
        "confidence": "medium"
      }
    },
    {
      "entity": "NAFLD Activity Score (NAS)",
      "type": "DiagnosticMethod",
      "description": "非酒精性脂肪肝活动评分",
      "attributes": {
        "normal_range": "通常0-8分",
        "confidence": "high"
      }
    },
    {
      "entity": "mitochondrial biogenesis",
      "type": "MedicalConcept",
      "description": "线粒体生物发生",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "autophagy",
      "type": "MedicalConcept",
      "description": "自噬",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "mitophagy",
      "type": "MedicalConcept",
      "description": "线粒体自噬",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "inflammation",
      "type": "MedicalConcept",
      "description": "炎症",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "antioxidant defense",
      "type": "MedicalConcept",
      "description": "抗氧化防御",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "MASLD development",
      "type": "Complication",
      "description": "代谢功能障碍相关脂肪性肝病发展",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "hepatic mitochondrial activity",
      "type": "MedicalConcept",
      "description": "肝脏线粒体活性",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "青年发病2型糖尿病",
      "type": "Disease",
      "description": "青少年时期发病的2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "糖代谢紊乱",
      "type": "MedicalConcept",
      "description": "血糖调节机制异常导致的代谢失调",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "口服糖耐量异常",
      "type": "Symptom",
      "description": "OGTT试验中血糖反应异常",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "高热量饮食",
      "type": "RiskFactor",
      "description": "能量摄入超过需求的饮食模式",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "Western饮食",
      "type": "RiskFactor",
      "description": "高脂高糖的典型西方化饮食",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "血清雌二醇检测",
      "type": "DiagnosticMethod",
      "description": "通过ELISA法测定雌激素水平",
      "attributes": {
        "normal_range": "随月经周期变化",
        "confidence": "high"
      }
    },
    {
      "entity": "qPCR",
      "type": "DiagnosticMethod",
      "description": "定量检测基因表达水平",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Western blot",
      "type": "DiagnosticMethod",
      "description": "蛋白质表达水平检测技术",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "雌激素信号通路抑制",
      "type": "Complication",
      "description": "ERα表达下降导致的信号传导障碍",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "卵巢成熟障碍",
      "type": "Complication",
      "description": "次级卵泡减少和闭锁卵泡增加",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "CYP19A1下调",
      "type": "MedicalConcept",
      "description": "芳香化酶表达减少影响雌激素合成",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "p-IRS-1",
      "type": "MedicalConcept",
      "description": "胰岛素受体底物1磷酸化水平",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "p-Akt",
      "type": "MedicalConcept",
      "description": "胰岛素信号通路关键蛋白磷酸化状态",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "BHPI",
      "type": "Treatment",
      "description": "雌激素受体拮抗剂",
      "attributes": {
        "type": "药物干预",
        "confidence": "high"
      }
    },
    {
      "entity": "Maturity-onset diabetes of the young (MODY)",
      "type": "Disease",
      "description": "一种单基因型糖尿病，占所有糖尿病病例的1-2%",
      "attributes": {
        "icd_code": "E11.8",
        "confidence": "high"
      }
    },
    {
      "entity": "GCK-MODY",
      "type": "Disease",
      "description": "MODY的第二常见亚型，与GCK基因突变相关",
      "attributes": {
        "icd_code": "E11.8",
        "confidence": "high"
      }
    },
    {
      "entity": "fetal macrosomia",
      "type": "Complication",
      "description": "胎儿体重异常增加（>4000g）",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "diet management",
      "type": "Treatment",
      "description": "通过饮食调整控制血糖",
      "attributes": {
        "type": "lifestyle",
        "confidence": "high"
      }
    },
    {
      "entity": "fetal genotyping",
      "type": "DiagnosticMethod",
      "description": "通过基因检测确定胎儿MODY状态",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fetal birthweight (FBW)",
      "type": "DiagnosticMethod",
      "description": "新生儿出生体重评估",
      "attributes": {
        "normal_range": "2500-4000g",
        "confidence": "medium"
      }
    },
    {
      "entity": "gestational age at delivery",
      "type": "MedicalConcept",
      "description": "分娩时的孕周",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "maternal glycemia",
      "type": "MedicalConcept",
      "description": "妊娠期母体血糖水平",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "PRISMA guidelines",
      "type": "Guideline",
      "description": "系统评价和荟萃分析的报告规范",
      "attributes": {
        "organization": "PRISMA Group",
        "confidence": "high"
      }
    },
    {
      "entity": "GCK gene mutation",
      "type": "RiskFactor",
      "description": "导致GCK-MODY的遗传因素",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "iatrogenic prematurity",
      "type": "Complication",
      "description": "医源性早产",
      "attributes": {
        "target": "fetus",
        "confidence": "medium"
      }
    },
    {
      "entity": "Per- and polyfluoroalkyl substances (PFAS)",
      "type": "MedicalConcept",
      "description": "A group of man-made chemicals used in various industrial and consumer products, studied for their potential health effects."
    },
    {
      "entity": "Birth outcomes",
      "type": "MedicalConcept",
      "description": "Health indicators of newborns, including birth weight, gestational age, and congenital anomalies."
    },
    {
      "entity": "Cohort study",
      "type": "MedicalConcept",
      "description": "A type of observational study that follows a group of people over time to examine health outcomes."
    },
    {
      "entity": "Paternal exposure",
      "type": "MedicalConcept",
      "description": "Exposure of the father to certain substances or environmental factors before conception or during pregnancy."
    },
    {
      "entity": "Maternal exposure",
      "type": "MedicalConcept",
      "description": "Exposure of the mother to certain substances or environmental factors during pregnancy."
    },
    {
      "entity": "preexisting diabetes mellitus",
      "type": "Disease",
      "description": "妊娠前已存在的糖尿病",
      "attributes": {
        "icd_code": "O24.0",
        "confidence": "high"
      }
    },
    {
      "entity": "type 2 diabetes mellitus",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11.9",
        "confidence": "high"
      }
    },
    {
      "entity": "type 1 diabetes mellitus",
      "type": "Disease",
      "description": "1型糖尿病",
      "attributes": {
        "icd_code": "E10.9",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal complications",
      "type": "Complication",
      "description": "新生儿并发症（新生儿）",
      "attributes": {
        "target": "newborn",
        "confidence": "medium"
      }
    },
    {
      "entity": "hybrid closed-loop insulin pump",
      "type": "Treatment",
      "description": "混合闭环胰岛素泵治疗",
      "attributes": {
        "type": "device",
        "confidence": "high"
      }
    },
    {
      "entity": "glucagon-like peptide-1 receptor agonists",
      "type": "Treatment",
      "description": "GLP-1受体激动剂治疗",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "time in range",
      "type": "MedicalConcept",
      "description": "血糖在目标范围内的时间",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "time above range",
      "type": "MedicalConcept",
      "description": "血糖高于目标范围的时间",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "time below range",
      "type": "MedicalConcept",
      "description": "血糖低于目标范围的时间",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "carbohydrate restrictive diet",
      "type": "Treatment",
      "description": "碳水化合物限制饮食",
      "attributes": {
        "type": "dietary",
        "confidence": "medium"
      }
    },
    {
      "entity": "Endocrine Society guidelines",
      "type": "Guideline",
      "description": "内分泌学会指南",
      "attributes": {
        "organization": "Endocrine Society",
        "confidence": "high"
      }
    },
    {
      "entity": "Preexisting diabetes",
      "type": "Disease",
      "description": "糖尿病在怀孕前已经存在",
      "attributes": {
        "icd_code": "O24.0",
        "confidence": "high"
      }
    },
    {
      "entity": "maternal hyperglycemia",
      "type": "MedicalConcept",
      "description": "孕妇高血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycated hemoglobin",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白",
      "attributes": {
        "normal_range": "<6.5%",
        "confidence": "high"
      }
    },
    {
      "entity": "glucagon-like peptide-1 receptor agonist",
      "type": "Treatment",
      "description": "GLP-1受体激动剂",
      "attributes": {
        "type": "medication",
        "confidence": "high"
      }
    },
    {
      "entity": "carbohydrate-restricted diet",
      "type": "Treatment",
      "description": "限制碳水化合物饮食",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "continuous glucose monitor",
      "type": "DiagnosticMethod",
      "description": "连续血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "self-monitoring of blood glucose",
      "type": "DiagnosticMethod",
      "description": "自我血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline",
      "type": "Guideline",
      "description": "内分泌学会和欧洲内分泌学会联合临床实践指南",
      "attributes": {
        "organization": "Endocrine Society and European Society of Endocrinology",
        "confidence": "high"
      }
    },
    {
      "entity": "glucometrics",
      "type": "MedicalConcept",
      "description": "血糖指标",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "CGM",
      "type": "DiagnosticMethod",
      "description": "连续血糖监测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "T2DM",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "T1DM",
      "type": "Disease",
      "description": "1型糖尿病",
      "attributes": {
        "icd_code": "E10",
        "confidence": "high"
      }
    },
    {
      "entity": "PDM",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24",
        "confidence": "high"
      }
    },
    {
      "entity": "postprandial glucose",
      "type": "DiagnosticMethod",
      "description": "餐后血糖",
      "attributes": {
        "normal_range": "1-hour <140 mg/dL (7.8 mmol/L), 2-hour <120 mg/dL (6.7 mmol/L)",
        "confidence": "high"
      }
    },
    {
      "entity": "hybrid closed-loop pump",
      "type": "Treatment",
      "description": "混合闭环胰岛素泵",
      "attributes": {
        "type": "胰岛素治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "insulin pump",
      "type": "Treatment",
      "description": "胰岛素泵",
      "attributes": {
        "type": "胰岛素治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "multiple daily insulin injections",
      "type": "Treatment",
      "description": "每日多次胰岛素注射",
      "attributes": {
        "type": "胰岛素治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "early delivery",
      "type": "Treatment",
      "description": "提前分娩",
      "attributes": {
        "type": "产科干预",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum endocrine care",
      "type": "Treatment",
      "description": "产后内分泌管理",
      "attributes": {
        "type": "糖尿病管理",
        "confidence": "high"
      }
    },
    {
      "entity": "PCC",
      "type": "MedicalConcept",
      "description": "孕前保健",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "obesity management",
      "type": "Treatment",
      "description": "肥胖管理",
      "attributes": {
        "type": "生活方式干预",
        "confidence": "medium"
      }
    },
    {
      "entity": "European Journal of Endocrinology",
      "type": "Guideline",
      "description": "欧洲内分泌学杂志",
      "attributes": {
        "organization": "European Society of Endocrinology",
        "confidence": "high"
      }
    },
    {
      "entity": "The Journal of Clinical Endocrinology & Metabolism",
      "type": "Guideline",
      "description": "临床内分泌与代谢杂志",
      "attributes": {
        "organization": "The Endocrine Society",
        "confidence": "high"
      }
    },
    {
      "entity": "preconception care",
      "type": "MedicalConcept",
      "description": "孕前护理",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "contraception",
      "type": "Treatment",
      "description": "避孕",
      "attributes": {
        "type": "preventive",
        "confidence": "high"
      }
    },
    {
      "entity": "optimal nutrition",
      "type": "MedicalConcept",
      "description": "孕期最佳营养管理",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "obesity management",
      "type": "MedicalConcept",
      "description": "肥胖管理",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "small-for-gestational-age birth",
      "type": "Complication",
      "description": "小于胎龄儿",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "high fat, sugar, and sodium diet",
      "type": "RiskFactor",
      "description": "高脂肪、高糖、高钠饮食",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "BMI",
      "type": "RiskFactor",
      "description": "体重指数",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "lower socioeconomic status",
      "type": "RiskFactor",
      "description": "较低社会经济地位",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "non-Hispanic Black race/ethnicity",
      "type": "RiskFactor",
      "description": "非西班牙裔黑人种族/民族",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "food frequency questionnaire",
      "type": "DiagnosticMethod",
      "description": "食物频率问卷",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "precision nutrition",
      "type": "MedicalConcept",
      "description": "精准营养",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary patterns",
      "type": "MedicalConcept",
      "description": "饮食模式",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "perinatal outcomes",
      "type": "MedicalConcept",
      "description": "围产期结局",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "serum uric acid-to-serum creatinine ratio",
      "type": "MedicalConcept",
      "description": "血清尿酸与血清肌酐比值",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "thyroid function",
      "type": "MedicalConcept",
      "description": "甲状腺功能",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "free thyroxine (FT4)",
      "type": "DiagnosticMethod",
      "description": "游离甲状腺素",
      "attributes": {
        "normal_range": "0.93-1.7 ng/dL",
        "confidence": "high"
      }
    },
    {
      "entity": "prepregnancy BMI",
      "type": "RiskFactor",
      "description": "孕前体重指数",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "euthyroid function",
      "type": "MedicalConcept",
      "description": "甲状腺功能正常状态",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "TSH",
      "type": "DiagnosticMethod",
      "description": "促甲状腺激素",
      "attributes": {
        "normal_range": "0.4-4.0 mIU/L",
        "confidence": "high"
      }
    },
    {
      "entity": "metabolic changes",
      "type": "MedicalConcept",
      "description": "代谢变化",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "early prevention and management of GDM",
      "type": "Treatment",
      "description": "妊娠期糖尿病的早期预防和管理",
      "attributes": {
        "type": "综合管理",
        "confidence": "high"
      }
    },
    {
      "entity": "Depressive disorders",
      "type": "MedicalConcept",
      "description": "Mental health conditions characterized by persistent sadness and loss of interest."
    },
    {
      "entity": "Diabetes management behaviors",
      "type": "MedicalConcept",
      "description": "Actions taken by individuals with diabetes to control their condition, such as monitoring blood sugar and foot care."
    },
    {
      "entity": "Bad mental health days",
      "type": "MedicalConcept",
      "description": "Days where an individual experiences poor mental health, affecting daily functioning."
    },
    {
      "entity": "Behavioral Risk Factor Surveillance System",
      "type": "MedicalConcept",
      "description": "A system collecting data on health-related risk behaviors and conditions in the U.S. population."
    },
    {
      "entity": "American Indian/Alaska Native adults",
      "type": "MedicalConcept",
      "description": "A demographic group studied for health disparities, particularly in mental health and chronic conditions."
    },
    {
      "entity": "Gestational Diabetes",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "preterm labor",
      "type": "Complication",
      "description": "早产",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "small for gestational age infants",
      "type": "Complication",
      "description": "小于胎龄儿",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "Body Mass Index",
      "type": "MedicalConcept",
      "description": "体重指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "older age",
      "type": "RiskFactor",
      "description": "高龄产妇",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "higher pre-pregnancy BMI",
      "type": "RiskFactor",
      "description": "孕前高体重指数",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "Declaration of Helsinki",
      "type": "Guideline",
      "description": "赫尔辛基宣言",
      "attributes": {
        "organization": "World Medical Association",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病是否需要终身治疗？",
      "type": "Question",
      "description": "关于产后血糖管理的常见疑问",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "hyperglycemia",
      "type": "MedicalConcept",
      "description": "高血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "hippocampal volume reduction",
      "type": "Complication",
      "description": "海马体积减少",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "dark neurons",
      "type": "Complication",
      "description": "暗神经元",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "PI3K/mTOR signaling pathway",
      "type": "MedicalConcept",
      "description": "PI3K/mTOR信号通路",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "CNS impairments",
      "type": "Complication",
      "description": "中枢神经系统损伤",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "streptozotocin",
      "type": "MedicalConcept",
      "description": "链脲佐菌素",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Beclin-1",
      "type": "MedicalConcept",
      "description": "自噬相关基因",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "LC-3",
      "type": "MedicalConcept",
      "description": "自噬相关基因",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "ATG-7",
      "type": "MedicalConcept",
      "description": "自噬相关基因",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "real-time PCR",
      "type": "DiagnosticMethod",
      "description": "实时聚合酶链反应",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "hematoxylin and eosin staining",
      "type": "DiagnosticMethod",
      "description": "苏木精和伊红染色",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "toluidine blue staining",
      "type": "DiagnosticMethod",
      "description": "甲苯胺蓝染色",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glucose toxicity",
      "type": "MedicalConcept",
      "description": "高血糖引起的代谢失调和多器官损伤",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "gestational diabetes mellitus (GDM)",
      "type": "Disease",
      "description": "妊娠期糖尿病",
      "attributes": {
        "icd_code": "O24.4",
        "confidence": "high"
      }
    },
    {
      "entity": "fetal lung dysplasia",
      "type": "Complication",
      "description": "胎儿肺发育不良",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "oxidative stress",
      "type": "MedicalConcept",
      "description": "氧化应激",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "inflammatory cascades",
      "type": "MedicalConcept",
      "description": "炎症级联反应",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycolysis",
      "type": "MedicalConcept",
      "description": "糖酵解",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "mitochondrial dysfunction",
      "type": "MedicalConcept",
      "description": "线粒体功能障碍",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "respiratory infections",
      "type": "Complication",
      "description": "呼吸道感染",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "acute respiratory distress syndrome (ARDS)",
      "type": "Complication",
      "description": "急性呼吸窘迫综合征",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "metabolic dysregulation",
      "type": "MedicalConcept",
      "description": "代谢失调",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "gut-lung axis modulation",
      "type": "Treatment",
      "description": "肠-肺轴调节",
      "attributes": {
        "type": "therapeutic strategy",
        "confidence": "medium"
      }
    },
    {
      "entity": "personalized approaches",
      "type": "Treatment",
      "description": "个性化治疗方法",
      "attributes": {
        "type": "therapeutic strategy",
        "confidence": "medium"
      }
    },
    {
      "entity": "immune dysregulation",
      "type": "MedicalConcept",
      "description": "免疫失调",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "genetic modifiers",
      "type": "RiskFactor",
      "description": "遗传修饰因子",
      "attributes": {
        "modifiable": false,
        "confidence": "medium"
      }
    },
    {
      "entity": "epigenetic modifiers",
      "type": "RiskFactor",
      "description": "表观遗传修饰因子",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "diabetes-associated pneumopathy",
      "type": "Disease",
      "description": "糖尿病相关肺病",
      "attributes": {
        "icd_code": "E14.8",
        "confidence": "high"
      }
    },
    {
      "entity": "Type 2 diabetes",
      "type": "Disease",
      "description": "2型糖尿病",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "T2DM risk communication",
      "type": "MedicalConcept",
      "description": "2型糖尿病风险沟通",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "group education sessions",
      "type": "Treatment",
      "description": "团体教育课程",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "digital support resources",
      "type": "Treatment",
      "description": "数字支持资源",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "individualised information",
      "type": "Treatment",
      "description": "个性化信息",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "continuous and harmonious T2DM risk communication",
      "type": "Treatment",
      "description": "持续和协调的2型糖尿病风险沟通",
      "attributes": {
        "type": "education",
        "confidence": "medium"
      }
    },
    {
      "entity": "preventative actions",
      "type": "MedicalConcept",
      "description": "预防措施",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "health behaviours",
      "type": "MedicalConcept",
      "description": "健康行为",
      "attributes": {
        "confidence": "low"
      }
    },
    {
      "entity": "semi-structured interviews",
      "type": "DiagnosticMethod",
      "description": "半结构化访谈",
      "attributes": {
        "confidence": "low"
      }
    },
    {
      "entity": "牙周炎",
      "type": "Disease",
      "description": "牙周组织的慢性炎症性疾病",
      "attributes": {
        "icd_code": "K05.3",
        "confidence": "high"
      }
    },
    {
      "entity": "系统性炎症",
      "type": "MedicalConcept",
      "description": "全身性炎症反应状态",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "临床附着水平",
      "type": "DiagnosticMethod",
      "description": "评估牙周组织破坏程度的指标",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "白细胞计数",
      "type": "DiagnosticMethod",
      "description": "血液中白细胞数量检测",
      "attributes": {
        "normal_range": "4-10×10^9/L",
        "confidence": "high"
      }
    },
    {
      "entity": "单核细胞计数",
      "type": "DiagnosticMethod",
      "description": "血液中单核细胞数量检测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "单核细胞-淋巴细胞比值",
      "type": "DiagnosticMethod",
      "description": "系统性炎症标志物",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "NHANES",
      "type": "Guideline",
      "description": "美国国家健康与营养调查",
      "attributes": {
        "organization": "美国CDC",
        "confidence": "high"
      }
    },
    {
      "entity": "Insulin resistance",
      "type": "MedicalConcept",
      "description": "生理性胰岛素抵抗增强胎儿营养供应，但过度则导致病理状态",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "triglyceride-glucose (TyG) index",
      "type": "DiagnosticMethod",
      "description": "评估胰岛素抵抗的生物标志物",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "gestational hypertension",
      "type": "Disease",
      "description": "妊娠期高血压",
      "attributes": {
        "icd_code": "O13",
        "confidence": "high"
      }
    },
    {
      "entity": "low birth weight (LBW)",
      "type": "Complication",
      "description": "低出生体重",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "small-for-gestational-age (SGA)",
      "type": "Complication",
      "description": "小于胎龄儿",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "large-for-gestational-age (LGA)",
      "type": "Complication",
      "description": "大于胎龄儿",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "body mass index",
      "type": "RiskFactor",
      "description": "体重指数",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "triglycerides",
      "type": "DiagnosticMethod",
      "description": "甘油三酯检测",
      "attributes": {
        "normal_range": "<1.7 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "causal mediation analysis",
      "type": "MedicalConcept",
      "description": "因果中介分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Respiratory distress syndrome (RDS)",
      "type": "Disease",
      "description": "一种常见于早产儿的呼吸系统疾病，表现为呼吸困难和高死亡率",
      "attributes": {
        "icd_code": "P22.0",
        "confidence": "high"
      }
    },
    {
      "entity": "hypertensive disorders during pregnancy",
      "type": "Disease",
      "description": "妊娠期间的高血压疾病",
      "attributes": {
        "icd_code": "O13-O16",
        "confidence": "high"
      }
    },
    {
      "entity": "advanced maternal age (≥ 35 years)",
      "type": "RiskFactor",
      "description": "高龄产妇（年龄≥35岁）",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "cesarean section",
      "type": "RiskFactor",
      "description": "剖宫产",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "gestational age < 32 weeks",
      "type": "RiskFactor",
      "description": "妊娠年龄小于32周",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "birth weight < 1500 g",
      "type": "RiskFactor",
      "description": "出生体重小于1500克",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "asphyxia",
      "type": "RiskFactor",
      "description": "窒息",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "pneumonia",
      "type": "Complication",
      "description": "肺炎",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "sepsis",
      "type": "Complication",
      "description": "败血症",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "hypoxic-ischemic encephalopathy (HIE)",
      "type": "Complication",
      "description": "缺氧缺血性脑病",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "bronchopulmonary dysplasia (BPD)",
      "type": "Complication",
      "description": "支气管肺发育不良",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "corticosteroid",
      "type": "Treatment",
      "description": "皮质类固醇治疗",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "mechanical ventilation",
      "type": "Treatment",
      "description": "机械通气",
      "attributes": {
        "type": "mechanical",
        "confidence": "high"
      }
    },
    {
      "entity": "nasal continuous positive airway pressure ventilation (NCPAP)",
      "type": "Treatment",
      "description": "鼻持续气道正压通气",
      "attributes": {
        "type": "mechanical",
        "confidence": "high"
      }
    },
    {
      "entity": "adiposity indices",
      "type": "MedicalConcept",
      "description": "肥胖指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "body mass index",
      "type": "MedicalConcept",
      "description": "身体质量指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "relative fat mass",
      "type": "MedicalConcept",
      "description": "相对脂肪质量",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum endocrine metabolism",
      "type": "MedicalConcept",
      "description": "产后内分泌代谢",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "prior gestational diabetes mellitus",
      "type": "RiskFactor",
      "description": "既往妊娠期糖尿病史",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "multivariate logistic regression",
      "type": "DiagnosticMethod",
      "description": "多变量逻辑回归分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "mediation analysis",
      "type": "DiagnosticMethod",
      "description": "中介分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Spearman correlation analysis",
      "type": "DiagnosticMethod",
      "description": "Spearman相关分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "dietary components",
      "type": "Food",
      "description": "饮食成分",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "National Health and Nutrition Examination Survey",
      "type": "Guideline",
      "description": "国家健康与营养调查",
      "attributes": {
        "organization": "CDC",
        "confidence": "high"
      }
    },
    {
      "entity": "高血压疾病妊娠",
      "type": "Disease",
      "description": "妊娠期间出现的高血压相关疾病",
      "attributes": {
        "icd_code": "O13-O16",
        "confidence": "high"
      }
    },
    {
      "entity": "妊娠期糖尿病",
      "type": "Complication",
      "description": "妊娠期间出现的糖尿病",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "流产",
      "type": "Complication",
      "description": "妊娠20周前的妊娠丢失",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "胚胎移植",
      "type": "Treatment",
      "description": "将胚胎移植到子宫内的过程",
      "attributes": {
        "type": "手术",
        "confidence": "high"
      }
    },
    {
      "entity": "雌激素补充",
      "type": "Treatment",
      "description": "通过药物补充雌激素",
      "attributes": {
        "type": "药物",
        "confidence": "high"
      }
    },
    {
      "entity": "孕酮",
      "type": "Treatment",
      "description": "用于支持妊娠的激素治疗",
      "attributes": {
        "type": "药物",
        "confidence": "high"
      }
    },
    {
      "entity": "B-hCG测试",
      "type": "DiagnosticMethod",
      "description": "检测妊娠激素水平的测试",
      "attributes": {
        "normal_range": "阳性/阴性",
        "confidence": "high"
      }
    },
    {
      "entity": "超声检查",
      "type": "DiagnosticMethod",
      "description": "通过超声波检查子宫内膜厚度",
      "attributes": {
        "normal_range": "≥7 mm",
        "confidence": "high"
      }
    },
    {
      "entity": "snoring",
      "type": "RiskFactor",
      "description": "打鼾",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "sleep-disordered breathing",
      "type": "MedicalConcept",
      "description": "睡眠呼吸障碍",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fasting blood sugar",
      "type": "DiagnosticMethod",
      "description": "空腹血糖",
      "attributes": {
        "normal_range": "3.9-5.5 mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "Epworth Sleepiness Scale",
      "type": "DiagnosticMethod",
      "description": "Epworth嗜睡量表",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "ADA criteria",
      "type": "Guideline",
      "description": "美国糖尿病协会标准",
      "attributes": {
        "organization": "American Diabetes Association",
        "confidence": "high"
      }
    },
    {
      "entity": "prenatal care",
      "type": "Treatment",
      "description": "产前护理",
      "attributes": {
        "type": "预防性治疗",
        "confidence": "medium"
      }
    },
    {
      "entity": "daytime sleepiness",
      "type": "Symptom",
      "description": "日间嗜睡",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "Is snoring associated with GDM risk?",
      "type": "Question",
      "description": "打鼾是否与妊娠期糖尿病风险相关？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Latent Autoimmune Diabetes in Adults (LADA)",
      "type": "Disease",
      "description": "一种表型上类似于2型糖尿病但具有1型糖尿病自身免疫成分的糖尿病类型",
      "attributes": {
        "icd_code": "E10.9",
        "confidence": "high"
      }
    },
    {
      "entity": "prediabetes",
      "type": "Disease",
      "description": "糖尿病前期",
      "attributes": {
        "icd_code": "R73.09",
        "confidence": "high"
      }
    },
    {
      "entity": "autoantibodies",
      "type": "MedicalConcept",
      "description": "自身抗体",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "C-peptide",
      "type": "DiagnosticMethod",
      "description": "C肽检测",
      "attributes": {
        "normal_range": "0.8-5.2 ng/mL",
        "confidence": "high"
      }
    },
    {
      "entity": "A1c",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白检测",
      "attributes": {
        "normal_range": "<5.7%",
        "confidence": "high"
      }
    },
    {
      "entity": "glutamic acid decarboxylase antibody (GADA)",
      "type": "DiagnosticMethod",
      "description": "谷氨酸脱羧酶抗体检测",
      "attributes": {
        "normal_range": "0.0-5.0 IU/mL",
        "confidence": "high"
      }
    },
    {
      "entity": "basal/bolus insulin regimen",
      "type": "Treatment",
      "description": "基础/餐时胰岛素治疗方案",
      "attributes": {
        "type": "胰岛素治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetes complications",
      "type": "Complication",
      "description": "糖尿病并发症",
      "attributes": {
        "target": "mother",
        "confidence": "medium"
      }
    },
    {
      "entity": "glucose intolerance",
      "type": "MedicalConcept",
      "description": "葡萄糖不耐受",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fetal overgrowth",
      "type": "Complication",
      "description": "胎儿过度生长",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "birth complications",
      "type": "Complication",
      "description": "分娩并发症",
      "attributes": {
        "target": "mother",
        "confidence": "medium"
      }
    },
    {
      "entity": "long-term metabolic disorders",
      "type": "Complication",
      "description": "长期代谢紊乱",
      "attributes": {
        "target": "mother",
        "confidence": "medium"
      }
    },
    {
      "entity": "small-for-gestational-age",
      "type": "Complication",
      "description": "小于胎龄儿",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum glycemic and lipid profiles",
      "type": "DiagnosticMethod",
      "description": "产后血糖和血脂检测",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "pre-pregnancy BMI",
      "type": "RiskFactor",
      "description": "孕前BMI",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "gestational weight gain",
      "type": "RiskFactor",
      "description": "妊娠期体重增加",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "NICU admission",
      "type": "Complication",
      "description": "新生儿重症监护室入院",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "Homeostasis Model Assessment of Insulin Resistance",
      "type": "DiagnosticMethod",
      "description": "胰岛素抵抗评估模型",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "triglyceride levels",
      "type": "DiagnosticMethod",
      "description": "甘油三酯水平",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "maternal insulin resistance",
      "type": "MedicalConcept",
      "description": "母体胰岛素抵抗",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "early diagnosis",
      "type": "Treatment",
      "description": "早期诊断",
      "attributes": {
        "type": "diagnostic",
        "confidence": "high"
      }
    },
    {
      "entity": "effective glycemic control",
      "type": "Treatment",
      "description": "有效血糖控制",
      "attributes": {
        "type": "management",
        "confidence": "high"
      }
    },
    {
      "entity": "structured postpartum follow-up",
      "type": "Treatment",
      "description": "结构化产后随访",
      "attributes": {
        "type": "management",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum depression",
      "type": "Disease",
      "description": "产后抑郁症",
      "attributes": {
        "icd_code": "F53.0",
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum psychosis",
      "type": "Disease",
      "description": "产后精神病",
      "attributes": {
        "icd_code": "F53.1",
        "confidence": "high"
      }
    },
    {
      "entity": "preeclampsia/eclampsia",
      "type": "Disease",
      "description": "子痫前期/子痫",
      "attributes": {
        "icd_code": "O14/O15",
        "confidence": "high"
      }
    },
    {
      "entity": "placental abruption",
      "type": "Complication",
      "description": "胎盘早剥",
      "attributes": {
        "target": "母亲/胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "intrauterine growth restriction (IUGR)",
      "type": "Complication",
      "description": "宫内生长受限",
      "attributes": {
        "target": "胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "chorioamnionitis",
      "type": "Complication",
      "description": "绒毛膜羊膜炎",
      "attributes": {
        "target": "母亲/胎儿",
        "confidence": "high"
      }
    },
    {
      "entity": "cesarean delivery",
      "type": "Treatment",
      "description": "剖宫产",
      "attributes": {
        "type": "手术",
        "confidence": "high"
      }
    },
    {
      "entity": "DSM-5 criteria",
      "type": "DiagnosticMethod",
      "description": "精神疾病诊断与统计手册第五版标准",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "psychosocial risk factors",
      "type": "RiskFactor",
      "description": "心理社会风险因素",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "stress-diathesis model",
      "type": "MedicalConcept",
      "description": "压力-素质模型",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "inflammatory models",
      "type": "MedicalConcept",
      "description": "炎症模型",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "postpartum mental health screenings",
      "type": "DiagnosticMethod",
      "description": "产后心理健康筛查",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Preeclampsia",
      "type": "Disease",
      "description": "妊高症",
      "attributes": {
        "icd_code": "O14",
        "confidence": "high"
      }
    },
    {
      "entity": "cesarean section",
      "type": "Complication",
      "description": "剖宫产",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal intensive care unit (NICU) admission",
      "type": "Complication",
      "description": "新生儿重症监护室入院",
      "attributes": {
        "target": "neonate",
        "confidence": "high"
      }
    },
    {
      "entity": "intensive care unit (ICU) admission",
      "type": "Complication",
      "description": "重症监护室入院",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "multidisciplinary management",
      "type": "Treatment",
      "description": "多学科管理",
      "attributes": {
        "type": "management",
        "confidence": "medium"
      }
    },
    {
      "entity": "targeted interventions",
      "type": "Treatment",
      "description": "针对性干预",
      "attributes": {
        "type": "intervention",
        "confidence": "medium"
      }
    },
    {
      "entity": "early diagnosis",
      "type": "MedicalConcept",
      "description": "早期诊断",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "perinatal care",
      "type": "MedicalConcept",
      "description": "围产期护理",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "autophagy-related biomarkers",
      "type": "MedicalConcept",
      "description": "自噬相关生物标志物",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "gene expression profiling",
      "type": "DiagnosticMethod",
      "description": "基因表达谱分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "weighted gene co-expression network analysis",
      "type": "DiagnosticMethod",
      "description": "加权基因共表达网络分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "gene ontology",
      "type": "DiagnosticMethod",
      "description": "基因本体分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "KEGG enrichment analyses",
      "type": "DiagnosticMethod",
      "description": "KEGG富集分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "machine learning modeling",
      "type": "DiagnosticMethod",
      "description": "机器学习建模",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "immune infiltration analyses",
      "type": "DiagnosticMethod",
      "description": "免疫浸润分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "single-cell RNA sequencing",
      "type": "DiagnosticMethod",
      "description": "单细胞RNA测序",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "reverse transcription quantitative polymerase chain reaction",
      "type": "DiagnosticMethod",
      "description": "逆转录定量聚合酶链反应",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "precision medicine strategies",
      "type": "Treatment",
      "description": "精准医学策略",
      "attributes": {
        "type": "therapeutic strategy",
        "confidence": "medium"
      }
    },
    {
      "entity": "fasting plasma glucose",
      "type": "DiagnosticMethod",
      "description": "空腹血糖",
      "attributes": {
        "normal_range": "4.6-5.1 mmol/L (83-92 mg/dL)",
        "confidence": "high"
      }
    },
    {
      "entity": "glycated albumin",
      "type": "DiagnosticMethod",
      "description": "糖化白蛋白",
      "attributes": {
        "normal_range": "<37.56%",
        "confidence": "high"
      }
    },
    {
      "entity": "IADPSG criteria",
      "type": "Guideline",
      "description": "国际糖尿病与妊娠研究组标准",
      "attributes": {
        "organization": "International Association of Diabetes and Pregnancy Study Group",
        "confidence": "high"
      }
    },
    {
      "entity": "two-tiered modality",
      "type": "Treatment",
      "description": "两阶段诊断策略",
      "attributes": {
        "type": "诊断策略",
        "confidence": "medium"
      }
    },
    {
      "entity": "ROC curve analysis",
      "type": "MedicalConcept",
      "description": "受试者工作特征曲线分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "postpartum diabetes mellitus",
      "type": "Disease",
      "description": "产后糖尿病",
      "attributes": {
        "icd_code": "O24.9",
        "confidence": "high"
      }
    },
    {
      "entity": "impaired glucose tolerance",
      "type": "MedicalConcept",
      "description": "糖耐量受损",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "oral glucose challenge test",
      "type": "DiagnosticMethod",
      "description": "口服葡萄糖激发试验",
      "attributes": {
        "normal_range": "50-g 1-h",
        "confidence": "high"
      }
    },
    {
      "entity": "Carpenter-Coustan criteria",
      "type": "Guideline",
      "description": "Carpenter-Coustan标准",
      "attributes": {
        "organization": "Carpenter and Coustan",
        "confidence": "high"
      }
    },
    {
      "entity": "socioeconomic status",
      "type": "RiskFactor",
      "description": "社会经济地位",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "ethnicity",
      "type": "RiskFactor",
      "description": "种族",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "postpartum DM",
      "type": "Complication",
      "description": "产后糖尿病",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "child birth weight",
      "type": "Complication",
      "description": "新生儿出生体重",
      "attributes": {
        "target": "新生儿",
        "confidence": "medium"
      }
    },
    {
      "entity": "gestational age",
      "type": "MedicalConcept",
      "description": "孕周",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "What is the association between gestational glucose intolerance and postpartum diabetes?",
      "type": "Question",
      "description": "妊娠期糖耐量异常与产后糖尿病的关联是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "pregestational diabetes mellitus",
      "type": "Disease",
      "description": "孕前糖尿病",
      "attributes": {
        "icd_code": "O24.0",
        "confidence": "high"
      }
    },
    {
      "entity": "vascular complications",
      "type": "Complication",
      "description": "血管并发症",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "hypoglycemia",
      "type": "Complication",
      "description": "新生儿低血糖",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "perinatal death",
      "type": "Complication",
      "description": "围产期死亡",
      "attributes": {
        "target": "newborn",
        "confidence": "high"
      }
    },
    {
      "entity": "LGA",
      "type": "Complication",
      "description": "大于胎龄儿",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "SGA",
      "type": "Complication",
      "description": "小于胎龄儿",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "cesarean",
      "type": "Treatment",
      "description": "剖宫产",
      "attributes": {
        "type": "surgical",
        "confidence": "high"
      }
    },
    {
      "entity": "expectant management",
      "type": "Treatment",
      "description": "期待治疗",
      "attributes": {
        "type": "non-surgical",
        "confidence": "high"
      }
    },
    {
      "entity": "SMFM",
      "type": "Guideline",
      "description": "母胎医学会指南",
      "attributes": {
        "organization": "Society for Maternal-Fetal Medicine",
        "confidence": "high"
      }
    },
    {
      "entity": "elective delivery",
      "type": "Treatment",
      "description": "选择性分娩",
      "attributes": {
        "type": "surgical/non-surgical",
        "confidence": "high"
      }
    },
    {
      "entity": "Placenta Growth Factor (PlGF)",
      "type": "MedicalConcept",
      "description": "A biomarker reflecting placental development and function.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Glycosylated Fibronectin (GlyFn)",
      "type": "MedicalConcept",
      "description": "A biomarker reflecting pathological changes in placental development.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "GlyFn/PlGF ratio",
      "type": "DiagnosticMethod",
      "description": "A ratio combining GlyFn and PlGF levels to predict preeclampsia.",
      "attributes": {
        "normal_range": "Not specified",
        "confidence": "high"
      }
    },
    {
      "entity": "prior PE",
      "type": "RiskFactor",
      "description": "History of preeclampsia in previous pregnancies.",
      "attributes": {
        "modifiable": false,
        "confidence": "high"
      }
    },
    {
      "entity": "diabetes mellitus",
      "type": "Disease",
      "description": "A chronic metabolic disorder characterized by high blood sugar levels.",
      "attributes": {
        "icd_code": "E11",
        "confidence": "high"
      }
    },
    {
      "entity": "high-risk pregnancies",
      "type": "MedicalConcept",
      "description": "Pregnancies with increased risk of complications due to various factors.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "systolic blood pressure",
      "type": "MedicalConcept",
      "description": "The pressure in the arteries when the heart beats.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "BMI",
      "type": "MedicalConcept",
      "description": "Body Mass Index, a measure of body fat based on height and weight.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Helsinki Declaration",
      "type": "Guideline",
      "description": "A set of ethical principles regarding human experimentation.",
      "attributes": {
        "organization": "World Medical Association",
        "confidence": "high"
      }
    },
    {
      "entity": "Letrozole ovulation regimen",
      "type": "MedicalConcept",
      "description": "A treatment protocol using letrozole to induce ovulation, particularly in women with polycystic ovary syndrome."
    },
    {
      "entity": "Frozen-thawed embryo transfer",
      "type": "MedicalConcept",
      "description": "A procedure in assisted reproductive technology where previously frozen embryos are thawed and transferred to the uterus."
    },
    {
      "entity": "Polycystic ovary syndrome",
      "type": "MedicalConcept",
      "description": "A hormonal disorder causing enlarged ovaries with small cysts, often leading to infertility."
    },
    {
      "entity": "Randomised controlled trial",
      "type": "MedicalConcept",
      "description": "A scientific study where participants are randomly assigned to different groups to test the efficacy of interventions."
    },
    {
      "entity": "Multi-centre study",
      "type": "MedicalConcept",
      "description": "A research study conducted across multiple locations to ensure diverse participant representation and generalizability of results."
    },
    {
      "entity": "long-term child health outcomes",
      "type": "Complication",
      "description": "长期儿童健康影响",
      "attributes": {
        "target": "胎儿/新生儿",
        "confidence": "medium"
      }
    },
    {
      "entity": "neonatologists' knowledge, attitudes, and practices (KAP)",
      "type": "MedicalConcept",
      "description": "新生儿科医生对妊娠期糖尿病并发症的知识、态度和实践",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "follow-up protocols",
      "type": "Treatment",
      "description": "随访方案",
      "attributes": {
        "type": "管理策略",
        "confidence": "medium"
      }
    },
    {
      "entity": "specialist referrals",
      "type": "Treatment",
      "description": "专科转诊",
      "attributes": {
        "type": "管理策略",
        "confidence": "medium"
      }
    },
    {
      "entity": "standardized protocols",
      "type": "Guideline",
      "description": "标准化协议",
      "attributes": {
        "organization": "未指定",
        "confidence": "low"
      }
    },
    {
      "entity": "β-cells",
      "type": "MedicalConcept",
      "description": "Pancreatic cells responsible for insulin production",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "abnormal placental function",
      "type": "MedicalConcept",
      "description": "Dysfunction in the placenta affecting nutrient and oxygen exchange",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "breast cancer",
      "type": "Disease",
      "description": "Malignant tumor originating from breast tissue",
      "attributes": {
        "icd_code": "C50",
        "confidence": "high"
      }
    },
    {
      "entity": "Newcastle-Ottawa Scale",
      "type": "DiagnosticMethod",
      "description": "A tool for assessing the quality of non-randomized studies in meta-analyses",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "hazard ratio",
      "type": "MedicalConcept",
      "description": "A measure of association between an exposure and an outcome over time",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "95% confidence interval",
      "type": "MedicalConcept",
      "description": "A range of values within which the true effect size is likely to fall with 95% probability",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "subgroup analysis",
      "type": "MedicalConcept",
      "description": "Analysis of data subsets to explore heterogeneity",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "sensitivity analysis",
      "type": "MedicalConcept",
      "description": "Method to assess the robustness of study results",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "funnel plot analysis",
      "type": "MedicalConcept",
      "description": "Graphical method to detect publication bias",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "publication bias",
      "type": "MedicalConcept",
      "description": "Selective publication of research findings based on their results",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "myocardial hypertrophy",
      "type": "Complication",
      "description": "心肌肥厚",
      "attributes": {
        "target": "新生儿",
        "confidence": "high"
      }
    },
    {
      "entity": "ANGPTL7",
      "type": "MedicalConcept",
      "description": "血管生成素样蛋白7",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "cardiac ultrasound",
      "type": "DiagnosticMethod",
      "description": "心脏超声",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "ELISA",
      "type": "DiagnosticMethod",
      "description": "酶联免疫吸附试验",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "interventricular septum thickness",
      "type": "DiagnosticMethod",
      "description": "室间隔厚度",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "poor glycaemic control",
      "type": "RiskFactor",
      "description": "血糖控制不佳",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "umbilical cord blood levels",
      "type": "DiagnosticMethod",
      "description": "脐带血水平检测",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "IVS/LVPW ratio",
      "type": "DiagnosticMethod",
      "description": "室间隔与左室后壁厚度比",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "pregnancy-associated AKI (PrAKI)",
      "type": "Disease",
      "description": "Acute kidney injury during pregnancy and the postpartum period",
      "attributes": {
        "icd_code": "O90.4",
        "confidence": "high"
      }
    },
    {
      "entity": "sepsis",
      "type": "Disease",
      "description": "A life-threatening condition caused by the body's response to an infection",
      "attributes": {
        "icd_code": "A41.9",
        "confidence": "high"
      }
    },
    {
      "entity": "autoimmune disorders",
      "type": "Disease",
      "description": "Conditions where the immune system attacks the body's own tissues",
      "attributes": {
        "icd_code": "M35.9",
        "confidence": "high"
      }
    },
    {
      "entity": "maternal comorbidities",
      "type": "RiskFactor",
      "description": "Pre-existing health conditions in the mother that increase the risk of PrAKI",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "nephrotoxic medications",
      "type": "RiskFactor",
      "description": "Medications that can cause kidney damage",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "maternal mortality",
      "type": "Complication",
      "description": "Death of the mother related to pregnancy or childbirth",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "premature birth",
      "type": "Complication",
      "description": "Birth of the baby before 37 weeks of pregnancy",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "small for gestational age",
      "type": "Complication",
      "description": "Baby born smaller than the usual size for the number of weeks of pregnancy",
      "attributes": {
        "target": "fetus",
        "confidence": "high"
      }
    },
    {
      "entity": "Acute Disease Quality Initiative",
      "type": "Guideline",
      "description": "Consensus report on the management of acute kidney injury during pregnancy",
      "attributes": {
        "organization": "Acute Disease Quality Initiative",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiometabolic biomarkers",
      "type": "MedicalConcept",
      "description": "心脏代谢生物标志物",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "insulin-like growth factor (IGF) axis markers",
      "type": "MedicalConcept",
      "description": "胰岛素样生长因子轴标志物",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "adipokines",
      "type": "MedicalConcept",
      "description": "脂肪因子",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "amino acids (AAs)",
      "type": "MedicalConcept",
      "description": "氨基酸",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "phospholipid fatty acids (FAs)",
      "type": "MedicalConcept",
      "description": "磷脂脂肪酸",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "area under receiver operating characteristics curve (AUC)",
      "type": "MedicalConcept",
      "description": "受试者工作特征曲线下面积",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "decision curve analysis",
      "type": "MedicalConcept",
      "description": "决策曲线分析",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "early-pregnancy random plasma samples",
      "type": "DiagnosticMethod",
      "description": "早孕期随机血浆样本",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "mid-pregnancy fasting samples",
      "type": "DiagnosticMethod",
      "description": "中孕期空腹样本",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "子痫前期",
      "type": "Disease",
      "description": "妊娠期高血压疾病的一种严重形式",
      "attributes": {
        "icd_code": "O14",
        "confidence": "high"
      }
    },
    {
      "entity": "内分泌干扰物",
      "type": "MedicalConcept",
      "description": "干扰内分泌系统功能的化学物质",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "表观遗传修饰",
      "type": "MedicalConcept",
      "description": "不改变DNA序列的基因表达调控机制",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "塑料增塑剂暴露",
      "type": "RiskFactor",
      "description": "接触BPA和邻苯二甲酸盐等化学物质",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "无创生物标志物",
      "type": "DiagnosticMethod",
      "description": "通过循环核酸分析检测妊娠并发症",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "植入失败",
      "type": "Complication",
      "description": "胚胎未能成功着床",
      "attributes": {
        "target": "母亲",
        "confidence": "medium"
      }
    },
    {
      "entity": "carbohydrate metabolism",
      "type": "MedicalConcept",
      "description": "妊娠期母体碳水化合物代谢的生理性改变",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "50 g glucose loading test (GCT)",
      "type": "DiagnosticMethod",
      "description": "50克葡萄糖负荷试验，妊娠期糖尿病筛查方法",
      "attributes": {
        "normal_range": "<140 mg/dl",
        "confidence": "high"
      }
    },
    {
      "entity": "3-hour glucose tolerance test (GTT)",
      "type": "DiagnosticMethod",
      "description": "3小时葡萄糖耐量试验，用于确诊妊娠期糖尿病",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "placental changes",
      "type": "MedicalConcept",
      "description": "妊娠期糖尿病相关的胎盘病理学改变",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "fractalkine (FKN)",
      "type": "MedicalConcept",
      "description": "趋化因子FKN在妊娠期糖尿病中的免疫组化表达",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "neonatal care",
      "type": "MedicalConcept",
      "description": "Medical care provided to newborn infants, especially those who are ill or born prematurely."
    },
    {
      "entity": "kangaroo care",
      "type": "MedicalConcept",
      "description": "A method of holding a baby that involves skin-to-skin contact, often used for premature or low birth weight infants."
    },
    {
      "entity": "phototherapy",
      "type": "MedicalConcept",
      "description": "Treatment of jaundice in newborns using light to break down bilirubin in the skin."
    },
    {
      "entity": "resuscitation equipment",
      "type": "MedicalConcept",
      "description": "Tools and devices used to revive newborns who are not breathing or have no heartbeat at birth."
    },
    {
      "entity": "HIV status documentation",
      "type": "MedicalConcept",
      "description": "Recording of the mother's HIV status, which is critical for preventing mother-to-child transmission of HIV."
    },
    {
      "entity": "Certified Diabetes Educator",
      "type": "MedicalConcept",
      "description": "专业认证的糖尿病教育者",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Board Certified-Advanced Diabetes Management",
      "type": "MedicalConcept",
      "description": "高级糖尿病管理委员会认证",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Academy of Nutrition and Dietetics Standards of Practice",
      "type": "Guideline",
      "description": "营养与饮食学会实践标准",
      "attributes": {
        "organization": "Academy of Nutrition and Dietetics",
        "confidence": "high"
      }
    },
    {
      "entity": "American Association of Diabetes Educators",
      "type": "Guideline",
      "description": "美国糖尿病教育者协会",
      "attributes": {
        "organization": "American Association of Diabetes Educators",
        "confidence": "high"
      }
    },
    {
      "entity": "Academy of Nutrition and Dietetics",
      "type": "Guideline",
      "description": "营养与饮食学会",
      "attributes": {
        "organization": "Academy of Nutrition and Dietetics",
        "confidence": "high"
      }
    },
    {
      "entity": "MNT",
      "type": "Treatment",
      "description": "医学营养治疗",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "DSMES",
      "type": "Treatment",
      "description": "糖尿病自我管理教育与支持",
      "attributes": {
        "type": "education and support",
        "confidence": "high"
      }
    },
    {
      "entity": "hemoglobin A1c (A1C)",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白",
      "attributes": {
        "normal_range": "<5.7%",
        "confidence": "high"
      }
    },
    {
      "entity": "DPP",
      "type": "Guideline",
      "description": "糖尿病预防计划",
      "attributes": {
        "organization": "National Institutes of Health",
        "confidence": "high"
      }
    },
    {
      "entity": "Da Qing Diabetes Prevention Study",
      "type": "Guideline",
      "description": "大庆糖尿病预防研究",
      "attributes": {
        "organization": "Chinese Academy of Medical Sciences",
        "confidence": "high"
      }
    },
    {
      "entity": "Finnish Diabetes Prevention Study (DPS)",
      "type": "Guideline",
      "description": "芬兰糖尿病预防研究",
      "attributes": {
        "organization": "National Public Health Institute of Finland",
        "confidence": "high"
      }
    },
    {
      "entity": "U.S. Diabetes Prevention Program Outcomes Study (DPPOS)",
      "type": "Guideline",
      "description": "美国糖尿病预防计划结果研究",
      "attributes": {
        "organization": "National Institutes of Health",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiovascular disease (CVD)",
      "type": "Disease",
      "description": "心血管疾病",
      "attributes": {
        "icd_code": "I25.1",
        "confidence": "high"
      }
    },
    {
      "entity": "macronutrients",
      "type": "MedicalConcept",
      "description": "宏量营养素",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "dietary fiber",
      "type": "Food",
      "description": "膳食纤维",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "vegetables",
      "type": "Food",
      "description": "蔬菜",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "pulses (beans, peas, and lentils)",
      "type": "Food",
      "description": "豆类（豆子、豌豆和扁豆）",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "fruits",
      "type": "Food",
      "description": "水果",
      "attributes": {
        "glycemic_index": "variable",
        "confidence": "high"
      }
    },
    {
      "entity": "whole intact grains",
      "type": "Food",
      "description": "全谷物",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "USDA Dietary Guidelines For Americans (DGA)",
      "type": "Guideline",
      "description": "美国膳食指南",
      "attributes": {
        "organization": "USDA",
        "confidence": "high"
      }
    },
    {
      "entity": "Mediterranean-style",
      "type": "Food",
      "description": "地中海式饮食",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "A1C reduction",
      "type": "MedicalConcept",
      "description": "糖化血红蛋白降低",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Lowered triglycerides",
      "type": "MedicalConcept",
      "description": "甘油三酯降低",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Reduced risk of major cardiovascular events",
      "type": "MedicalConcept",
      "description": "主要心血管事件风险降低",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Vegetarian or vegan",
      "type": "Food",
      "description": "素食或纯素食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Low-fat",
      "type": "Food",
      "description": "低脂饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Very low-fat",
      "type": "Food",
      "description": "极低脂饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Low-carbohydrate",
      "type": "Food",
      "description": "低碳水化合物饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Very low-carbohydrate (VLC)",
      "type": "Food",
      "description": "极低碳水化合物饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Dietary Approaches to Stop Hypertension (DASH)",
      "type": "Food",
      "description": "高血压防治饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "Paleo",
      "type": "Food",
      "description": "旧石器时代饮食",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "high"
      }
    },
    {
      "entity": "glycemic index (GI)",
      "type": "MedicalConcept",
      "description": "血糖指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycemic load (GL)",
      "type": "MedicalConcept",
      "description": "血糖负荷",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "nonstarchy vegetables",
      "type": "Food",
      "description": "非淀粉类蔬菜",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "avocados",
      "type": "Food",
      "description": "鳄梨",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "berries",
      "type": "Food",
      "description": "浆果",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "pulses",
      "type": "Food",
      "description": "豆类",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "beans",
      "type": "Food",
      "description": "豆类",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "peas",
      "type": "Food",
      "description": "豌豆",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "lentils",
      "type": "Food",
      "description": "扁豆",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "synthetic sources of trans fats",
      "type": "Food",
      "description": "合成反式脂肪来源",
      "attributes": {
        "glycemic_index": "N/A",
        "confidence": "high"
      }
    },
    {
      "entity": "ruminant trans fats",
      "type": "Food",
      "description": "反刍动物反式脂肪",
      "attributes": {
        "glycemic_index": "N/A",
        "confidence": "high"
      }
    },
    {
      "entity": "Do carbohydrate needs differ for people with diabetes compared with the general population?",
      "type": "Question",
      "description": "糖尿病患者的碳水化合物需求是否与一般人群不同？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What are the dietary fiber needs of people with diabetes?",
      "type": "Question",
      "description": "糖尿病患者的膳食纤维需求是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "Does the use of glycemic index and glycemic load impact glycemia?",
      "type": "Question",
      "description": "血糖指数和血糖负荷的使用是否影响血糖？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What are the total protein needs of people with diabetes?",
      "type": "Question",
      "description": "糖尿病患者的蛋白质总需求是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What are the dietary fat and cholesterol goals for people with diabetes?",
      "type": "Question",
      "description": "糖尿病患者的膳食脂肪和胆固醇目标是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "polyunsaturated fat",
      "type": "Food",
      "description": "A type of dietary fat that is beneficial for health, found in plant and animal foods.",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "omega-3 fatty acids",
      "type": "Food",
      "description": "Essential fatty acids found in fish oils and certain plant oils, known for their health benefits.",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "eicosapentaenoic acid (EPA)",
      "type": "Food",
      "description": "An omega-3 fatty acid found in fish oil, known for its anti-inflammatory properties.",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "Mediterranean-style eating pattern",
      "type": "Treatment",
      "description": "A diet rich in fruits, vegetables, whole grains, olive oil, and fish, associated with reduced diabetes risk.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "low-fat eating pattern",
      "type": "Treatment",
      "description": "A diet that limits fat intake, often used for weight loss and diabetes management.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "low-carbohydrate eating plan",
      "type": "Treatment",
      "description": "A diet that restricts carbohydrate intake, often used to manage blood sugar levels.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "vegetarian eating pattern",
      "type": "Treatment",
      "description": "A diet that excludes meat, often associated with lower diabetes risk.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "vegan eating pattern",
      "type": "Treatment",
      "description": "A diet that excludes all animal products, often associated with lower diabetes risk.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "DASH eating pattern",
      "type": "Treatment",
      "description": "A diet designed to stop hypertension, also associated with lower diabetes risk.",
      "attributes": {
        "type": "dietary",
        "confidence": "high"
      }
    },
    {
      "entity": "What is the role of fat in the prevention of type 2 diabetes?",
      "type": "Question",
      "description": "A common question regarding the impact of dietary fat on diabetes prevention.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What is the evidence for specific eating patterns to manage prediabetes and prevent type 2 diabetes?",
      "type": "Question",
      "description": "A common question regarding the effectiveness of dietary patterns in diabetes prevention.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What is the evidence for specific eating patterns to manage type 2 diabetes?",
      "type": "Question",
      "description": "A common question regarding the effectiveness of dietary patterns in diabetes management.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycemia",
      "type": "MedicalConcept",
      "description": "血糖水平",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "weight loss",
      "type": "Symptom",
      "description": "体重减轻",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "A1C",
      "type": "DiagnosticMethod",
      "description": "糖化血红蛋白",
      "attributes": {
        "normal_range": "<5.7%",
        "confidence": "high"
      }
    },
    {
      "entity": "nonfat dairy",
      "type": "Food",
      "description": "脱脂乳制品",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "What is the evidence to support specific eating patterns in the management of type 1 diabetes?",
      "type": "Question",
      "description": "关于1型糖尿病管理中特定饮食模式的证据是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "glycemic variability",
      "type": "MedicalConcept",
      "description": "血糖波动",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "euglycemia",
      "type": "MedicalConcept",
      "description": "正常血糖状态",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "hypoglycemia",
      "type": "MedicalConcept",
      "description": "低血糖",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "weight loss",
      "type": "MedicalConcept",
      "description": "体重减轻",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "HDL-C",
      "type": "DiagnosticMethod",
      "description": "高密度脂蛋白胆固醇",
      "attributes": {
        "normal_range": ">40 mg/dL (男性), >50 mg/dL (女性)",
        "confidence": "high"
      }
    },
    {
      "entity": "VLC eating pattern",
      "type": "Treatment",
      "description": "极低碳水化合物饮食模式",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "Mediterranean-style eating plan",
      "type": "Treatment",
      "description": "地中海式饮食计划",
      "attributes": {
        "type": "饮食控制",
        "confidence": "high"
      }
    },
    {
      "entity": "metabolic surgery",
      "type": "Treatment",
      "description": "代谢手术",
      "attributes": {
        "type": "手术治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "weight loss medications",
      "type": "Treatment",
      "description": "减肥药物",
      "attributes": {
        "type": "药物治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "overweight",
      "type": "RiskFactor",
      "description": "超重",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "limited health literacy",
      "type": "RiskFactor",
      "description": "健康素养有限",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "numeracy",
      "type": "RiskFactor",
      "description": "计算能力",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "disordered eating",
      "type": "RiskFactor",
      "description": "饮食失调",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "added sugars",
      "type": "Food",
      "description": "添加糖",
      "attributes": {
        "glycemic_index": "高",
        "confidence": "high"
      }
    },
    {
      "entity": "refined grains",
      "type": "Food",
      "description": "精制谷物",
      "attributes": {
        "glycemic_index": "高",
        "confidence": "high"
      }
    },
    {
      "entity": "whole foods",
      "type": "Food",
      "description": "全食物",
      "attributes": {
        "glycemic_index": "低至中",
        "confidence": "high"
      }
    },
    {
      "entity": "sugar-sweetened beverages",
      "type": "Food",
      "description": "含糖饮料",
      "attributes": {
        "glycemic_index": "高",
        "confidence": "high"
      }
    },
    {
      "entity": "fish",
      "type": "Food",
      "description": "鱼类",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "processed red meats",
      "type": "Food",
      "description": "加工红肉",
      "attributes": {
        "glycemic_index": "中",
        "confidence": "high"
      }
    },
    {
      "entity": "CVD",
      "type": "Complication",
      "description": "心血管疾病",
      "attributes": {
        "target": "母亲",
        "confidence": "high"
      }
    },
    {
      "entity": "Does the current evidence support specific eating patterns for the management of diabetes?",
      "type": "Question",
      "description": "当前证据是否支持特定的饮食模式用于糖尿病管理？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What is the role of weight loss therapy in people with prediabetes or diabetes with overweight or obesity?",
      "type": "Question",
      "description": "减肥治疗在超重或肥胖的糖尿病前期或糖尿病患者中的作用是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "aerobic exercise",
      "type": "Treatment",
      "description": "有氧运动",
      "attributes": {
        "type": "lifestyle intervention",
        "confidence": "high"
      }
    },
    {
      "entity": "energy deficit",
      "type": "MedicalConcept",
      "description": "能量赤字",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "macronutrient composition",
      "type": "MedicalConcept",
      "description": "宏量营养素组成",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "serum lipids",
      "type": "DiagnosticMethod",
      "description": "血清脂质",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "blood pressure",
      "type": "DiagnosticMethod",
      "description": "血压",
      "attributes": {
        "normal_range": "<120/80 mmHg",
        "confidence": "high"
      }
    },
    {
      "entity": "individualized eating plans",
      "type": "Treatment",
      "description": "个体化饮食计划",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "calorie reduction",
      "type": "MedicalConcept",
      "description": "热量减少",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "meal replacements",
      "type": "Treatment",
      "description": "代餐",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "behavioral interventions",
      "type": "Treatment",
      "description": "行为干预",
      "attributes": {
        "type": "lifestyle intervention",
        "confidence": "high"
      }
    },
    {
      "entity": "weight gain",
      "type": "Complication",
      "description": "体重增加",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "hypotension",
      "type": "Complication",
      "description": "低血压",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "telehealth programs",
      "type": "Treatment",
      "description": "远程医疗项目",
      "attributes": {
        "type": "lifestyle intervention",
        "confidence": "medium"
      }
    },
    {
      "entity": "type 2 diabetes remission",
      "type": "MedicalConcept",
      "description": "2型糖尿病缓解",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "low-carbohydrate Mediterranean-style eating pattern",
      "type": "Treatment",
      "description": "低碳水化合物地中海式饮食模式",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "low-fat eating plan",
      "type": "Treatment",
      "description": "低脂饮食计划",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "microvascular disease complications",
      "type": "Complication",
      "description": "微血管疾病并发症",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "cardiovascular risk factors",
      "type": "RiskFactor",
      "description": "心血管风险因素",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "weight management",
      "type": "Treatment",
      "description": "体重管理",
      "attributes": {
        "type": "lifestyle intervention",
        "confidence": "high"
      }
    },
    {
      "entity": "GI",
      "type": "MedicalConcept",
      "description": "血糖指数",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "fiber",
      "type": "Food",
      "description": "膳食纤维",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "lean protein",
      "type": "Food",
      "description": "瘦肉蛋白",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "glucagon-like peptide 1 receptor agonists",
      "type": "Treatment",
      "description": "GLP-1受体激动剂",
      "attributes": {
        "type": "pharmacotherapy",
        "confidence": "high"
      }
    },
    {
      "entity": "sodium–glucose cotransporter 2 inhibitors",
      "type": "Treatment",
      "description": "SGLT2抑制剂",
      "attributes": {
        "type": "pharmacotherapy",
        "confidence": "high"
      }
    },
    {
      "entity": "disordered eating",
      "type": "Disease",
      "description": "饮食失调",
      "attributes": {
        "icd_code": "F50",
        "confidence": "high"
      }
    },
    {
      "entity": "sugar substitutes",
      "type": "Food",
      "description": "Artificial sweeteners used to replace caloric sweeteners",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "sugar alcohols",
      "type": "Food",
      "description": "Sweeteners with fewer calories than sugar but not as sweet",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "alcohol consumption",
      "type": "RiskFactor",
      "description": "Moderate alcohol consumption and its effects on diabetes",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "delayed hypoglycemia",
      "type": "Complication",
      "description": "Hypoglycemia occurring after alcohol consumption, especially in individuals using insulin or insulin secretagogues",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "moderate alcohol intake",
      "type": "MedicalConcept",
      "description": "Consumption of alcohol in moderate amounts, defined as one drink or less per day for women and two drinks or less per day for men",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "insulin secretagogues",
      "type": "Treatment",
      "description": "Medications that stimulate the pancreas to release more insulin",
      "attributes": {
        "type": "pharmacological",
        "confidence": "high"
      }
    },
    {
      "entity": "vitamin B12 deficiency",
      "type": "Complication",
      "description": "A potential side effect of long-term metformin use",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "chromium supplementation",
      "type": "Treatment",
      "description": "The use of chromium supplements to potentially improve glucose metabolism",
      "attributes": {
        "type": "supplement",
        "confidence": "medium"
      }
    },
    {
      "entity": "vitamin D supplementation",
      "type": "Treatment",
      "description": "The use of vitamin D supplements to potentially improve glycemia",
      "attributes": {
        "type": "supplement",
        "confidence": "medium"
      }
    },
    {
      "entity": "herbal supplements",
      "type": "Treatment",
      "description": "The use of herbs like cinnamon, curcumin, or aloe vera for diabetes management",
      "attributes": {
        "type": "supplement",
        "confidence": "medium"
      }
    },
    {
      "entity": "peripheral neuropathy",
      "type": "Symptom",
      "description": "周围神经病变",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "anemia",
      "type": "Symptom",
      "description": "贫血",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "carbohydrate counting",
      "type": "Treatment",
      "description": "碳水化合物计数",
      "attributes": {
        "type": "nutrition therapy",
        "confidence": "high"
      }
    },
    {
      "entity": "fatty fish",
      "type": "Food",
      "description": "富含脂肪的鱼类",
      "attributes": {
        "glycemic_index": "low",
        "confidence": "high"
      }
    },
    {
      "entity": "Does the use of metformin affect vitamin B12 status?",
      "type": "Question",
      "description": "二甲双胍的使用是否影响维生素B12状态？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "What is the role of the RDN in medication adjustment?",
      "type": "Question",
      "description": "注册营养师在药物调整中的作用是什么？",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "saturated fat",
      "type": "Food",
      "description": "饱和脂肪，与心血管疾病风险相关",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "monounsaturated fat",
      "type": "Food",
      "description": "单不饱和脂肪，改善血糖和心血管风险",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "CVD",
      "type": "Disease",
      "description": "心血管疾病",
      "attributes": {
        "icd_code": "I00-I99",
        "confidence": "high"
      }
    },
    {
      "entity": "CHD",
      "type": "Disease",
      "description": "冠心病",
      "attributes": {
        "icd_code": "I20-I25",
        "confidence": "high"
      }
    },
    {
      "entity": "ischemic stroke",
      "type": "Disease",
      "description": "缺血性卒中",
      "attributes": {
        "icd_code": "I63",
        "confidence": "high"
      }
    },
    {
      "entity": "trans fat",
      "type": "Food",
      "description": "反式脂肪，增加心血管风险",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "EPA",
      "type": "Food",
      "description": "二十碳五烯酸，一种Omega-3脂肪酸",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "DHA",
      "type": "Food",
      "description": "二十二碳六烯酸，一种Omega-3脂肪酸",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "ALA",
      "type": "Food",
      "description": "α-亚麻酸，植物来源的Omega-3脂肪酸",
      "attributes": {
        "glycemic_index": "无直接数据",
        "confidence": "high"
      }
    },
    {
      "entity": "sodium intake",
      "type": "RiskFactor",
      "description": "钠摄入量，与高血压和心血管风险相关",
      "attributes": {
        "modifiable": true,
        "confidence": "high"
      }
    },
    {
      "entity": "hypertension",
      "type": "Disease",
      "description": "高血压",
      "attributes": {
        "icd_code": "I10",
        "confidence": "high"
      }
    },
    {
      "entity": "Diabetic Kidney Disease",
      "type": "Disease",
      "description": "糖尿病肾病",
      "attributes": {
        "icd_code": "E11.2",
        "confidence": "high"
      }
    },
    {
      "entity": "Gastroparesis",
      "type": "Disease",
      "description": "胃轻瘫，糖尿病并发症",
      "attributes": {
        "icd_code": "K31.84",
        "confidence": "high"
      }
    },
    {
      "entity": "low-protein eating plan",
      "type": "Treatment",
      "description": "低蛋白饮食计划",
      "attributes": {
        "type": "饮食治疗",
        "confidence": "high"
      }
    },
    {
      "entity": "soy-based protein",
      "type": "Food",
      "description": "大豆蛋白，改善心血管风险因素",
      "attributes": {
        "glycemic_index": "低",
        "confidence": "high"
      }
    },
    {
      "entity": "diabetic gastroparesis",
      "type": "Disease",
      "description": "A condition where the stomach takes too long to empty its contents, often associated with diabetes.",
      "attributes": {
        "icd_code": "K31.84",
        "confidence": "high"
      }
    },
    {
      "entity": "gastric emptying",
      "type": "MedicalConcept",
      "description": "The process by which food leaves the stomach and enters the small intestine.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "small-particle-size foods",
      "type": "Food",
      "description": "Foods that are easy to mash into small particles, recommended for gastroparesis.",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "medium"
      }
    },
    {
      "entity": "high-fiber foods",
      "type": "Food",
      "description": "Foods rich in fiber, which may be difficult to digest for those with gastroparesis.",
      "attributes": {
        "glycemic_index": "varies",
        "confidence": "medium"
      }
    },
    {
      "entity": "postprandial hyperglycemia",
      "type": "MedicalConcept",
      "description": "High blood sugar levels after eating.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "malnutrition",
      "type": "Complication",
      "description": "A condition resulting from inadequate nutrition, can affect individuals with gastroparesis.",
      "attributes": {
        "target": "mother",
        "confidence": "high"
      }
    },
    {
      "entity": "enteral nutrition",
      "type": "Treatment",
      "description": "Nutrition delivered directly into the digestive tract, used when oral intake is insufficient.",
      "attributes": {
        "type": "nutritional support",
        "confidence": "high"
      }
    },
    {
      "entity": "parenteral nutrition",
      "type": "Treatment",
      "description": "Nutrition delivered intravenously, used when the digestive tract cannot be used.",
      "attributes": {
        "type": "nutritional support",
        "confidence": "high"
      }
    },
    {
      "entity": "personalized nutrition",
      "type": "MedicalConcept",
      "description": "Tailoring dietary recommendations based on individual genetic, metabolomic, and microbiome profiles.",
      "attributes": {
        "confidence": "medium"
      }
    },
    {
      "entity": "genetic variants",
      "type": "RiskFactor",
      "description": "Genetic differences that may influence diabetes risk and response to diet.",
      "attributes": {
        "modifiable": false,
        "confidence": "medium"
      }
    },
    {
      "entity": "microbiome variations",
      "type": "RiskFactor",
      "description": "Differences in gut microbiota that may affect diabetes outcomes.",
      "attributes": {
        "modifiable": true,
        "confidence": "medium"
      }
    },
    {
      "entity": "What can I eat?",
      "type": "Question",
      "description": "A common question asked by individuals newly diagnosed with diabetes.",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "MORC2",
      "type": "MedicalConcept",
      "description": "An oncogenic chromatin-remodeling enzyme involved in DNA repair and cell-cycle checkpoint control."
    },
    {
      "entity": "NAT10",
      "type": "MedicalConcept",
      "description": "An acetyltransferase that acetylates MORC2, regulating its role in DNA damage response and checkpoint control."
    },
    {
      "entity": "DNA damage-induced G2 checkpoint",
      "type": "MedicalConcept",
      "description": "A cellular mechanism that halts the cell cycle at the G2 phase to allow DNA repair before progression."
    },
    {
      "entity": "H3T11P",
      "type": "MedicalConcept",
      "description": "Histone H3 phosphorylation at threonine 11, involved in transcriptional regulation during DNA damage response."
    },
    {
      "entity": "CDK1 and Cyclin B1",
      "type": "MedicalConcept",
      "description": "Key regulators of the cell cycle, whose repression is critical for G2 checkpoint activation."
    },
    {
      "entity": "polyimides (PIs)",
      "type": "MedicalConcept",
      "description": "Aromatic polymers with high heat resistance and antimicrobial properties, synthesized for medical and industrial applications."
    },
    {
      "entity": "antimicrobial activity",
      "type": "MedicalConcept",
      "description": "The ability of a substance to kill or inhibit the growth of microorganisms, relevant in medical devices and coatings."
    },
    {
      "entity": "heavy metal ions (Hg2+ and Co2+)",
      "type": "MedicalConcept",
      "description": "Toxic metal ions that can be removed from water sources using polymeric adsorbents, important for environmental and health safety."
    },
    {
      "entity": "SiO2 nanoparticles",
      "type": "MedicalConcept",
      "description": "Inorganic nanoparticles used to enhance polymer properties, including heat resistance and antimicrobial effects in medical materials."
    },
    {
      "entity": "polymer nanocomposites (PNCs)",
      "type": "MedicalConcept",
      "description": "Materials combining polymers and nanoparticles, used in medical and technological applications for improved performance."
    },
    {
      "entity": "体重减轻",
      "type": "Symptom",
      "description": "非自主性体重下降",
      "attributes": {
        "confidence": "high"
      }
    },
    {
      "entity": "口服葡萄糖耐量试验",
      "type": "DiagnosticMethod",
      "description": "通过口服葡萄糖后检测血糖水平来诊断糖代谢异常",
      "attributes": {
        "normal_range": "空腹<5.1mmol/L, 1小时<10.0mmol/L, 2小时<8.5mmol/L",
        "confidence": "high"
      }
    },
    {
      "entity": "血糖监测",
      "type": "MedicalConcept",
      "description": "定期检测血糖水平以评估控制情况",
      "attributes": {
        "confidence": "high"
      }
    }
  ],
  "relations": [
    {
      "subject": "妊娠期糖尿病",
      "predicate": "IS_A",
      "object": "糖尿病",
      "attributes": {
        "evidence": "妊娠期糖尿病(GDM)是指女性在怀孕期间首次出现的糖尿病。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "血糖水平升高",
      "attributes": {
        "evidence": "这种情况发生是因为怀孕期间产生的激素会阻碍胰岛素正常工作，导致血糖水平升高。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "35岁以上高龄产妇",
      "attributes": {
        "evidence": "高风险人群包括：35岁以上高龄产妇、有糖尿病家族史、既往妊娠期糖尿病史、既往分娩过巨大儿、超重或肥胖者(BMI≥25)、多囊卵巢综合征患者等。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "肥胖",
      "attributes": {
        "evidence": "高风险人群包括：35岁以上高龄产妇、有糖尿病家族史、既往妊娠期糖尿病史、既往分娩过巨大儿、超重或肥胖者(BMI≥25)、多囊卵巢综合征患者等。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "糖尿病家族史",
      "attributes": {
        "evidence": "高风险人群包括：35岁以上高龄产妇、有糖尿病家族史、既往妊娠期糖尿病史、既往分娩过巨大儿、超重或肥胖者(BMI≥25)、多囊卵巢综合征患者等。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "OGTT",
      "attributes": {
        "evidence": "通常使用75g口服葡萄糖耐量试验(OGTT)进行诊断。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "胰岛素治疗",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "饮食控制",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "运动疗法",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "妊娠高血压",
      "attributes": {
        "evidence": "对母亲的风险包括：妊娠高血压、早产、剖宫产率增加、产后发展为2型糖尿病的风险增加等；",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "巨大儿",
      "attributes": {
        "evidence": "对胎儿的风险包括：巨大儿(体重超过4公斤)、低血糖、黄疸、肩难产、出生后发展为肥胖和2型糖尿病的风险增加等。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "新生儿低血糖",
      "attributes": {
        "evidence": "对胎儿的风险包括：巨大儿(体重超过4公斤)、低血糖、黄疸、肩难产、出生后发展为肥胖和2型糖尿病的风险增加等。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "低GI食物",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "加餐可选择低GI食物如坚果、酸奶等。",
        "confidence": "high",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "高糖食物",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "应避免：1)高糖食物如甜点、糖果、蜂蜜、果酱等；",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "全麦面包",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "推荐食物：1)高纤维食物如全谷物、豆类、蔬菜；",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "低脂牛奶",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "推荐食物：2)优质蛋白如瘦肉、鱼、蛋、豆制品；",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "高纤维食物",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "推荐食物：1)高纤维食物如全谷物、豆类、蔬菜；",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "饮食控制",
      "predicate": "ANSWERS",
      "object": "如何管理血糖",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "剖宫产",
      "attributes": {
        "evidence": "妊娠期糖尿病增加剖宫产风险，特别是当血糖控制不佳导致胎儿过大(巨大儿)时。",
        "confidence": "high",
        "strength": "strong",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "大多数妇女分娩后血糖会恢复正常，但有约50%的妇女将来发展为2型糖尿病的风险增加。",
        "confidence": "high",
        "strength": "strong",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "75g OGTT",
      "attributes": {
        "evidence": "产后6-12周应进行75g OGTT复查，确认血糖是否恢复正常。",
        "confidence": "high",
        "strength": "strong",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "母乳喂养",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "建议妊娠期糖尿病患者积极母乳喂养。",
        "confidence": "high",
        "strength": "strong",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "母乳喂养",
      "predicate": "CAN_CAUSE",
      "object": "胰岛素敏感性",
      "attributes": {
        "evidence": "母乳喂养有助于改善母亲的胰岛素敏感性，降低产后发展为2型糖尿病的风险。",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "健康体重",
      "predicate": "RECOMMENDED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "降低风险的措施包括：1)保持健康体重；",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "规律运动",
      "predicate": "RECOMMENDED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "2)坚持规律运动，每周至少150分钟；",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "精制碳水化合物",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "3)健康饮食，限制精制碳水化合物和添加糖；",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "添加糖",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "3)健康饮食，限制精制碳水化合物和添加糖；",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "血糖筛查",
      "predicate": "RECOMMENDED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "4)定期血糖筛查；",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "吸烟",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "6)避免吸烟和过量饮酒。",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "过量饮酒",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "6)避免吸烟和过量饮酒。",
        "confidence": "high",
        "strength": "moderate",
        "source": "分娩与产后 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "既往妊娠期糖尿病史",
      "attributes": {
        "evidence": "高风险人群包括：既往妊娠期糖尿病史",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "超重或肥胖(BMI≥25)",
      "attributes": {
        "evidence": "高风险人群包括：超重或肥胖者(BMI≥25)",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "多囊卵巢综合征",
      "attributes": {
        "evidence": "高风险人群包括：多囊卵巢综合征患者",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "早产",
      "attributes": {
        "evidence": "对母亲的风险包括：早产",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "剖宫产率增加",
      "attributes": {
        "evidence": "对母亲的风险包括：剖宫产率增加",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "黄疸",
      "attributes": {
        "evidence": "对胎儿的风险包括：黄疸",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "肩难产",
      "attributes": {
        "evidence": "对胎儿的风险包括：肩难产",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "ANSWERS",
      "object": "什么是妊娠期糖尿病？",
      "attributes": {
        "evidence": "妊娠期糖尿病(GDM)是指女性在怀孕期间首次出现的糖尿病",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "ANSWERS",
      "object": "妊娠期糖尿病有哪些风险？",
      "attributes": {
        "evidence": "对母亲的风险包括...对胎儿的风险包括...",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "ANSWERS",
      "object": "哪些人群容易患妊娠期糖尿病？",
      "attributes": {
        "evidence": "高风险人群包括...",
        "confidence": "high",
        "strength": "strong",
        "source": "基础知识 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "妊娠高血压疾病",
      "attributes": {
        "evidence": "妊娠期糖尿病可能导致的并发症包括：妊娠高血压疾病",
        "confidence": "high",
        "strength": "moderate",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "羊水过多",
      "attributes": {
        "evidence": "妊娠期糖尿病可能导致的并发症包括：羊水过多",
        "confidence": "high",
        "strength": "moderate",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "呼吸窘迫综合征",
      "attributes": {
        "evidence": "妊娠期糖尿病可能导致的并发症包括：呼吸窘迫综合征",
        "confidence": "high",
        "strength": "moderate",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "胎盘早剥",
      "attributes": {
        "evidence": "妊娠期糖尿病患者胎盘早剥的风险略有增加",
        "confidence": "high",
        "strength": "moderate",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "血糖控制",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "良好的血糖控制可以显著降低这些并发症的风险",
        "confidence": "high",
        "strength": "strong",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "定期产检",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "良好的血糖控制和定期产检可以帮助早期发现并降低这一风险",
        "confidence": "high",
        "strength": "strong",
        "source": "并发症 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "心理压力",
      "attributes": {
        "evidence": "被诊断为妊娠期糖尿病可能带来焦虑和压力",
        "confidence": "high",
        "strength": "strong",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "产后抑郁",
      "attributes": {
        "evidence": "研究表明，妊娠期糖尿病患者产后抑郁的风险略高",
        "confidence": "high",
        "strength": "moderate",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "激素变化",
      "attributes": {
        "evidence": "这可能与激素变化、血糖波动和育儿压力相关",
        "confidence": "medium",
        "strength": "moderate",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "血糖波动",
      "attributes": {
        "evidence": "这可能与激素变化、血糖波动和育儿压力相关",
        "confidence": "medium",
        "strength": "moderate",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "育儿压力",
      "attributes": {
        "evidence": "这可能与激素变化、血糖波动和育儿压力相关",
        "confidence": "medium",
        "strength": "moderate",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "心理专家咨询",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "如有需要，咨询心理专家",
        "confidence": "high",
        "strength": "strong",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "社会支持",
      "predicate": "RECOMMENDED_FOR",
      "object": "产后抑郁",
      "attributes": {
        "evidence": "保持社会支持，并在感到情绪低落持续两周以上时及时咨询专业人士",
        "confidence": "high",
        "strength": "strong",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "心理专家咨询",
      "predicate": "RECOMMENDED_FOR",
      "object": "产后抑郁",
      "attributes": {
        "evidence": "并在感到情绪低落持续两周以上时及时咨询专业人士",
        "confidence": "high",
        "strength": "strong",
        "source": "心理健康 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "血糖监测",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "ANSWERS",
      "object": "妊娠期糖尿病如何治疗？",
      "attributes": {
        "evidence": "治疗包括饮食控制、适当运动、血糖监测，必要时使用胰岛素。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "饮食控制",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "饮食原则包括：1)控制总热量摄入，根据孕前BMI和孕期体重增长情况个体化制定；2)合理分配三大营养素，碳水化合物40-50%，蛋白质15-20%，脂肪30-35%；3)减少精制碳水化合物，增加膳食纤维；4)少食多餐，通常三餐加三次加餐；5)避免含糖饮料和精制糖。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "运动疗法",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "适合的运动包括散步、游泳、孕妇瑜伽等低强度有氧运动。建议每周至少150分钟中等强度有氧运动，最好分散在一周中的大多数天进行，每次运动10-30分钟。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "散步",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "适合的运动包括散步、游泳、孕妇瑜伽等低强度有氧运动。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "孕妇瑜伽",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "适合的运动包括散步、游泳、孕妇瑜伽等低强度有氧运动。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "血糖监测",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "使用血糖仪定期检测空腹和餐后血糖。一般建议每天监测4-6次：空腹和三餐后1或2小时。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "血糖仪",
      "predicate": "DIAGNOSED_BY",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "使用血糖仪定期检测空腹和餐后血糖。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "空腹血糖",
      "predicate": "DIAGNOSED_BY",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "使用血糖仪定期检测空腹和餐后血糖。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "餐后血糖",
      "predicate": "DIAGNOSED_BY",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "使用血糖仪定期检测空腹和餐后血糖。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "胰岛素治疗",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "当饮食和运动无法有效控制血糖时，医生可能会建议使用胰岛素。通常在1-2周的生活方式干预后，如果空腹血糖仍≥5.3mmol/L或餐后1小时血糖≥7.8mmol/L，需要考虑胰岛素治疗。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "二甲双胍",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "大多数口服降糖药在妊娠期是不推荐使用的。二甲双胍在某些特定情况下可能会使用，但需要在医生严格指导下进行，不应自行服用任何降糖药物。",
        "confidence": "high",
        "strength": "moderate",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "含糖饮料",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "避免含糖饮料和精制糖。",
        "confidence": "high",
        "strength": "strong",
        "source": "治疗管理 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "血糖异常",
      "attributes": {
        "evidence": "遵守规律饮食和监测血糖",
        "confidence": "high",
        "strength": "strong",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "健康零食",
      "attributes": {
        "evidence": "携带健康零食应对延误",
        "confidence": "high",
        "strength": "moderate",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "久坐",
      "attributes": {
        "evidence": "长途旅行时定时活动避免久坐",
        "confidence": "high",
        "strength": "moderate",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "时差影响",
      "attributes": {
        "evidence": "注意时差对用药和进餐时间的影响",
        "confidence": "medium",
        "strength": "moderate",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "过度疲劳",
      "attributes": {
        "evidence": "保持规律作息，避免过度疲劳",
        "confidence": "medium",
        "strength": "moderate",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "饮食计划",
      "attributes": {
        "evidence": "提前计划饮食，必要时自带健康食物",
        "confidence": "high",
        "strength": "strong",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "ANSWERS",
      "object": "如何管理血糖",
      "attributes": {
        "evidence": "遵守规律饮食和监测血糖",
        "confidence": "high",
        "strength": "strong",
        "source": "生活调整 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "75g口服葡萄糖耐量试验(OGTT)",
      "attributes": {
        "evidence": "通常使用75g口服葡萄糖耐量试验(OGTT)进行诊断。",
        "confidence": "high",
        "strength": "strong",
        "source": "诊断与筛查 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "既往GDM史",
      "attributes": {
        "evidence": "对于高风险孕妇(如有糖尿病家族史、既往GDM史、BMI≥30等)，可能会在首次产前检查时进行早期筛查。",
        "confidence": "high",
        "strength": "moderate",
        "source": "诊断与筛查 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "BMI≥30",
      "attributes": {
        "evidence": "对于高风险孕妇(如有糖尿病家族史、既往GDM史、BMI≥30等)，可能会在首次产前检查时进行早期筛查。",
        "confidence": "high",
        "strength": "moderate",
        "source": "诊断与筛查 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病如何诊断？",
      "predicate": "ANSWERS",
      "object": "75g口服葡萄糖耐量试验(OGTT)",
      "attributes": {
        "evidence": "Q: 妊娠期糖尿病如何诊断？ A: 通常使用75g口服葡萄糖耐量试验(OGTT)进行诊断。",
        "confidence": "high",
        "strength": "strong",
        "source": "诊断与筛查 FAQ"
      }
    },
    {
      "subject": "少食多餐",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "建议少食多餐，一日三餐加上2-3次加餐",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "精制碳水化合物",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "3)精制碳水化合物如白面包、白米饭等",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "低GI水果",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "4)低GI水果如苹果、梨、橙子(适量)",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "少食多餐",
      "predicate": "ANSWERS",
      "object": "如何安排一日三餐？",
      "attributes": {
        "evidence": "Q: 如何安排一日三餐？ A: 建议少食多餐",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "高糖食物",
      "predicate": "ANSWERS",
      "object": "哪些食物应该避免？",
      "attributes": {
        "evidence": "Q: 哪些食物应该避免？ A: 应避免：1)高糖食物如甜点、糖果、蜂蜜、果酱等",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "高纤维食物",
      "predicate": "ANSWERS",
      "object": "哪些食物可以多吃？",
      "attributes": {
        "evidence": "Q: 哪些食物可以多吃？ A: 推荐食物：1)高纤维食物如全谷物、豆类、蔬菜",
        "confidence": "high",
        "strength": "strong",
        "source": "饮食建议 FAQ"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "IS_A",
      "object": "内分泌疾病",
      "attributes": {
        "evidence": "GDM 会显著增加不良妊娠结局的风险，包括自然流产、胎儿畸形、先兆子痫、胎儿死亡、巨大儿、新生儿低血糖、新生儿高胆红素血症和新生儿呼吸窘迫综合征等",
        "confidence": "high",
        "strength": "strong",
        "source": "中国妊娠期糖尿病母儿共同管理指南（2024版）"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "高龄产妇",
      "attributes": {
        "evidence": "随着我国糖尿病患病人数的快速增长以及生育政策放开后高龄产妇的增加，妊娠期糖尿病（gestational diabetes mellitus，GDM）患病人数逐年攀升",
        "confidence": "high",
        "strength": "strong",
        "source": "中国妊娠期糖尿病母儿共同管理指南（2024版）"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "先兆子痫",
      "attributes": {
        "evidence": "GDM 会显著增加不良妊娠结局的风险，包括自然流产、胎儿畸形、先兆子痫、胎儿死亡、巨大儿、新生儿低血糖、新生儿高胆红素血症和新生儿呼吸窘迫综合征等",
        "confidence": "high",
        "strength": "strong",
        "source": "中国妊娠期糖尿病母儿共同管理指南（2024版）"
      }
    },
    {
      "subject": "中国妊娠期糖尿病母儿共同管理指南",
      "predicate": "RECOMMENDS",
      "object": "产后筛查",
      "attributes": {
        "evidence": "该指南强调 GDM 孕妇及其子代共同管理的重要性及必要性，阐述了 GDM 孕妇及其子代监测和管理的具体策略",
        "confidence": "high",
        "strength": "strong",
        "source": "中国妊娠期糖尿病母儿共同管理指南（2024版）"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "血糖升高",
      "attributes": {
        "evidence": "经生活方式干预1周后，应行24 h血糖轮廓试验［自我血糖监测（self‑monitoring of blood glucose，SMBG）或持续葡萄糖监测（continuous glucose monitoring，CGM）］，包括夜间血糖、三餐前30 min血糖、三餐后2 h血糖及尿酮体检测。如果 FPG 或餐前血糖≥5.",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "低GI食物",
      "attributes": {
        "evidence": "低 GI 饮食模式有助于改善 GDM 孕妇血糖控制，减少胰岛素治疗需求，降低新生儿出生体重和巨大儿风险，改善 GDM 母婴结局",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "高糖食物",
      "attributes": {
        "evidence": "GDM 孕妇饮食中应包括新鲜蔬菜、水果、全谷物、豆类、鱼类和充足的水分，适量摄入乳制品和坚果，适量摄入红肉，严格限制摄入油炸食品、腌制食品、精制谷物，避免饮酒、吸烟以及服用非必要的药物",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "二甲双胍",
      "attributes": {
        "evidence": "GDM 孕妇因主客观原因无法使用胰岛素，在排除禁忌证后，经知情同意可使用二甲双胍控制血糖",
        "confidence": "high",
        "strength": "strong",
        "source": "中国研究型医院 2024 年12 月第 11 卷第 6 期"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "胰岛素抵抗",
      "attributes": {
        "evidence": "孕前超重或肥胖的 GDM 孕妇，可能出现胰岛素抵抗",
        "confidence": "high",
        "strength": "strong",
        "source": "中国研究型医院 2024 年12 月第 11 卷第 6 期"
      }
    },
    {
      "subject": "ADA指南",
      "predicate": "RECOMMENDS",
      "object": "产后筛查",
      "attributes": {
        "evidence": "ADA指南 RECOMMENDS 产后筛查",
        "confidence": "high",
        "strength": "strong",
        "source": "中国研究型医院 2024 年12 月第 11 卷第 6 期"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "低血糖",
      "attributes": {
        "evidence": "低血糖可表现为交感神经兴奋（如心悸、焦虑、出汗、头晕、手抖、饥饿感等）和中枢神经系统症状（如神志改变、认知障碍、抽搐和昏迷），需注意识别。",
        "confidence": "high",
        "strength": "strong",
        "source": "中国研究型医院 2024 年12 月第 11 卷第 6 期"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "母乳喂养",
      "attributes": {
        "evidence": "母乳喂养为 GDM 产妇及其子代带来了多种代谢益处。在有 GDM 病史的女性中，有证据表明，较长时间的母乳喂养，与未来患 T2DM、代谢综合征、心血管疾病的风险降低有关。",
        "confidence": "high",
        "strength": "strong",
        "source": "中国研究型医院 2024 年12 月第 11 卷第 6 期"
      }
    },
    {
      "subject": "母乳喂养",
      "predicate": "CAN_CAUSE",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "母乳喂养可以降低儿童肥胖的发生风险，纯母乳喂养的时间与儿童肥胖发生率呈剂量反应关系，即母乳喂养时间越长，儿童肥胖的发生风险越低",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "纯母乳喂养",
      "predicate": "RECOMMENDED_FOR",
      "object": "婴儿",
      "attributes": {
        "evidence": "建议纯母乳喂养满 6 个月，尽早开奶，按需哺乳，亲喂哺乳，满 6 月龄时在添加辅食的基础上，母乳喂养可持续到 2岁及以上",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "婴儿",
      "predicate": "HAS_SYMPTOM",
      "object": "维生素D缺乏",
      "attributes": {
        "evidence": "纯母乳喂养的婴儿出生后数日开始每日补充维生素 D 400 IU（10 μg）",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "辅食添加",
      "predicate": "HAS_RISK_FACTOR",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "婴儿固体辅食添加早于4个月或摄入高蛋白质饮食可增加儿童期发生肥胖的风险",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "儿童及青少年",
      "predicate": "RECOMMENDED_FOR",
      "object": "全谷物",
      "attributes": {
        "evidence": "鼓励 2 岁以上儿童保证膳食多样性，在日常膳食中适量食用全谷物",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "含糖饮料",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "儿童及青少年",
      "attributes": {
        "evidence": "减少或限制含糖饮料摄入，足量饮水，少量多次",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "不吃早餐",
      "predicate": "HAS_RISK_FACTOR",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "不吃早餐和早餐食物种类单一会影响儿童能量和营养素的摄入，增加儿童肥胖的发生风险",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "视屏行为",
      "predicate": "HAS_RISK_FACTOR",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "儿童视屏行为会影响食物选择、食物摄入量、睡眠时间和身体活动水平等，从而增加超重肥胖的发生风险",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "GDM",
      "predicate": "TREATED_BY",
      "object": "运动干预",
      "attributes": {
        "evidence": "GDM 孕妇的管理应将运动干预、营养干预、药物治疗、血糖监测、产后随访有机结合",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "GDM",
      "predicate": "TREATED_BY",
      "object": "营养干预",
      "attributes": {
        "evidence": "GDM 孕妇的管理应将运动干预、营养干预、药物治疗、血糖监测、产后随访有机结合",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "运动疗法",
      "predicate": "ANSWERS",
      "object": "如何管理血糖",
      "attributes": {
        "evidence": "Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review",
        "confidence": "high",
        "strength": "strong",
        "source": "J Physiother, 2016"
      }
    },
    {
      "subject": "地中海饮食",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "Assaf‑Balut C, García de la Torre N, Durán A, et al. A Mediterranean diet with additional extra virgin olive oil and pistachios reduces the incidence of gestational diabetes mellitus (GDM): a randomized controlled trial: the St. Carlos GDM prevention study[J]. PLoS One, 2017, 12(10):e0185873.",
        "confidence": "high",
        "strength": "strong",
        "source": "PLoS One"
      }
    },
    {
      "subject": "益生菌",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "Mu J, Guo X, Zhou Y, et al. The effects of probiotics/synbiotics on glucose and lipid metabolism in women with gestational diabetes mellitus: a Meta‑analysis of randomized controlled trials[J]. Nutrients, 2023, 15(6):1375.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Nutrients"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "空腹血糖",
      "attributes": {
        "evidence": "中国血糖监测临床应用指南 (2021 年版)",
        "confidence": "high",
        "strength": "strong",
        "source": "中华医学会糖尿病学分会, 2021"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood",
        "confidence": "high",
        "strength": "moderate",
        "source": "Lawlor DA, Lichtenstein P, Långström N. Circulation, 2011"
      }
    },
    {
      "subject": "母乳喂养",
      "predicate": "RECOMMENDED_FOR",
      "object": "儿童肥胖预防",
      "attributes": {
        "evidence": "The association between breastfeeding and childhood obesity: a meta-analysis",
        "confidence": "high",
        "strength": "moderate",
        "source": "Yan J, Liu L, Zhu Y, et al. BMC Public Health, 2014"
      }
    },
    {
      "subject": "高糖食物",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "儿童肥胖",
      "attributes": {
        "evidence": "Unhealthy food and beverage consumption in children and risk of overweight and obesity: a systematic review and Meta-analysis",
        "confidence": "high",
        "strength": "strong",
        "source": "Rousham EK, Goudet S, Markey O, et al. Adv Nutr, 2022"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "IS_A",
      "object": "temporary disease",
      "attributes": {
        "evidence": "GDM is a temporary disease that occurs during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "INTRODUCTION section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "GDM can lead to an increased risk of developing type 2 diabetes (T2D) later in life",
        "confidence": "high",
        "strength": "strong",
        "source": "INTRODUCTION section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "diabetes family history",
      "attributes": {
        "evidence": "my mother-in-law has diabetes so it is easy for me to follow the diet for GDM",
        "confidence": "high",
        "strength": "moderate",
        "source": "MRS PARIMALA testimony"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "TREATED_BY",
      "object": "diet",
      "attributes": {
        "evidence": "I was advised to follow a diet – restrict sugar and carbohydrates, eat more wheat products",
        "confidence": "high",
        "strength": "strong",
        "source": "MRS PARIMALA testimony"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "TREATED_BY",
      "object": "exercise",
      "attributes": {
        "evidence": "I was advised to follow a diet...and to exercise",
        "confidence": "high",
        "strength": "strong",
        "source": "MRS PARIMALA testimony"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "high blood pressure",
      "attributes": {
        "evidence": "many of these women experience pregnancy related complications including high blood pressure",
        "confidence": "high",
        "strength": "moderate",
        "source": "INTRODUCTION section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "large birth weight babies",
      "attributes": {
        "evidence": "many of these women experience pregnancy related complications including...large birth weight babies",
        "confidence": "high",
        "strength": "moderate",
        "source": "INTRODUCTION section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "obstructed labour",
      "attributes": {
        "evidence": "many of these women experience pregnancy related complications including...obstructed labour",
        "confidence": "high",
        "strength": "moderate",
        "source": "INTRODUCTION section"
      }
    },
    {
      "subject": "IDF Model of Care",
      "predicate": "RECOMMENDS",
      "object": "postpartum follow up",
      "attributes": {
        "evidence": "This presents a good opportunity for a T2D prevention project in women who experienced GDM as follow up rates in India after delivery are generally much lower",
        "confidence": "high",
        "strength": "moderate",
        "source": "KEY ACCOMPLISHMENTS section"
      }
    },
    {
      "subject": "WINGS project",
      "predicate": "RECOMMENDS",
      "object": "Medical Nutrition therapy (MNT)",
      "attributes": {
        "evidence": "This project aimed to provide a situational examination of the burden of GDM in India. It looked to establish a model of care using evidence-based guidelines for GDM treatment",
        "confidence": "medium",
        "strength": "moderate",
        "source": "AIM OF THE WINGS PROJECT section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "The IDF approach for care and management of Gestational Diabetes Mellitus",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "hyperglycaemia",
      "attributes": {
        "evidence": "When I was eight weeks pregnant, the Doctor told me that my blood sugar levels are too high.",
        "confidence": "high",
        "strength": "strong",
        "source": "Patient testimony"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "OGTT",
      "attributes": {
        "evidence": "Initial testing of recruited pregnant women: testing involved a fasting oral glucose tolerance test (OGTT)",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "TREATED_BY",
      "object": "Medical Nutrition therapy (MNT)",
      "attributes": {
        "evidence": "Medical Nutrition therapy (MNT) to improve glucose levels",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "TREATED_BY",
      "object": "Insulin & Oral Hypoglycaemic Agents (OHA)",
      "attributes": {
        "evidence": "Insulin & Oral Hypoglycaemic Agents (OHA) for glycaemic control",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "RECOMMENDED_FOR",
      "object": "Breastfeeding",
      "attributes": {
        "evidence": "Breastfeeding – short-term and long-term benefits",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "IDF Model of Care",
      "predicate": "RECOMMENDS",
      "object": "postpartum screening",
      "attributes": {
        "evidence": "Six-weeks post-delivery check up – to monitor future risk of developing T2D",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF report"
      }
    },
    {
      "subject": "diet",
      "predicate": "ANSWERS",
      "object": "how to manage blood sugar",
      "attributes": {
        "evidence": "I am now following a meal plan prescribed by the Doctor and my sugar levels are well under control.",
        "confidence": "high",
        "strength": "strong",
        "source": "Patient testimony"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "tiredness",
      "attributes": {
        "evidence": "I often felt tired, dizzy and not able to do my day to day activities.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "The IDF approach for care and management of Gestational Diabetes Mellitus, Page 18"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "dysglycaemia",
      "attributes": {
        "evidence": "Among Asian Indians rapid conversion to dysglycaemia occurs (even by 6-12 weeks postpartum).",
        "confidence": "high",
        "strength": "strong",
        "source": "DOI:10.4103/2230-8210.183469"
      }
    },
    {
      "subject": "exercise",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "A low cost culturally appropriate model of care can bring about significant improvements in physical activity in women with GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "DOI:10.1111/JOG.13249"
      }
    },
    {
      "subject": "IDF Model of Care",
      "predicate": "RECOMMENDS",
      "object": "postpartum follow-up",
      "attributes": {
        "evidence": "Therefore there is a need for a strategy to increase postpartum follow-up rates among women with GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "DOI:10.4103/2230-8210.183469"
      }
    },
    {
      "subject": "WINGS project",
      "predicate": "ANSWERS",
      "object": "how to manage GDM",
      "attributes": {
        "evidence": "The results from the WINGS Model of Care demonstrated impressive success in managing more than 85% of women with GDM without drugs and also showed a significant improvement in physical activity of women with GDM under GDM Model of Care.",
        "confidence": "high",
        "strength": "strong",
        "source": "The IDF approach for care and management of Gestational Diabetes Mellitus, Page 17"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "high blood sugar levels",
      "attributes": {
        "evidence": "Now I often feel very weak and tired due to my high blood sugar levels.",
        "confidence": "high",
        "strength": "strong",
        "source": "patient testimony"
      }
    },
    {
      "subject": "IDF Model of Care",
      "predicate": "TREATED_BY",
      "object": "Medical Nutrition therapy (MNT)",
      "attributes": {
        "evidence": "The WINGS Model of Care for GDM offers a comprehensive package of tools for every level of care which includes guides for health care professionals providing care for women diagnosed with GDM.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "IDF WINGS Model of Care report"
      }
    },
    {
      "subject": "IDF Model of Care",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "After implementation of the IDF Model of Care, women with GDM were found to have pregnancy outcomes comparable to women without GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF WINGS Model of Care report"
      }
    },
    {
      "subject": "WINGS project",
      "predicate": "ANSWERS",
      "object": "how to manage Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "The WINGS Model of Care for GDM offers a comprehensive package of tools for every level of care which includes guides for health care professionals providing care for women diagnosed with GDM, community health workers who follow up women in remote areas having limited medical access and also to pregnant women with educational games to improve awareness on GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "IDF WINGS Model of Care report"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "diabetes",
      "attributes": {
        "evidence": "The recommendations cover the management of type 1 diabetes, type 2 diabetes, gestational diabetes mellitus, and other types of diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "Diabetes is a complex, chronic condition requiring continuous medical care with multifactorial risk-reduction strategies beyond glucose management.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "family history of diabetes",
      "attributes": {
        "evidence": "Diabetes is a complex, chronic condition requiring continuous medical care with multifactorial risk-reduction strategies beyond glucose management.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "advanced maternal age",
      "attributes": {
        "evidence": "The recommendations cover the management of type 1 diabetes, type 2 diabetes, gestational diabetes mellitus, and other types of diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "diabetes",
      "predicate": "CAN_CAUSE",
      "object": "diabetic retinopathy",
      "attributes": {
        "evidence": "The Standards of Care does not provide comprehensive treatment plans for complications associated with diabetes, such as diabetic retinopathy or diabetic foot ulcers.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "diabetes",
      "predicate": "CAN_CAUSE",
      "object": "diabetic foot ulcers",
      "attributes": {
        "evidence": "The Standards of Care does not provide comprehensive treatment plans for complications associated with diabetes, such as diabetic retinopathy or diabetic foot ulcers.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "ADA guidelines",
      "predicate": "RECOMMENDS",
      "object": "postpartum screening",
      "attributes": {
        "evidence": "The ADA strives to improve and update the Standards of Care to ensure that clinicians, health plans, and policy makers can continue to rely on it as the most authoritative source for current guidelines for diabetes care.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "diet control",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "Ongoing diabetes self-management education and support are critical to empowering people, preventing acute complications, and reducing the risk of long-term complications.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "exercise therapy",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "Ongoing diabetes self-management education and support are critical to empowering people, preventing acute complications, and reducing the risk of long-term complications.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "Standards of Care in Diabetes—2023",
      "predicate": "RECOMMENDS",
      "object": "postpartum screening",
      "attributes": {
        "evidence": "The ADA Standards of Care is an essential resource for health care professionals caring for people with diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "The ADA has been actively involved in developing and disseminating diabetes care clinical practice recommendations and related documents for more than 30 years.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "OGTT",
      "attributes": {
        "evidence": "The annual Standards of Care supplement to Diabetes Care contains the official ADA position, is authored by the ADA, and provides all of the ADA’s current clinical practice recommendations.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "insulin therapy",
      "attributes": {
        "evidence": "The ADA Standards of Care is an essential resource for health care professionals caring for people with diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Standards of Care in Diabetes—2023"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "先天性畸形",
      "attributes": {
        "evidence": "Explain to women with diabetes who are planning a pregnancy that: • if they have good blood glucose control before conception and throughout their pregnancy, this will reduce the risk of miscarriage, congenital malformation, stillbirth and neonatal death",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE guideline"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "产后筛查",
      "attributes": {
        "evidence": "5 Postnatal treatment for women diagnosed with gestational diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline"
      }
    },
    {
      "subject": "实时连续血糖监测",
      "predicate": "RECOMMENDED_FOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "1.1 Preconception care for women with diabetes: insulin pump therapy and real-time continuous glucose monitoring",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "hypoglycaemia",
      "attributes": {
        "evidence": "the risks of hypoglycaemia and impaired awareness of hypoglycaemia during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "impaired awareness of hypoglycaemia",
      "attributes": {
        "evidence": "the risks of hypoglycaemia and impaired awareness of hypoglycaemia during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "large for gestational age",
      "attributes": {
        "evidence": "the increased risk of having a baby who is large for gestational age",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "large for gestational age",
      "predicate": "CAN_CAUSE",
      "object": "birth trauma",
      "attributes": {
        "evidence": "which increases the likelihood of birth trauma",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "large for gestational age",
      "predicate": "CAN_CAUSE",
      "object": "induction of labour",
      "attributes": {
        "evidence": "which increases the likelihood of ... induction of labour",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "large for gestational age",
      "predicate": "CAN_CAUSE",
      "object": "caesarean section",
      "attributes": {
        "evidence": "which increases the likelihood of ... caesarean section deliveries",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "metformin",
      "attributes": {
        "evidence": "Women with diabetes may be advised to use metformin as an adjunct or alternative to insulin in the preconception period and during pregnancy",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "folic acid",
      "attributes": {
        "evidence": "Advise women with diabetes who are planning a pregnancy to take folic acid (5 mg/day) until 12 weeks of gestation to reduce the risk of having a baby with a neural tube defect",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "HbA1c",
      "attributes": {
        "evidence": "Offer up to monthly measurement of HbA1c levels for women with diabetes who are planning a pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "BMI of 30 kg/m2 or over",
      "attributes": {
        "evidence": "At the booking appointment, check for the following risk factors: • BMI of 30 kg/m2 or over",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "previous macrosomic baby weighing 4.5 kg or more",
      "attributes": {
        "evidence": "At the booking appointment, check for the following risk factors: • previous macrosomic baby weighing 4.5 kg or more",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "previous gestational diabetes",
      "attributes": {
        "evidence": "At the booking appointment, check for the following risk factors: • previous gestational diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "family history of diabetes (first-degree relative with diabetes)",
      "attributes": {
        "evidence": "At the booking appointment, check for the following risk factors: • family history of diabetes (first-degree relative with diabetes)",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "an ethnicity with a high prevalence of diabetes",
      "attributes": {
        "evidence": "At the booking appointment, check for the following risk factors: • an ethnicity with a high prevalence of diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "75-g 2-hour oral glucose tolerance test (OGTT)",
      "attributes": {
        "evidence": "Use the 75-g 2-hour oral glucose tolerance test (OGTT) to test for gestational diabetes in women with risk factors",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "insulin",
      "attributes": {
        "evidence": "If metformin is contraindicated or unacceptable to the woman, offer insulin",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "fetal macrosomia",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of fetal macrosomia",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "trauma during birth",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of trauma during birth (for her and her baby)",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "induction of labour",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of induction of labour",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "caesarean section",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of caesarean section",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "neonatal hypoglycaemia",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of neonatal hypoglycaemia",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "perinatal death",
      "attributes": {
        "evidence": "that good blood glucose control throughout pregnancy will reduce the risk of perinatal death",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "preconception blood glucose control",
      "attributes": {
        "evidence": "healthcare professionals (including the diabetes care team) should explain the benefits of preconception blood glucose control",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "retinal assessment before pregnancy",
      "attributes": {
        "evidence": "For women with diabetes who are seeking preconception care, offer a retinal assessment at their first appointment",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "renal assessment before pregnancy",
      "attributes": {
        "evidence": "Offer women with diabetes a renal assessment (including a measure of albuminuria) before stopping contraception",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting plasma glucose level",
      "attributes": {
        "evidence": "For women with gestational diabetes who have a fasting plasma glucose level of 7.0 mmol/litre or above at diagnosis, offer: immediate treatment with insulin, with or without metformin and diet and exercise changes.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "macrosomia",
      "attributes": {
        "evidence": "For women with gestational diabetes who have a fasting plasma glucose level of between 6.0 and 6.9 mmol/litre and complications such as macrosomia or hydramnios, consider: immediate treatment with insulin, with or without metformin and diet and exercise changes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hydramnios",
      "attributes": {
        "evidence": "For women with gestational diabetes who have a fasting plasma glucose level of between 6.0 and 6.9 mmol/litre and complications such as macrosomia or hydramnios, consider: immediate treatment with insulin, with or without metformin and diet and exercise changes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "diet and exercise changes",
      "attributes": {
        "evidence": "For women with gestational diabetes who have a fasting plasma glucose level of 7.0 mmol/litre or above at diagnosis, offer: immediate treatment with insulin, with or without metformin and diet and exercise changes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "continuous subcutaneous insulin infusion",
      "attributes": {
        "evidence": "Offer continuous subcutaneous insulin infusion (CSII; also known as insulin pump therapy) to pregnant women with insulin-treated diabetes who: are using multiple daily injections of insulin and do not achieve blood glucose control without significant disabling hypoglycaemia.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "real-time continuous glucose monitoring",
      "attributes": {
        "evidence": "Offer real-time continuous glucose monitoring (rtCGM) to all pregnant women with type 1 diabetes to help them meet their pregnancy blood glucose targets and improve neonatal outcomes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "intermittently scanned continuous glucose monitoring",
      "attributes": {
        "evidence": "Offer intermittently scanned continuous glucose monitoring (isCGM, commonly referred to as 'flash') to pregnant women with type 1 diabetes who are unable to use rtCGM or express a clear preference for isCGM.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "diabetic ketoacidosis",
      "attributes": {
        "evidence": "Immediately admit pregnant women with suspected diabetic ketoacidosis for level 2 critical care, where they can receive both medical and obstetric care.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "diabetic retinopathy",
      "attributes": {
        "evidence": "After pregnant women with pre-existing diabetes have had their first antenatal clinic appointment: offer retinal assessment by digital imaging with mydriasis using tropicamide (unless they have had a retinal assessment in the last 3 months) if they have diabetic retinopathy, offer an additional retinal assessment at 16 to 20 weeks offer another retinal assessment at 28 weeks.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "Diabetic retinopathy",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "rapid optimisation of blood glucose control",
      "attributes": {
        "evidence": "Diabetic retinopathy should not be considered a contraindication to rapid optimisation of blood glucose control in women who present with a high HbA1c in early pregnancy.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "Diabetic retinopathy",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "vaginal birth",
      "attributes": {
        "evidence": "Diabetic retinopathy should not be considered a contraindication to vaginal birth.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "pregnant women with diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "nephropathy",
      "attributes": {
        "evidence": "Consider referring pregnant women with diabetes to a nephrologist if: • their serum creatinine is 120 micromol/litre or more or • the urinary albumin:creatinine ratio is greater than 30 mg/mmol or • total protein excretion exceeds 0.5 g/day.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "pregnant women with diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "ultrasound scan",
      "attributes": {
        "evidence": "Offer women with diabetes an ultrasound scan at 20 weeks to detect fetal structural abnormalities, including examination of the fetal heart (4 chambers, outflow tracts and 3 vessels).",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "pregnant women with diabetes",
      "predicate": "TREATED_BY",
      "object": "ultrasound monitoring",
      "attributes": {
        "evidence": "Offer pregnant women with diabetes ultrasound monitoring of fetal growth and amniotic fluid volume every 4 weeks from 28 to 36 weeks.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "pregnant women with diabetes",
      "predicate": "TREATED_BY",
      "object": "induction of labour",
      "attributes": {
        "evidence": "Offer induction of labour or (if indicated) caesarean section to women with type 1 or type 2 diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "postpartum screening",
      "attributes": {
        "evidence": "Provide information and advice about: • timing, mode and management of birth • analgesia and anaesthesia • changes to blood glucose-lowering therapy during and after birth • care of the baby after birth • starting to breastfeed and the effect of breastfeeding on blood glucose control • contraception and follow-up.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "NICE guideline NG3"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "betamimetic medicines",
      "attributes": {
        "evidence": "Do not use betamimetic medicines for tocolysis in women with diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "elective birth by induced labour or caesarean section",
      "attributes": {
        "evidence": "Advise pregnant women with type 1 or type 2 diabetes and no other complications to have an elective birth by induced labour or (if indicated) caesarean section, between 37 weeks and 38 weeks plus 6 days of pregnancy.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "macrosomic fetus",
      "attributes": {
        "evidence": "For pregnant women with diabetes who have an ultrasound-diagnosed macrosomic fetus, explain the risks and benefits of vaginal birth, induction of labour and caesarean section.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "For women with diabetes and comorbidities such as obesity or autonomic neuropathy, offer an anaesthetic assessment in the third trimester of pregnancy.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "TREATED_BY",
      "object": "intravenous dextrose and insulin infusion",
      "attributes": {
        "evidence": "Consider intravenous dextrose and insulin infusion from the onset of established labour for women with type 1 diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "hypoglycaemia",
      "attributes": {
        "evidence": "Explain to women with insulin-treated pre-existing diabetes that they are at increased risk of hypoglycaemia in the postnatal period (especially when breastfeeding), and advise them to have a meal or snack available before or during feeds.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "metformin",
      "attributes": {
        "evidence": "Women with pre-existing type 2 diabetes who are breastfeeding can resume or continue metformin immediately after birth, but should avoid other oral blood glucose-lowering therapy while breastfeeding.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "hyperglycaemia",
      "attributes": {
        "evidence": "Remind women who were diagnosed with gestational diabetes of the symptoms of hyperglycaemia",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "congenital malformations",
      "attributes": {
        "evidence": "Babies born to women with diabetes have a high risk of having congenital malformations",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "胎儿宫内死亡",
      "attributes": {
        "evidence": "Unexpected intrauterine death remains a significant contributor to perinatal mortality in pregnant women with diabetes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "NICE 2025"
      }
    },
    {
      "subject": "实时连续血糖监测",
      "predicate": "TREATED_BY",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "The committee recommended that rtCGM should be offered to all women with type 1 diabetes to help women meet their pregnancy blood glucose targets and improve neonatal outcomes.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE 2025"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "产后出血",
      "attributes": {
        "evidence": "Miscarriage, pre-eclampsia and preterm labour are more common in women with pre-existing diabetes.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "NICE指南"
      }
    },
    {
      "subject": "NICE指南",
      "predicate": "RECOMMENDS",
      "object": "实时连续血糖监测",
      "attributes": {
        "evidence": "The committee believed that education and support are important for pregnant women using continuous glucose monitoring (CGM), to ensure they get the full benefit. Therefore, they updated and expanded the 2015 recommendation on providing support.",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "多尿",
      "attributes": {
        "evidence": "Diabetes in pregnancy: management from preconception to the postnatal period",
        "confidence": "high",
        "strength": "strong",
        "source": "NICE指南"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "Gestational diabetes also increases with the same risk factors seen for type 2 diabetes such as obesity and increased age.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "increased age",
      "attributes": {
        "evidence": "Gestational diabetes also increases with the same risk factors seen for type 2 diabetes such as obesity and increased age.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "preeclampsia",
      "attributes": {
        "evidence": "Women with GDM have a higher risk of developing preeclampsia (9.8% in those with a fasting glucose less than 115 mg/dL and 18% in those with a fasting glucose greater than or equal to 115 mg/dL).",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "cesarean delivery",
      "attributes": {
        "evidence": "25% of women with GDM who require medication and 17% of women with diet-controlled GDM underwent cesarean delivery versus 9.5% of controls.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Furthermore, women with GDM have an increased risk of developing diabetes (predominantly type 2 diabetes) later in life.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "macrosomia",
      "attributes": {
        "evidence": "The offspring of women with GDM are at increased risk of macrosomia, neonatal hypoglycemia, hyperbilirubinemia, shoulder dystocia, and birth trauma.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "neonatal hypoglycemia",
      "attributes": {
        "evidence": "The offspring of women with GDM are at increased risk of macrosomia, neonatal hypoglycemia, hyperbilirubinemia, shoulder dystocia, and birth trauma.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "OGTT",
      "attributes": {
        "evidence": "The two-step approach to testing for GDM that is commonly used in the United States is based on first screening with the administration of a 50-g oral glucose solution followed by a 1-hour venous glucose determination. Women whose glucose levels meet or exceed an institution’s screening threshold then undergo a 100-g, 3-hour diagnostic OGTT.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "insulin therapy",
      "attributes": {
        "evidence": "Gestational diabetes mellitus that requires medication to achieve euglycemia is often termed class A2GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "diet-controlled GDM",
      "attributes": {
        "evidence": "Gestational diabetes that is adequately controlled without medication is often termed diet-controlled GDM or class A1GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "ACOG Practice Bulletin"
      }
    },
    {
      "subject": "U.S. Preventive Services Task Force",
      "predicate": "RECOMMENDS",
      "object": "screening all pregnant women for GDM at or beyond 24 weeks of gestation",
      "attributes": {
        "evidence": "Therefore, in 2014, the U.S. Preventive Services Task Force made a recommendation to screen all pregnant women for GDM at or beyond 24 weeks of gestation",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "nutrition therapy",
      "attributes": {
        "evidence": "Once a woman with GDM begins nutrition therapy (dietary counseling), surveillance of blood glucose levels is required to confirm that glycemic control has been established.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "ADA guidelines",
      "predicate": "RECOMMENDS",
      "object": "nutritional counseling",
      "attributes": {
        "evidence": "The ADA recommends nutritional counseling by a registered dietitian and development of a personalized nutrition plan based on the individual’s body mass index for all patients with GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "complex carbohydrates",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "Given these findings and the results of other treatment trials, complex carbohydrates are recommended over simple carbohydrates because they are digested more slowly, are less likely to produce significant postprandial hyperglycemia, and potentially reduce insulin resistance.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "postprandial hyperglycemia",
      "attributes": {
        "evidence": "A diet composed of 50–60% carbohydrates often will result in excessive weight gain and postprandial hyperglycemia.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "ACOG recommendations",
      "predicate": "RECOMMENDS",
      "object": "two-step screening approach",
      "attributes": {
        "evidence": "In light of this, the American College of Obstetricians and Gynecologists (ACOG) supports the two-step process and recommends that implications of suggested changes.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "dietary modifications",
      "attributes": {
        "evidence": "Most commonly, GDM management begins with the nonpharmacologic approaches of dietary modifications, exercise, and glucose monitoring.",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "exercise",
      "attributes": {
        "evidence": "Most commonly, GDM management begins with the nonpharmacologic approaches of dietary modifications, exercise, and glucose monitoring.",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "glucose monitoring",
      "attributes": {
        "evidence": "Most commonly, GDM management begins with the nonpharmacologic approaches of dietary modifications, exercise, and glucose monitoring.",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "metformin",
      "attributes": {
        "evidence": "Oral antidiabetic medications (eg, metformin and glyburide) increasingly are being used among women with GDM, despite the fact that they have not been approved by the U.S. Food and Drug Administration for this indication (62) and even though insulin continues to be the ADA-recommended first-line therapy (19).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "glyburide",
      "attributes": {
        "evidence": "Oral antidiabetic medications (eg, metformin and glyburide) increasingly are being used among women with GDM, despite the fact that they have not been approved by the U.S. Food and Drug Administration for this indication (62) and even though insulin continues to be the ADA-recommended first-line therapy (19).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "ADA guidelines",
      "predicate": "RECOMMENDS",
      "object": "insulin therapy",
      "attributes": {
        "evidence": "Oral antidiabetic medications (eg, metformin and glyburide) increasingly are being used among women with GDM, despite the fact that they have not been approved by the U.S. Food and Drug Administration for this indication (62) and even though insulin continues to be the ADA-recommended first-line therapy (19).",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "glyburide",
      "predicate": "CAN_CAUSE",
      "object": "macrosomia",
      "attributes": {
        "evidence": "Previous meta-analyses have noted increased risks of macrosomia and hypoglycemia with glyburide compared with insulin in the treatment of GDM (66, 67); whereas a more recent meta-analysis only demonstrated higher rates of neonatal hypoglycemia (72).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "glyburide",
      "predicate": "CAN_CAUSE",
      "object": "neonatal hypoglycemia",
      "attributes": {
        "evidence": "Previous meta-analyses have noted increased risks of macrosomia and hypoglycemia with glyburide compared with insulin in the treatment of GDM (66, 67); whereas a more recent meta-analysis only demonstrated higher rates of neonatal hypoglycemia (72).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "glyburide",
      "predicate": "CAN_CAUSE",
      "object": "preeclampsia",
      "attributes": {
        "evidence": "Observational studies have reported higher rates of preeclampsia, hyperbilirubinemia, and stillbirth with use of glyburide as compared with insulin, but many other outcomes have not been statistically significantly different (62, 76–81).",
        "confidence": "medium",
        "strength": "weak",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "metformin",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "the placental transfer of the drug, and the absence of long-term data in exposed offspring",
        "confidence": "medium",
        "strength": "moderate",
        "source": "ADA guidelines"
      }
    },
    {
      "subject": "glyburide",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "the evidence indicates that glyburide treatment should not be recommended as a first-choice pharmacologic treatment because, in most studies, it does not yield equivalent outcomes to insulin or metformin",
        "confidence": "high",
        "strength": "strong",
        "source": "multiple studies"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "poor glycemic control",
      "attributes": {
        "evidence": "GDM with poor glycemic control",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "shoulder dystocia",
      "attributes": {
        "evidence": "shoulder dystocia is more likely at any given fetal weight in pregnancies complicated by diabetes than in pregnancies not complicated by diabetes",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "RECOMMENDED_FOR",
      "object": "cesarean delivery",
      "attributes": {
        "evidence": "women with GDM should be counseled regarding the risks and benefits of a scheduled cesarean delivery when the estimated fetal weight is 4,500 g or more",
        "confidence": "high",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "ACOG recommendations",
      "predicate": "RECOMMENDS",
      "object": "postpartum screening",
      "attributes": {
        "evidence": "The ADA and ACOG recommend repeat testing every 1–3 years for women who had a pregnancy affected by GDM and normal postpartum screening test results.",
        "confidence": "high",
        "strength": "strong",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "carbohydrate intolerance",
      "attributes": {
        "evidence": "Women with GDM should be counseled regarding the risks and benefits of a scheduled cesarean delivery when the estimated fetal weight is 4,500 g or more.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Practice Bulletin Gestational Diabetes Mellitus"
      }
    },
    {
      "subject": "low-glycemic index diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diabetes Care 2009;32:996–1000"
      }
    },
    {
      "subject": "diet-controlled GDM",
      "predicate": "ANSWERS",
      "object": "How to manage blood sugar",
      "attributes": {
        "evidence": "Different types of dietary advice for women with gestational diabetes mellitus.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD009275"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "RECOMMENDED_FOR",
      "object": "diet-controlled GDM",
      "attributes": {
        "evidence": "Women with gestational diabetes mellitus randomized to a higher-complex carbohydrate/low-fat diet manifest lower adipose tissue insulin resistance, inflammation, glucose, and free fatty acids.",
        "confidence": "high",
        "strength": "strong",
        "source": "Diabetes Care 2016;39:39–42"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "RECOMMENDED_FOR",
      "object": "physical activity",
      "attributes": {
        "evidence": "Physical activity patterns and gestational diabetes outcomes - the wings project.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Diabetes Res Clin Pract 2016;116:253–62"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "RECOMMENDED_FOR",
      "object": "walking intervention",
      "attributes": {
        "evidence": "A walking intervention improves capillary glucose control in women with gestational diabetes mellitus: a pilot study.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Appl Physiol Nutr Metab 2008;33:511–7"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "fetal macrosomia",
      "attributes": {
        "evidence": "The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus.",
        "confidence": "high",
        "strength": "strong",
        "source": "Am J Obstet Gynecol 2009"
      }
    },
    {
      "subject": "ACOG recommendations",
      "predicate": "RECOMMENDS",
      "object": "postpartum glucose testing",
      "attributes": {
        "evidence": "Rates of postpartum glucose testing after gestational diabetes mellitus.",
        "confidence": "high",
        "strength": "strong",
        "source": "Obstet Gynecol 2006"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational weight gain",
      "attributes": {
        "evidence": "GWG also influenced GDM",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "dietary Approaches to Stop Hypertension",
      "attributes": {
        "evidence": "Lower DII and higher DASH were associated with lower risk of GDM",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "gestational weight gain",
      "predicate": "TREATED_BY",
      "object": "Healthy Eating Index-2015",
      "attributes": {
        "evidence": "higher HEI-2015 and AHEI-2010 were associated with lower risk of GWG",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "gestational weight gain",
      "predicate": "HAS_RISK_FACTOR",
      "object": "advanced maternal age",
      "attributes": {
        "evidence": "higher HEI-2015 and AHEI-2010 were associated with lower risk of GWG, especially for advanced maternal age",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "fruits and vegetables",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "We recommend that pregnant women take dietary precautions with foods consisting of fruits and vegetables, low-fat dairy products, whole grains, and legumes",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "low-fat dairy products",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "We recommend that pregnant women take dietary precautions with foods consisting of fruits and vegetables, low-fat dairy products, whole grains, and legumes",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "whole grains",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "We recommend that pregnant women take dietary precautions with foods consisting of fruits and vegetables, low-fat dairy products, whole grains, and legumes",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "legumes",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "We recommend that pregnant women take dietary precautions with foods consisting of fruits and vegetables, low-fat dairy products, whole grains, and legumes",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 2;25(1):683"
      }
    },
    {
      "subject": "Gestational diabetes",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Gestational diabetes is associated with an increased risk of developing type 2 diabetes later in life.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Self-care interventions",
      "predicate": "RECOMMENDED_FOR",
      "object": "prevention of type 2 diabetes",
      "attributes": {
        "evidence": "Self-care interventions are known to prevent type 2 diabetes in high-risk populations.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Self-care interventions",
      "predicate": "TREATED_BY",
      "object": "diet and physical activity",
      "attributes": {
        "evidence": "the lifestyle intervention focusing on diet and physical activity may have little to no effect",
        "confidence": "medium",
        "strength": "weak",
        "source": "Results"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose tolerance test",
      "attributes": {
        "evidence": "blood glucose level two hours after the oral glucose tolerance test",
        "confidence": "high",
        "strength": "strong",
        "source": "Study Eligibility Criteria"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting blood glucose",
      "attributes": {
        "evidence": "fasting blood glucose",
        "confidence": "high",
        "strength": "strong",
        "source": "Study Eligibility Criteria"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "glycated haemoglobin",
      "attributes": {
        "evidence": "glycated haemoglobin",
        "confidence": "high",
        "strength": "strong",
        "source": "Study Eligibility Criteria"
      }
    },
    {
      "subject": "GRADE approach",
      "predicate": "RECOMMENDS",
      "object": "evaluation of evidence certainty",
      "attributes": {
        "evidence": "The certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.",
        "confidence": "high",
        "strength": "strong",
        "source": "Study Appraisal and Synthesis Methods"
      }
    },
    {
      "subject": "gestational diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "excessive weight gain",
      "attributes": {
        "evidence": "Excessive weight gain during pregnancy is associated with an increased risk of developing gestational diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "gestational diabetes",
      "predicate": "CAN_CAUSE",
      "object": "pre-eclampsia",
      "attributes": {
        "evidence": "Excessive weight gain during pregnancy is associated with an increased risk of developing gestational diabetes, hypertensive disorders such as pre-eclampsia",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "gestational diabetes",
      "predicate": "CAN_CAUSE",
      "object": "preterm birth",
      "attributes": {
        "evidence": "Excessive weight gain during pregnancy is associated with an increased risk of developing gestational diabetes, preterm birth",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "gestational diabetes",
      "predicate": "CAN_CAUSE",
      "object": "long-term obesity",
      "attributes": {
        "evidence": "Excessive weight gain during pregnancy is associated with an increased risk of developing gestational diabetes and a greater likelihood of long-term obesity in both mother and child",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "plant-based diets",
      "predicate": "RECOMMENDED_FOR",
      "object": "maternal health",
      "attributes": {
        "evidence": "An increasing interest in plant-based diets presents an opportunity to consider a range of dietary patterns that support both maternal health and environmental sustainability",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "vitamin B12",
      "predicate": "RECOMMENDED_FOR",
      "object": "plant-based diets",
      "attributes": {
        "evidence": "However, such shifts must be carefully managed to ensure adequate intake of nutrients commonly found in animal products, such as vitamin B12",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "healthy weight",
      "predicate": "RECOMMENDED_FOR",
      "object": "pregnancy",
      "attributes": {
        "evidence": "Maintaining a healthy weight before and during pregnancy plays a key role in supporting maternal and fetal wellbeing",
        "confidence": "high",
        "strength": "strong",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "British Nutrition Foundation",
      "predicate": "RECOMMENDS",
      "object": "healthy weight",
      "attributes": {
        "evidence": "Supporting women to achieve and maintain a healthy weight in the periconceptional period and throughout pregnancy is therefore a public health priority",
        "confidence": "high",
        "strength": "strong",
        "source": "Diet in Pregnancy: A Review of Current Challenges and Recommendations. A British Nutrition Foundation Briefing Paper."
      }
    },
    {
      "subject": "Ultra-processed foods",
      "predicate": "CAN_CAUSE",
      "object": "obesity",
      "attributes": {
        "evidence": "Consumption of UPF is robustly linked to a range of non-communicable diseases, including obesity",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Ultra-processed foods",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Consumption of UPF is robustly linked to a range of non-communicable diseases, including type 2 diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Ultra-processed foods",
      "predicate": "CAN_CAUSE",
      "object": "cardiovascular disease",
      "attributes": {
        "evidence": "Consumption of UPF is robustly linked to a range of non-communicable diseases, including cardiovascular disease",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Ultra-processed foods",
      "predicate": "CAN_CAUSE",
      "object": "mental disorders",
      "attributes": {
        "evidence": "Consumption of UPF is robustly linked to a range of non-communicable diseases, including mental disorders in adults",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Poor maternal nutrition",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high UPF consumption",
      "attributes": {
        "evidence": "Poor maternal nutrition, including high UPF consumption, has been associated with an increased risk of hypertensive disorders, gestational diabetes, and adverse birth weights",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Poor maternal nutrition",
      "predicate": "CAN_CAUSE",
      "object": "hypertensive disorders",
      "attributes": {
        "evidence": "Poor maternal nutrition, including high UPF consumption, has been associated with an increased risk of hypertensive disorders",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Poor maternal nutrition",
      "predicate": "CAN_CAUSE",
      "object": "gestational diabetes",
      "attributes": {
        "evidence": "Poor maternal nutrition, including high UPF consumption, has been associated with an increased risk of gestational diabetes",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Poor maternal nutrition",
      "predicate": "CAN_CAUSE",
      "object": "adverse birth weights",
      "attributes": {
        "evidence": "Poor maternal nutrition, including high UPF consumption, has been associated with an increased risk of adverse birth weights",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "inadequate nutrition",
      "predicate": "HAS_RISK_FACTOR",
      "object": "developmental impairments",
      "attributes": {
        "evidence": "inadequate nutrition is a key risk factor for developmental impairments",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "micronutrient deficiencies",
      "predicate": "CAN_CAUSE",
      "object": "impair neurodevelopment",
      "attributes": {
        "evidence": "micronutrient deficiencies, often exacerbated by diets high in UPFs, which can impair neurodevelopment",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "micronutrient deficiencies",
      "predicate": "CAN_CAUSE",
      "object": "cognitive performance",
      "attributes": {
        "evidence": "micronutrient deficiencies, often exacerbated by diets high in UPFs, which can impair cognitive performance",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Early-life exposure to UPFs",
      "predicate": "CAN_CAUSE",
      "object": "lasting cognitive deficits",
      "attributes": {
        "evidence": "Early-life exposure to UPFs may contribute to lasting cognitive deficits",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Early-life exposure to UPFs",
      "predicate": "CAN_CAUSE",
      "object": "increased susceptibility to mental health disorders",
      "attributes": {
        "evidence": "Early-life exposure to UPFs may contribute to increased susceptibility to mental health disorders",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "fasting blood glucose",
      "attributes": {
        "evidence": "To evaluate the effect of patient education interventions on fasting blood glucose (FBG) in patients with gestational diabetes mellitus (GDM).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "patient education",
      "predicate": "TREATED_BY",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "A GDM-specific education intervention resulted in improved glucose control during pregnancy and up to 6 weeks postpartum.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "patient education",
      "predicate": "RECOMMENDED_FOR",
      "object": "glucose control",
      "attributes": {
        "evidence": "A GDM-specific education intervention resulted in improved glucose control during pregnancy and up to 6 weeks postpartum.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "randomized controlled trials",
      "predicate": "DIAGNOSED_BY",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "Randomized controlled trials which evaluated the effect of GDM-specific education on biochemical assessment of FBG during pregnancy or within 6 weeks postpartum in patients with GDM were included.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Cochrane risk of bias tool",
      "predicate": "DIAGNOSED_BY",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "Cochrane risk of bias tool was used to assess study quality.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "postpartum",
      "attributes": {
        "evidence": "Randomized controlled trials which evaluated the effect of GDM-specific education on biochemical assessment of FBG during pregnancy or within 6 weeks postpartum in patients with GDM were included.",
        "confidence": "low",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "血糖控制",
      "attributes": {
        "evidence": "This study examined the impact of blood glucose-regulated gestational diabetes (GDM) on fetal pulmonary artery Doppler parameters",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Predictability of fetal pulmonary artery Doppler on neonatal outcomes in pregnant women with gestational diabetes mellitus"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "CAN_CAUSE",
      "object": "metabolic dysfunction-associated steatotic liver disease (MASLD)",
      "attributes": {
        "evidence": "Gestational Diabetes Mellitus (GDM) impacts roughly 1 in 7 pregnancies and results in metabolic dysfunction-associated steatotic liver disease (MASLD) in 30% of these women.",
        "confidence": "high",
        "strength": "strong",
        "source": "Introduction section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high-fat, high-sucrose (HFHS) diet",
      "attributes": {
        "evidence": "One week prior to conception and throughout pregnancy, mice were fed either a low-fat control diet (CD) or a high-fat, high-sucrose (HFHS) diet to induce an established model of GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "HAS_SYMPTOM",
      "object": "elevated hepatic TG",
      "attributes": {
        "evidence": "HFHS-induced model of GDM lead to significant elevations in liver triglycerides and NAFLD Activity Score (NAS) (P<0.0001, P<0.0001) independent of body weight gain during gestation.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "HAS_SYMPTOM",
      "object": "decreased liver mitochondrial activity",
      "attributes": {
        "evidence": "MASLD development in the GDM mice occurred in conjunction with significant reductions in hepatic mitochondrial activity at day 6.5 (citrate synthase, p<0.01) and day 17.5 (β-HAD, citrate synthase, P<0.001) compared to CD mice.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "HAS_SYMPTOM",
      "object": "inflammation",
      "attributes": {
        "evidence": "However, GDM lead to elevated protein and/or mRNA markers of mitochondrial biogenesis (Tfam), mitophagy (BNIP3, Bnip3, Sqstm1, Pink1), lipid handling (Mttp), inflammation (Il-1β, Tnf-α, Tgf-β) and antioxidant defense (Gxp1, Nfe2l2, Sod2) (P<0.05).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus (GDM)",
      "predicate": "HAS_SYMPTOM",
      "object": "antioxidant defense",
      "attributes": {
        "evidence": "However, GDM lead to elevated protein and/or mRNA markers of mitochondrial biogenesis (Tfam), mitophagy (BNIP3, Bnip3, Sqstm1, Pink1), lipid handling (Mttp), inflammation (Il-1β, Tnf-α, Tgf-β) and antioxidant defense (Gxp1, Nfe2l2, Sod2) (P<0.05).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "metabolic dysfunction-associated steatotic liver disease (MASLD)",
      "predicate": "DIAGNOSED_BY",
      "object": "NAFLD Activity Score (NAS)",
      "attributes": {
        "evidence": "HFHS-induced model of GDM lead to significant elevations in liver triglycerides and NAFLD Activity Score (NAS) (P<0.0001, P<0.0001) independent of body weight gain during gestation.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "青年发病2型糖尿病",
      "attributes": {
        "evidence": "Maternal GDM promotes a high incidence of YOT2D in female offspring by affecting ovarian maturation",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "高热量饮食",
      "predicate": "HAS_RISK_FACTOR",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "GDM mice were induced by Western diet (WD)",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "糖代谢紊乱",
      "attributes": {
        "evidence": "The serum estradiol level in GDM offspring mice was decreased during sexual maturation, accompanied by marked oral glucose intolerance, insulin resistance, and even diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "口服糖耐量异常",
      "attributes": {
        "evidence": "accompanied by marked oral glucose intolerance",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "卵巢成熟障碍",
      "attributes": {
        "evidence": "Maternal GDM promotes a high incidence of YOT2D in female offspring by affecting ovarian maturation",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "雌激素信号通路抑制",
      "attributes": {
        "evidence": "GDM suppressed the protein levels of ERα, p-IRS-1, and p-Akt in liver tissue, that is, estrogen signals and insulin signaling were simultaneously weakened",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "CAN_CAUSE",
      "object": "CYP19A1下调",
      "attributes": {
        "evidence": "the advance of sexual maturation and the decrease in serum estradiol in GDM offspring were mainly due to the downregulation of CYP19A1 in the ovaries",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "雌激素信号通路抑制",
      "predicate": "CAN_CAUSE",
      "object": "胰岛素抵抗",
      "attributes": {
        "evidence": "estrogen signals and insulin signaling were simultaneously weakened",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "IS_A",
      "object": "Maturity-onset diabetes of the young (MODY)",
      "attributes": {
        "evidence": "Maturity-onset diabetes of the young (MODY)-a monogenic form of diabetes-accounts for approximately 1-2% of all diabetes cases, with GCK-MODY being the second most commonly diagnosed type.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "HAS_RISK_FACTOR",
      "object": "fetal macrosomia",
      "attributes": {
        "evidence": "FBW was significantly higher in GCK-negative as compared to GCK-positive offspring. Accordingly, fetal macrosomia was notably more common among unaffected neonates.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "CAN_CAUSE",
      "object": "neonatal hypoglycemia",
      "attributes": {
        "evidence": "Data, such as MODY type, the gestational age at delivery, mode of delivery, insulin administration, mutational status of the fetus, fetal birthweight (FBW), occurrence of small-/large-for-gestational age fetus, shoulder dystocia, and neonatal hypoglycemia, were extracted and evaluated.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "TREATED_BY",
      "object": "insulin therapy",
      "attributes": {
        "evidence": "Women diagnosed with GCK-MODY treated with insulin delivered approximately 1-2 weeks earlier than those managed with diet alone.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "TREATED_BY",
      "object": "diet management",
      "attributes": {
        "evidence": "Women diagnosed with GCK-MODY treated with insulin delivered approximately 1-2 weeks earlier than those managed with diet alone.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "insulin therapy",
      "predicate": "CAN_CAUSE",
      "object": "iatrogenic prematurity",
      "attributes": {
        "evidence": "In the absence of fetal genotyping, conservative management should be prioritized to mitigate the risks of fetal growth restriction and iatrogenic prematurity.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "fetal genotyping",
      "predicate": "DIAGNOSED_BY",
      "object": "GCK gene mutation",
      "attributes": {
        "evidence": "Fetal genotype critically modifies perinatal outcomes in GCK-MODY pregnancies.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "PRISMA guidelines",
      "predicate": "RECOMMENDS",
      "object": "systematic literature search",
      "attributes": {
        "evidence": "A systematic literature search in the PubMed, Scopus, Web of Science, and Cochrane databases was conducted following the PRISMA guidelines.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "GCK-MODY",
      "predicate": "HAS_RISK_FACTOR",
      "object": "shoulder dystocia",
      "attributes": {
        "evidence": "Data, such as MODY type, the gestational age at delivery, mode of delivery, insulin administration, mutational status of the fetus, fetal birthweight (FBW), occurrence of small-/large-for-gestational age fetus, shoulder dystocia, and neonatal hypoglycemia, were extracted and evaluated.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Maternal prenatal exposures to PFAS",
      "predicate": "HAS_RISK_FACTOR",
      "object": "adverse birth outcomes",
      "attributes": {
        "evidence": "Maternal prenatal exposures to per- and polyfluoroalkyl substances (PFAS) have been linked to adverse birth outcomes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Paternal PFAS exposure",
      "predicate": "HAS_RISK_FACTOR",
      "object": "shorter birth length",
      "attributes": {
        "evidence": "Paternal exposure to several PFAS was also associated with a tendency for shorter birth length, but the estimated effect sizes were small.",
        "confidence": "medium",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "Maternal serum PFOA",
      "predicate": "HAS_RISK_FACTOR",
      "object": "lower birth weight",
      "attributes": {
        "evidence": "a higher level of maternal serum perfluorooctanoate (PFOA) was linked to a tendency towards lower birth weight and shorter birth length.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Maternal serum PFOA",
      "predicate": "HAS_RISK_FACTOR",
      "object": "shorter birth length",
      "attributes": {
        "evidence": "a higher level of maternal serum perfluorooctanoate (PFOA) was linked to a tendency towards lower birth weight and shorter birth length.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Paternal PFOA",
      "predicate": "HAS_RISK_FACTOR",
      "object": "shorter birth length",
      "attributes": {
        "evidence": "after adjusting for paternal PFOA, a higher level of maternal serum perfluorooctanoate (PFOA) was linked to a tendency towards lower birth weight and shorter birth length.",
        "confidence": "medium",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "preexisting diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "pregnancy-related complications",
      "attributes": {
        "evidence": "Women with preexisting diabetes mellitus (PDM) are at increased risk of pregnancy-related complications.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "hybrid closed-loop insulin pump",
      "predicate": "TREATED_BY",
      "object": "standard of care",
      "attributes": {
        "evidence": "Meta-analysis showed no significant difference between hybrid closed-loop insulin pump (HCL) and standard of care regarding time in range (TIR), time above range (TAR), and time below range (TBR).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "hybrid closed-loop insulin pump",
      "predicate": "HAS_SYMPTOM",
      "object": "better overnight TIR and TBR",
      "attributes": {
        "evidence": "HCL had better overnight TIR and TBR.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "type 2 diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "continuous glucose monitoring",
      "attributes": {
        "evidence": "For women with type 2 diabetes mellitus (T2DM), intermittent use of continuous glucose monitoring (CGM) was not associated with a significant change in the risk of large for gestational age (LGA) neonates.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "metformin",
      "predicate": "TREATED_BY",
      "object": "insulin",
      "attributes": {
        "evidence": "Adding metformin to insulin was associated with a lower risk of LGA (2 RCTs, 1126 patients).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "preexisting type 1 and type 2 diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "neonatal complications",
      "attributes": {
        "evidence": "Three retrospective studies (1724 patients) suggested increased neonatal complications when delivery was induced before 39 weeks of gestation (particularly before 38 weeks) in women with preexisting type 1 (T1DM) and T2DM.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "glucagon-like peptide-1 receptor agonists",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "neonatal complications",
      "attributes": {
        "evidence": "One retrospective study showed no increase in neonatal complications with periconceptional exposure to glucagon-like peptide-1 receptor agonists.",
        "confidence": "medium",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "Endocrine Society guidelines",
      "predicate": "RECOMMENDS",
      "object": "management of PDM in pregnancy",
      "attributes": {
        "evidence": "To summarize the available supporting evidence for the Endocrine Society guidelines about management of PDM in pregnancy.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.",
        "confidence": "high",
        "strength": "strong",
        "source": "Title of the guideline"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "maternal hyperglycemia",
      "attributes": {
        "evidence": "Reduction of maternal hyperglycemia prior to and during pregnancy can reduce these risks.",
        "confidence": "high",
        "strength": "strong",
        "source": "BACKGROUND section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "CAN_CAUSE",
      "object": "congenital malformations",
      "attributes": {
        "evidence": "Despite compelling evidence that preconception care (PCC), which includes achieving strict glycemic goals, reduces the risk of congenital malformations and other adverse pregnancy outcomes, only a minority of individuals receive PCC.",
        "confidence": "high",
        "strength": "strong",
        "source": "BACKGROUND section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "The increasing impact of obesity on pregnancy outcomes underscores the importance of optimal nutrition and management of insulin sensitizing medications during prenatal care for PDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "BACKGROUND section"
      }
    },
    {
      "subject": "type 2 diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "glucagon-like peptide-1 receptor agonist",
      "attributes": {
        "evidence": "In individuals with T2DM, we suggest discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RA) before conception rather than discontinuation between the start of pregnancy and the end of the first trimester (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "RESULTS section"
      }
    },
    {
      "subject": "type 2 diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "metformin",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM already on insulin, we suggest against routine addition of metformin (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "RESULTS section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "TREATED_BY",
      "object": "carbohydrate-restricted diet",
      "attributes": {
        "evidence": "In individuals with PDM, we suggest either a carbohydrate-restricted diet (<175 g/day) or usual diet (>175 g/day) during pregnancy (2 | ⊕OOO).",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RESULTS section"
      }
    },
    {
      "subject": "type 2 diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "continuous glucose monitor",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM, we suggest either the use of a continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "RESULTS section"
      }
    },
    {
      "subject": "type 2 diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "self-monitoring of blood glucose",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM, we suggest either the use of a continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "RESULTS section"
      }
    },
    {
      "subject": "Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline",
      "predicate": "RECOMMENDS",
      "object": "preconception care",
      "attributes": {
        "evidence": "Despite compelling evidence that preconception care (PCC), which includes achieving strict glycemic goals, reduces the risk of congenital malformations and other adverse pregnancy outcomes, only a minority of individuals receive PCC.",
        "confidence": "high",
        "strength": "strong",
        "source": "BACKGROUND section"
      }
    },
    {
      "subject": "CGM",
      "predicate": "RECOMMENDED_FOR",
      "object": "T2DM",
      "attributes": {
        "evidence": "There is indirect evidence supporting improved glucometrics with the use of CGM for individuals with T2DM outside of pregnancy",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text"
      }
    },
    {
      "subject": "CGM",
      "predicate": "RECOMMENDED_FOR",
      "object": "T1DM",
      "attributes": {
        "evidence": "substantial improvements in neonatal outcomes for individuals with T1DM using CGM during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "Text"
      }
    },
    {
      "subject": "hybrid closed-loop pump",
      "predicate": "RECOMMENDED_FOR",
      "object": "T1DM",
      "attributes": {
        "evidence": "In individuals with T1DM who are pregnant, we suggest the use of a hybrid closed-loop pump (pump adjusting automatically based on CGM) rather than an insulin pump with CGM (without an algorithm) or multiple daily insulin injections with CGM",
        "confidence": "high",
        "strength": "strong",
        "source": "Text"
      }
    },
    {
      "subject": "early delivery",
      "predicate": "RECOMMENDED_FOR",
      "object": "PDM",
      "attributes": {
        "evidence": "In individuals with PDM, we suggest early delivery based on risk assessment rather than expectant management",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text"
      }
    },
    {
      "subject": "postpartum endocrine care",
      "predicate": "RECOMMENDED_FOR",
      "object": "PDM",
      "attributes": {
        "evidence": "In individuals with PDM (including those with pregnancy loss or termination), we suggest postpartum endocrine care (diabetes management), in addition to usual obstetric care",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text"
      }
    },
    {
      "subject": "PCC",
      "predicate": "CAN_CAUSE",
      "object": "congenital malformations",
      "attributes": {
        "evidence": "demonstrating a strong association between PCC and both reduced HbA1c at the first prenatal visit and congenital malformations",
        "confidence": "high",
        "strength": "strong",
        "source": "Text"
      }
    },
    {
      "subject": "Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline",
      "predicate": "RECOMMENDS",
      "object": "postpartum endocrine care",
      "attributes": {
        "evidence": "In individuals with PDM (including those with pregnancy loss or termination), we suggest postpartum endocrine care (diabetes management), in addition to usual obstetric care",
        "confidence": "high",
        "strength": "strong",
        "source": "Text"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "glycated hemoglobin",
      "attributes": {
        "evidence": "This was suggested based on indirect evidence demonstrating a strong association between PCC and both reduced glycated hemoglobin (HbA1c) at the first prenatal visit and congenital malformations.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "TREATED_BY",
      "object": "insulin",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM already on insulin, we suggest against routine addition of metformin (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "TREATED_BY",
      "object": "metformin",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM already on insulin, we suggest against routine addition of metformin (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "TREATED_BY",
      "object": "continuous glucose monitor",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM, we suggest either the use of a continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Preexisting diabetes",
      "predicate": "TREATED_BY",
      "object": "self-monitoring of blood glucose",
      "attributes": {
        "evidence": "In pregnant individuals with T2DM, we suggest either the use of a continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline",
      "predicate": "RECOMMENDS",
      "object": "contraception",
      "attributes": {
        "evidence": "In individuals with diabetes mellitus who have the possibility of becoming pregnant, we suggest use of contraception when pregnancy is not desired (2 | ⊕⊕OO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline",
      "predicate": "RECOMMENDS",
      "object": "discontinuation of glucagon-like peptide-1 receptor agonist",
      "attributes": {
        "evidence": "In individuals with T2DM, we suggest discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RA) before conception rather than discontinuation between the start of pregnancy and the end of the first trimester (2 | ⊕OOO).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "fasting glucose > 126 mg/dL (7 mmol/L)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "adverse pregnancy outcomes",
      "attributes": {
        "evidence": "indirect evidence that associated adverse pregnancy outcomes with a fasting glucose > 126 mg/dL (7 mmol/L)",
        "confidence": "medium",
        "strength": "moderate",
        "source": "The Journal of Clinical Endocrinology & Metabolism and European Journal of Endocrinology"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high prepregnancy BMI",
      "attributes": {
        "evidence": "UA:SCr ratio and free thyroxine (FT4) were significantly higher in pregnant women with GDM in the highest preBMI quartile than the normal glucose tolerance group",
        "confidence": "high",
        "strength": "strong",
        "source": "Diabetes Metab Syndr Obes. 2025 Jul 7;18:2235-2246"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high UA:SCr ratio",
      "attributes": {
        "evidence": "UA:SCr ratio was associated with risk of GDM in pregnant women in the highest preBMI quartile",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diabetes Metab Syndr Obes. 2025 Jul 7;18:2235-2246"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high FT4",
      "attributes": {
        "evidence": "FT4 was associated with risk of GDM in pregnant women in the highest preBMI quartile",
        "confidence": "high",
        "strength": "moderate",
        "source": "Diabetes Metab Syndr Obes. 2025 Jul 7;18:2235-2246"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose tolerance test",
      "attributes": {
        "evidence": "oral glucose tolerance tests were conducted for 24-28 weeks to screen for GDM",
        "confidence": "high",
        "strength": "strong",
        "source": "Diabetes Metab Syndr Obes. 2025 Jul 7;18:2235-2246"
      }
    },
    {
      "subject": "euthyroid function",
      "predicate": "CAN_CAUSE",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "FT4 level within the normal range was correlated with UA:SCr ratio in women in the third and fourth prepregnancy BMI quartiles",
        "confidence": "medium",
        "strength": "weak",
        "source": "Diabetes Metab Syndr Obes. 2025 Jul 7;18:2235-2246"
      }
    },
    {
      "subject": "Depressive disorders",
      "predicate": "HAS_SYMPTOM",
      "object": "Bad mental health days",
      "attributes": {
        "evidence": "Depressive disorders and frequent bad mental health days were associated with lower odds of diabetes management behaviors among AI/AN adults.",
        "confidence": "high",
        "strength": "strong",
        "source": "Behavioral Risk Factor Surveillance System"
      }
    },
    {
      "subject": "Depressive disorders",
      "predicate": "CAN_CAUSE",
      "object": "Lower odds of diabetes management behaviors",
      "attributes": {
        "evidence": "Logistic regression models show that those reporting depressive disorders were significantly less likely to check their feet daily (adjusted odds ratio (AOR) = 0.56, 95% CI: 0.34-0.92).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Behavioral Risk Factor Surveillance System"
      }
    },
    {
      "subject": "Bad mental health days",
      "predicate": "CAN_CAUSE",
      "object": "Lower odds of diabetes management behaviors",
      "attributes": {
        "evidence": "Individuals with at least 14 bad mental health days were significantly less likely to have ever taken a diabetes management class (AOR = 0.59, 95% CI: 0.36-0.99) and check their feet daily (AOR = 0.37, 95% CI: 0.21-0.65) than those reporting no bad mental health days.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Behavioral Risk Factor Surveillance System"
      }
    },
    {
      "subject": "Diabetes management behaviors",
      "predicate": "HAS_RISK_FACTOR",
      "object": "Depressive disorders",
      "attributes": {
        "evidence": "Depressive disorders and frequent bad mental health days were associated with lower odds of diabetes management behaviors among AI/AN adults.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Behavioral Risk Factor Surveillance System"
      }
    },
    {
      "subject": "Diabetes management behaviors",
      "predicate": "HAS_RISK_FACTOR",
      "object": "Bad mental health days",
      "attributes": {
        "evidence": "Individuals with at least 14 bad mental health days were significantly less likely to have ever taken a diabetes management class (AOR = 0.59, 95% CI: 0.36-0.99) and check their feet daily (AOR = 0.37, 95% CI: 0.21-0.65) than those reporting no bad mental health days.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Behavioral Risk Factor Surveillance System"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "TREATED_BY",
      "object": "metformin",
      "attributes": {
        "evidence": "this study aims to investigate the association between metformin use in Gestational Diabetes (GDM) and the risk of short-term maternal and neonatal outcomes",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "TREATED_BY",
      "object": "diet control",
      "attributes": {
        "evidence": "compared maternal and neonatal outcomes in patients treated with metformin to those treated with diet control alone",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "older age",
      "attributes": {
        "evidence": "the metformin-treated group was older (33.3 ± 4.8 vs. 31.2 ± 5.0 years)",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "higher pre-pregnancy BMI",
      "attributes": {
        "evidence": "had higher pre-pregnancy Body Mass Index (BMI) (27.9 ± 4.6 vs. 26.0 ± 4.7 kg/m2)",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "metformin",
      "predicate": "CAN_CAUSE",
      "object": "preterm labor",
      "attributes": {
        "evidence": "Metformin use in gestational diabetes is not associated with an increased risk of preterm labor and small for gestational age infants compared to diet control alone",
        "confidence": "high",
        "strength": "weak",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "metformin",
      "predicate": "CAN_CAUSE",
      "object": "small for gestational age infants",
      "attributes": {
        "evidence": "Metformin use in gestational diabetes is not associated with an increased risk of preterm labor and small for gestational age infants compared to diet control alone",
        "confidence": "high",
        "strength": "weak",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting glucose",
      "attributes": {
        "evidence": "When adjusted for age, fasting glucose at diagnosis, pre-pregnancy weight, and gestational weight gain",
        "confidence": "medium",
        "strength": "moderate",
        "source": "BMC Pregnancy Childbirth. 2025 Jul 14;25(1):762"
      }
    },
    {
      "subject": "uRPL",
      "predicate": "IS_A",
      "object": "recurrent pregnancy loss",
      "attributes": {
        "evidence": "Unexplained recurrent pregnancy loss (uRPL), defined as the loss of two or more pregnancies without an identified cause",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "uRPL",
      "predicate": "HAS_RISK_FACTOR",
      "object": "imbalance in maternal-fetal immunological tolerance",
      "attributes": {
        "evidence": "Emerging evidence suggests that an imbalance in maternal-fetal immunological tolerance may play a key role in its pathogenesis.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "uRPL",
      "predicate": "TREATED_BY",
      "object": "G-CSF",
      "attributes": {
        "evidence": "Granulocyte colony-stimulating factor (G-CSF), a glycosylated polypeptide chain cell growth factor, has shown promise in improving pregnancy outcomes in uRPL",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "uRPL",
      "predicate": "TREATED_BY",
      "object": "dydrogesterone",
      "attributes": {
        "evidence": "All participants will also receive dydrogesterone and aspirin as supportive care.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "uRPL",
      "predicate": "TREATED_BY",
      "object": "aspirin",
      "attributes": {
        "evidence": "All participants will also receive dydrogesterone and aspirin as supportive care.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "G-CSF",
      "predicate": "CAN_CAUSE",
      "object": "pregnancy complications",
      "attributes": {
        "evidence": "The trial will also explore subgroup effects based on research centers (4 centers), age, number of pregnancy losses, and body mass index.",
        "confidence": "low",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "G-CSF",
      "predicate": "CAN_CAUSE",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "The trial will also explore subgroup effects based on research centers (4 centers), age, number of pregnancy losses, and body mass index.",
        "confidence": "low",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "metabolic disorder",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "CNS impairments",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder that disrupts fetal central nervous system (CNS) development.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "hippocampal volume reduction",
      "attributes": {
        "evidence": "Offspring from the STZ-D group exhibited significant reductions in hippocampal volume",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "dark neurons",
      "attributes": {
        "evidence": "Offspring from the STZ-D group exhibited... increased dark neurons in the CA1 and CA2 regions",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "insulin treatment",
      "attributes": {
        "evidence": "Insulin treatment mitigated these adverse effects, preserving hippocampal structure and reducing neuronal damage.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hyperglycemia",
      "attributes": {
        "evidence": "Maternal hyperglycemia disrupts hippocampal development by altering autophagy and activating the PI3K/mTOR pathway, contributing to neuronal damage.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "hyperglycemia",
      "predicate": "CAN_CAUSE",
      "object": "hippocampal volume reduction",
      "attributes": {
        "evidence": "Maternal hyperglycemia disrupts hippocampal development",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "hyperglycemia",
      "predicate": "CAN_CAUSE",
      "object": "neuronal damage",
      "attributes": {
        "evidence": "Maternal hyperglycemia disrupts hippocampal development by altering autophagy and activating the PI3K/mTOR pathway, contributing to neuronal damage.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "insulin treatment",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "Insulin treatment during pregnancy can counteract these effects, emphasizing the importance of glycemic control.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "PI3K/mTOR signaling pathway",
      "predicate": "CAN_CAUSE",
      "object": "neuronal damage",
      "attributes": {
        "evidence": "Maternal hyperglycemia disrupts hippocampal development by altering autophagy and activating the PI3K/mTOR pathway, contributing to neuronal damage.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "glucose toxicity",
      "predicate": "CAN_CAUSE",
      "object": "diabetic respiratory complications",
      "attributes": {
        "evidence": "Emerging evidence highlights glucose toxicity as a pivotal driver of diabetic respiratory complications",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "hyperglycemia",
      "predicate": "CAN_CAUSE",
      "object": "metabolic dysregulation",
      "attributes": {
        "evidence": "characterized by hyperglycemia-induced metabolic dysregulation and multi-organ damage",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "gestational diabetes mellitus (GDM)",
      "predicate": "CAN_CAUSE",
      "object": "fetal lung dysplasia",
      "attributes": {
        "evidence": "gestational diabetes mellitus (GDM)-associated fetal lung dysplasia via impaired epithelial differentiation",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "diabetes-associated respiratory complications",
      "predicate": "HAS_SYMPTOM",
      "object": "acute respiratory distress syndrome (ARDS)",
      "attributes": {
        "evidence": "Diabetes-associated respiratory complications encompass increased susceptibility to respiratory infections, acute respiratory distress syndrome (ARDS) with macrophage-driven glycolytic shifts",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "diabetes-associated respiratory complications",
      "predicate": "HAS_SYMPTOM",
      "object": "respiratory infections",
      "attributes": {
        "evidence": "Diabetes-associated respiratory complications encompass increased susceptibility to respiratory infections",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "hyperglycemia",
      "predicate": "CAN_CAUSE",
      "object": "oxidative stress",
      "attributes": {
        "evidence": "address the interplay between hyperglycemia, oxidative stress, and immune dysregulation",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "hyperglycemia",
      "predicate": "CAN_CAUSE",
      "object": "immune dysregulation",
      "attributes": {
        "evidence": "address the interplay between hyperglycemia, oxidative stress, and immune dysregulation",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "glucose toxicity",
      "predicate": "CAN_CAUSE",
      "object": "oxidative stress",
      "attributes": {
        "evidence": "due to its exposure to oxidative stress, inflammatory cascades, and disrupted metabolic reprogramming",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "glucose toxicity",
      "predicate": "CAN_CAUSE",
      "object": "inflammatory cascades",
      "attributes": {
        "evidence": "due to its exposure to oxidative stress, inflammatory cascades, and disrupted metabolic reprogramming",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "glucose toxicity",
      "predicate": "CAN_CAUSE",
      "object": "mitochondrial dysfunction",
      "attributes": {
        "evidence": "particularly in glycolysis and mitochondrial dysfunction",
        "confidence": "high",
        "strength": "strong",
        "source": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "Type 2 diabetes",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) increases women's risk of developing type 2 diabetes (T2DM) tenfold.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "Type 2 diabetes",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) increases women's risk of developing type 2 diabetes (T2DM) tenfold.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "group education sessions",
      "predicate": "RECOMMENDED_FOR",
      "object": "Type 2 diabetes risk communication",
      "attributes": {
        "evidence": "This included group education sessions, tangible and digital support resources, providing individualised information, and continuous and harmonious T2DM risk communication from healthcare professionals and health services.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "digital support resources",
      "predicate": "RECOMMENDED_FOR",
      "object": "Type 2 diabetes risk communication",
      "attributes": {
        "evidence": "This included group education sessions, tangible and digital support resources, providing individualised information, and continuous and harmonious T2DM risk communication from healthcare professionals and health services.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "individualised information",
      "predicate": "RECOMMENDED_FOR",
      "object": "Type 2 diabetes risk communication",
      "attributes": {
        "evidence": "This included group education sessions, tangible and digital support resources, providing individualised information, and continuous and harmonious T2DM risk communication from healthcare professionals and health services.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "continuous and harmonious T2DM risk communication",
      "predicate": "RECOMMENDED_FOR",
      "object": "Type 2 diabetes risk communication",
      "attributes": {
        "evidence": "This included group education sessions, tangible and digital support resources, providing individualised information, and continuous and harmonious T2DM risk communication from healthcare professionals and health services.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "semi-structured interviews",
      "predicate": "DIAGNOSED_BY",
      "object": "Type 2 diabetes risk communication",
      "attributes": {
        "evidence": "A qualitative study was conducted utilising semi-structured interviews.",
        "confidence": "low",
        "strength": "weak",
        "source": "Abstract"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_RISK_FACTOR",
      "object": "牙周炎",
      "attributes": {
        "evidence": "Compared to non-periodontitis, women with periodontitis have a 1.68 times higher risk of having GDM (OR = 1.68, 95% CI: 1.14-2.50).",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "牙周炎",
      "predicate": "CAN_CAUSE",
      "object": "系统性炎症",
      "attributes": {
        "evidence": "The association between periodontitis and GDM risk was found to be mediated by white blood cell count (WBC), monocyte count, and monocyte-lymphocyte ratio (MLR), with mediation proportions of 5.02%, 5.88%, and 5.20%, respectively.",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "系统性炎症",
      "predicate": "CAN_CAUSE",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "The association between periodontitis and GDM risk was found to be mediated by white blood cell count (WBC), monocyte count, and monocyte-lymphocyte ratio (MLR), with mediation proportions of 5.02%, 5.88%, and 5.20%, respectively.",
        "confidence": "high",
        "strength": "moderate",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "糖化血红蛋白",
      "attributes": {
        "evidence": "Linear regression analyses further revealed that hemoglobin A1c (HbA1c) levels were positively associated with periodontitis (Beta = 0.19, SE = 0.06, p < 0.01) and CAL (Beta = 0.06, SE = 0.03, p < 0.001), respectively.",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "牙周炎",
      "predicate": "HAS_SYMPTOM",
      "object": "临床附着水平",
      "attributes": {
        "evidence": "Clinical attachment level (CAL), the continuous periodontal parameter, also presented a significant association with GDM risk (OR = 1.50, 95% CI: 1.25-1.81 per 1-mm increase).",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "系统性炎症",
      "predicate": "HAS_SYMPTOM",
      "object": "白细胞计数",
      "attributes": {
        "evidence": "The association between periodontitis and GDM risk was found to be mediated by white blood cell count (WBC), monocyte count, and monocyte-lymphocyte ratio (MLR), with mediation proportions of 5.02%, 5.88%, and 5.20%, respectively.",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "系统性炎症",
      "predicate": "HAS_SYMPTOM",
      "object": "单核细胞计数",
      "attributes": {
        "evidence": "The association between periodontitis and GDM risk was found to be mediated by white blood cell count (WBC), monocyte count, and monocyte-lymphocyte ratio (MLR), with mediation proportions of 5.02%, 5.88%, and 5.20%, respectively.",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "系统性炎症",
      "predicate": "HAS_SYMPTOM",
      "object": "单核细胞-淋巴细胞比值",
      "attributes": {
        "evidence": "The association between periodontitis and GDM risk was found to be mediated by white blood cell count (WBC), monocyte count, and monocyte-lymphocyte ratio (MLR), with mediation proportions of 5.02%, 5.88%, and 5.20%, respectively.",
        "confidence": "high",
        "strength": "strong",
        "source": "BMC Oral Health. 2025 Jul 16;25(1):1179"
      }
    },
    {
      "subject": "gestational diabetes mellitus (GDM)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "insulin resistance",
      "attributes": {
        "evidence": "Insulin resistance during pregnancy, while physiologically adaptive to enhance fetal nutrient supply, becomes pathological when excessive, contributing to low birth weight (LBW).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting glucose and triglycerides",
      "attributes": {
        "evidence": "TyG index was calculated from first-trimester fasting glucose and triglycerides.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "gestational diabetes mellitus (GDM)",
      "attributes": {
        "evidence": "A 1-standard deviation TyG index increase was associated with elevated risks of gestational complications (i.e., GDM, gestational hypertension, and preeclampsia).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "gestational hypertension",
      "attributes": {
        "evidence": "A 1-standard deviation TyG index increase was associated with elevated risks of gestational complications (i.e., GDM, gestational hypertension, and preeclampsia).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "preeclampsia",
      "attributes": {
        "evidence": "A 1-standard deviation TyG index increase was associated with elevated risks of gestational complications (i.e., GDM, gestational hypertension, and preeclampsia).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "preterm birth",
      "attributes": {
        "evidence": "Higher TyG index level also showed positive associations with adverse birth outcomes: preterm birth (OR = 1.20, 95% CI: 1.08-1.34).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "low birth weight (LBW)",
      "attributes": {
        "evidence": "Higher TyG index level also showed positive associations with adverse birth outcomes: LBW (OR = 1.11, 95% CI: 1.00-1.24).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "triglyceride-glucose (TyG) index",
      "predicate": "CAN_CAUSE",
      "object": "large-for-gestational-age (LGA)",
      "attributes": {
        "evidence": "Higher TyG index level also showed positive associations with adverse birth outcomes: LGA (OR = 1.12, 95% CI: 1.05-1.21).",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "gestational diabetes mellitus (GDM)",
      "predicate": "CAN_CAUSE",
      "object": "low birth weight (LBW)",
      "attributes": {
        "evidence": "Mediation analysis revealed that individual gestational complications mediated 17.7% (GDM) of the TyG-LBW association.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "gestational hypertension",
      "predicate": "CAN_CAUSE",
      "object": "low birth weight (LBW)",
      "attributes": {
        "evidence": "Mediation analysis revealed that individual gestational complications mediated 11.1% (gestational hypertension) of the TyG-LBW association.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "preeclampsia",
      "predicate": "CAN_CAUSE",
      "object": "low birth weight (LBW)",
      "attributes": {
        "evidence": "Mediation analysis revealed that individual gestational complications mediated 18.9% (preeclampsia) of the TyG-LBW association.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "preterm birth",
      "predicate": "CAN_CAUSE",
      "object": "low birth weight (LBW)",
      "attributes": {
        "evidence": "Preterm birth alone mediated 89.0% of the TyG index-LBW association.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "advanced maternal age (≥ 35 years)",
      "attributes": {
        "evidence": "In the RDS group, the mothers of preterm infants with RDS were older (P < 0.001) and more of advanced maternal age (≥ 35 years, P < 0.005)",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational diabetes",
      "attributes": {
        "evidence": "Multivariate logistic regression analysis indicated that gestational diabetes (OR = 2.283, 95% CI 1.483-3.513) were independent risk factors for the occurrence of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hypertensive disorders during pregnancy",
      "attributes": {
        "evidence": "Multivariate logistic regression analysis indicated that hypertensive disorders during pregnancy (OR = 2.201, 95% CI 1.215-3.988) were independent risk factors for the occurrence of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational age < 32 weeks",
      "attributes": {
        "evidence": "Multivariate logistic regression analysis indicated that gestational age < 32 weeks (OR = 3.914, 95% CI 2.972-5.155) were independent risk factors for the occurrence of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "birth weight < 1500 g",
      "attributes": {
        "evidence": "Multivariate logistic regression analysis indicated that birth weight < 1500 g (OR = 6.610, 95% CI 2.777-13.735) were independent risk factors for the occurrence of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "asphyxia",
      "attributes": {
        "evidence": "Multivariate logistic regression analysis indicated that asphyxia (OR = 5.239, 95% CI 2.602-10.551) were independent risk factors for the occurrence of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "CAN_CAUSE",
      "object": "pneumonia",
      "attributes": {
        "evidence": "Preterm infants with RDS after birth had a higher rate of pneumonia",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "CAN_CAUSE",
      "object": "sepsis",
      "attributes": {
        "evidence": "Preterm infants with RDS after birth had a higher rate of sepsis",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "CAN_CAUSE",
      "object": "hypoxic-ischemic encephalopathy (HIE)",
      "attributes": {
        "evidence": "Preterm infants with RDS after birth had a higher rate of hypoxic-ischemic encephalopathy (HIE)",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "CAN_CAUSE",
      "object": "bronchopulmonary dysplasia (BPD)",
      "attributes": {
        "evidence": "Preterm infants with RDS after birth had a higher rate of bronchopulmonary dysplasia (BPD)",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "TREATED_BY",
      "object": "corticosteroid",
      "attributes": {
        "evidence": "Reasonable use of corticosteroid before birth and standardized use of ventilators after birth can prevent the occurrence of RDS and improve the prognosis of RDS in preterm infants.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "TREATED_BY",
      "object": "mechanical ventilation",
      "attributes": {
        "evidence": "With different ventilation modes, the incidence rates of sepsis, BPD and mortality of RDS in preterm infants were significantly increased, and the anti-infection times and the hospitalization time was prolonged in mechanical ventilation group compared with the nasal continuous positive airway pressure ventilation (NCPAP) group",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Respiratory distress syndrome (RDS)",
      "predicate": "TREATED_BY",
      "object": "nasal continuous positive airway pressure ventilation (NCPAP)",
      "attributes": {
        "evidence": "With different ventilation modes, the incidence rates of sepsis, BPD and mortality of RDS in preterm infants were significantly increased, and the anti-infection times and the hospitalization time was prolonged in mechanical ventilation group compared with the nasal continuous positive airway pressure ventilation (NCPAP) group",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "prior gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Women with prior gestational diabetes mellitus (GDM) are at a significantly increased risk of developing type 2 diabetes after childbirth.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "dietary inflammatory index",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Higher DII scores were associated with the occurrence of diabetes in women with prior GDM, partly mediated by adiposity indices, emphasizing the role of diet in diabetes risk.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "body mass index",
      "predicate": "IS_A",
      "object": "adiposity indices",
      "attributes": {
        "evidence": "Multivariate logistic regression was utilized to examine the correlation of DII with diabetes and adiposity indices, such as body mass index (BMI) and relative fat mass (RFM) in participants with prior GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "relative fat mass",
      "predicate": "IS_A",
      "object": "adiposity indices",
      "attributes": {
        "evidence": "Multivariate logistic regression was utilized to examine the correlation of DII with diabetes and adiposity indices, such as body mass index (BMI) and relative fat mass (RFM) in participants with prior GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "multivariate logistic regression",
      "predicate": "DIAGNOSED_BY",
      "object": "correlation of DII with diabetes and adiposity indices",
      "attributes": {
        "evidence": "Multivariate logistic regression was utilized to examine the correlation of DII with diabetes and adiposity indices, such as body mass index (BMI) and relative fat mass (RFM) in participants with prior GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "mediation analysis",
      "predicate": "DIAGNOSED_BY",
      "object": "effects of adiposity indices as potential mediators between DII and diabetes",
      "attributes": {
        "evidence": "Mediation analysis was conducted to examine the effects of adiposity indices as potential mediators between DII and diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Spearman correlation analysis",
      "predicate": "DIAGNOSED_BY",
      "object": "relationship between the 26 dietary components of the DII on adiposity indices and the occurrence of diabetes",
      "attributes": {
        "evidence": "Spearman correlation analysis was conducted to assess the relationship between the 26 dietary components of the DII on adiposity indices and the occurrence of diabetes in participants with prior GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "modified natural cycle",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational diabetes",
      "attributes": {
        "evidence": "Patients with a m-NC protocol had a lower risk of hypertensive disorders of pregnancy (HDP), but a higher risk of gestational diabetes, though the results were non-significant.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "artificial cycle",
      "predicate": "HAS_RISK_FACTOR",
      "object": "miscarriage",
      "attributes": {
        "evidence": "The modified natural group had significantly better clinical pregnancy and live birth rates, mainly due to the significantly higher miscarriage rate observed in the artificial cycle group.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "modified natural cycle",
      "predicate": "TREATED_BY",
      "object": "HCG trigger",
      "attributes": {
        "evidence": "Patients in the modified natural cycle group were followed by ultrasound until triggering criteria met, then HCG trigger was scheduled, and the embryo transferred 7 days later.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "artificial cycle",
      "predicate": "TREATED_BY",
      "object": "estrogen supplementation",
      "attributes": {
        "evidence": "In the artificial cycle group, patients received estrogen supplementation after downregulation, and when the endometrium reached a thickness ≥ 7 mm an embryo transfer was scheduled following intramuscular progesterone administration for 5 days.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "artificial cycle",
      "predicate": "TREATED_BY",
      "object": "progesterone",
      "attributes": {
        "evidence": "In the artificial cycle group, patients received estrogen supplementation after downregulation, and when the endometrium reached a thickness ≥ 7 mm an embryo transfer was scheduled following intramuscular progesterone administration for 5 days.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "modified natural cycle",
      "predicate": "DIAGNOSED_BY",
      "object": "ultrasound",
      "attributes": {
        "evidence": "Patients in the modified natural cycle group were followed by ultrasound until triggering criteria met, then HCG trigger was scheduled, and the embryo transferred 7 days later.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "artificial cycle",
      "predicate": "DIAGNOSED_BY",
      "object": "B-hCG test",
      "attributes": {
        "evidence": "A higher percentage of patients in the artificial cycle group had an initial positive B-hCG test result.",
        "confidence": "high",
        "strength": "strong",
        "source": "The science of frozen embryo transfer, is modified natural cycle better?"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "snoring",
      "attributes": {
        "evidence": "Persistent snorers had significantly higher fasting blood sugar levels, elevated 1-3-hour glucose levels, and a higher GDM prevalence (19.1% vs. 9.3%; p < 0.001) compared to soft snorers.",
        "confidence": "high",
        "strength": "strong",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose tolerance test",
      "attributes": {
        "evidence": "GDM was diagnosed at 24-28 weeks using an oral glucose tolerance test based on ADA criteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "elevated fasting blood sugar",
      "attributes": {
        "evidence": "Persistent snorers had significantly higher fasting blood sugar levels, elevated 1-3-hour glucose levels, and a higher GDM prevalence (19.1% vs. 9.3%; p < 0.001) compared to soft snorers.",
        "confidence": "high",
        "strength": "strong",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "snoring",
      "predicate": "CAN_CAUSE",
      "object": "Gestational diabetes mellitus",
      "attributes": {
        "evidence": "After adjusting for confounding variables, occasional snoring (AOR: 3.93; 95% CI: 1.73-8.95; p = 0.001), frequent snoring (AOR: 4.02; 95% CI: 1.56-10.36; p = 0.004), and persistent snoring (AOR: 3.24; 95% CI: 2.04-5.13; p < 0.001) were associated with significantly increased GDM risk.",
        "confidence": "high",
        "strength": "strong",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "sleep-disordered breathing",
      "predicate": "IS_A",
      "object": "snoring",
      "attributes": {
        "evidence": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "prenatal care",
      "predicate": "RECOMMENDS",
      "object": "sleep assessments",
      "attributes": {
        "evidence": "These findings highlight the potential role of sleep assessments in prenatal care for early identification and management of GDM risk.",
        "confidence": "high",
        "strength": "moderate",
        "source": "The association between husband-reported snoring and gestational diabetes mellitus: a study of sleep-disordered breathing in pregnancy."
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "IS_A",
      "object": "type 1 diabetes",
      "attributes": {
        "evidence": "While technically classed as type 1 diabetes, LADA is distinct from type 1 and 2 diabetes because of its intermediate progression that may or may not lead to complete insulin dependence.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "DIAGNOSED_BY",
      "object": "autoantibodies",
      "attributes": {
        "evidence": "Differentiation is made with the presence or absence of autoantibodies and C-peptide.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "DIAGNOSED_BY",
      "object": "C-peptide",
      "attributes": {
        "evidence": "Differentiation is made with the presence or absence of autoantibodies and C-peptide.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "TREATED_BY",
      "object": "basal/bolus insulin regimen",
      "attributes": {
        "evidence": "The pharmacist discontinued metformin and initiated a basal/bolus insulin regimen with titration.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "history of gestational diabetes",
      "attributes": {
        "evidence": "A 29-year-old Black female with a history of gestational diabetes and two-year history of prediabetes was ultimately diagnosed with type 2 diabetes with an A1c of 6.6% and was treated with metformin 500 mg twice daily.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "history of prediabetes",
      "attributes": {
        "evidence": "A 29-year-old Black female with a history of gestational diabetes and two-year history of prediabetes was ultimately diagnosed with type 2 diabetes with an A1c of 6.6% and was treated with metformin 500 mg twice daily.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Latent Autoimmune Diabetes in Adults (LADA)",
      "predicate": "CAN_CAUSE",
      "object": "diabetes complications",
      "attributes": {
        "evidence": "Recognition of the signs of LADA and proper diagnostic testing can lead to earlier optimal treatment and prevention of diabetes complications.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "autoantibody testing",
      "predicate": "RECOMMENDED_FOR",
      "object": "Latent Autoimmune Diabetes in Adults (LADA)",
      "attributes": {
        "evidence": "Autoantibody testing is crucial to determine the proper diagnosis when the C-peptide is low-normal and should be prioritized.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "metformin",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "Latent Autoimmune Diabetes in Adults (LADA)",
      "attributes": {
        "evidence": "The pharmacist discontinued metformin and initiated a basal/bolus insulin regimen with titration.",
        "confidence": "high",
        "strength": "strong",
        "source": "J Diabetes Metab Disord. 2025 Jul 14;24(2):170"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "fetal overgrowth",
      "attributes": {
        "evidence": "GDM poses significant risks to both neonatal and maternal health, including fetal overgrowth, birth complications, and long-term metabolic disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "birth complications",
      "attributes": {
        "evidence": "GDM poses significant risks to both neonatal and maternal health, including fetal overgrowth, birth complications, and long-term metabolic disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "long-term metabolic disorders",
      "attributes": {
        "evidence": "GDM poses significant risks to both neonatal and maternal health, including fetal overgrowth, birth complications, and long-term metabolic disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "maternal obesity",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) is a growing public health concern globally, particularly in the context of rising maternal obesity and glucose intolerance.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "glucose intolerance",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) is a growing public health concern globally, particularly in the context of rising maternal obesity and glucose intolerance.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "small-for-gestational-age",
      "attributes": {
        "evidence": "The primary objective was to assess the incidence of macrosomia and small-for-gestational-age (SGA) births in pregnancies complicated by GDM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "NICU admission",
      "attributes": {
        "evidence": "NICU admissions in 19 (20.2%) GDM neonates versus five (5.3%) non-GDM neonates.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "maternal insulin resistance",
      "attributes": {
        "evidence": "GDM (OR=2.8), higher pre-pregnancy BMI, and poor glycemic control (HbA1c >5.9%) were independent predictors of neonatal macrosomia and maternal insulin resistance.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting glucose",
      "attributes": {
        "evidence": "GDM mothers exhibited elevated fasting glucose at six weeks (mean 98.5 mg/dL) and six months (94.1 mg/dL) postpartum, compared to non-GDM mothers (85.3 mg/dL and 83.2 mg/dL, respectively; p<0.0001).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "Homeostasis Model Assessment of Insulin Resistance",
      "attributes": {
        "evidence": "Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and triglyceride levels were also significantly higher in the GDM group.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "HbA1c",
      "attributes": {
        "evidence": "GDM (OR=2.8), higher pre-pregnancy BMI, and poor glycemic control (HbA1c >5.9%) were independent predictors of neonatal macrosomia and maternal insulin resistance.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "glycemic control",
      "attributes": {
        "evidence": "These findings underscore the importance of early diagnosis, effective glycemic control, and structured postpartum follow-up to mitigate long-term risks.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "pre-pregnancy BMI",
      "attributes": {
        "evidence": "GDM (OR=2.8), higher pre-pregnancy BMI, and poor glycemic control (HbA1c >5.9%) were independent predictors of neonatal macrosomia and maternal insulin resistance.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational weight gain",
      "attributes": {
        "evidence": "Secondary objectives included evaluating postpartum glycemic and lipid profiles, comparing metabolic parameters at six weeks and six months between GDM and non-GDM groups, and identifying predictive and moderating variables such as glycemic control, pre-pregnancy BMI, and gestational weight gain.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "IS_A",
      "object": "postpartum psychiatric disorders",
      "attributes": {
        "evidence": "Postpartum psychiatric disorders, including postpartum depression (PPD) and postpartum psychosis (PPP), are major contributors to maternal morbidity and adverse child outcomes globally.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "IS_A",
      "object": "postpartum psychiatric disorders",
      "attributes": {
        "evidence": "Postpartum psychiatric disorders, including postpartum depression (PPD) and postpartum psychosis (PPP), are major contributors to maternal morbidity and adverse child outcomes globally.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "HAS_RISK_FACTOR",
      "object": "preeclampsia/eclampsia",
      "attributes": {
        "evidence": "Preeclampsia/eclampsia (aOR: 2.30; 95% CI: 1.45-3.64; p<0.001) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "HAS_RISK_FACTOR",
      "object": "postpartum hemorrhage",
      "attributes": {
        "evidence": "Postpartum hemorrhage (aOR: 2.10; 95% CI: 1.30-3.38; p=0.002) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "HAS_RISK_FACTOR",
      "object": "preterm birth",
      "attributes": {
        "evidence": "Preterm birth (aOR: 1.85; 95% CI: 1.20-2.85; p=0.004) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational diabetes mellitus (GDM)",
      "attributes": {
        "evidence": "GDM (aOR: 1.55; 95% CI: 1.00-2.40; p=0.049) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "HAS_RISK_FACTOR",
      "object": "preeclampsia/eclampsia",
      "attributes": {
        "evidence": "Preeclampsia/eclampsia (aOR: 2.30; 95% CI: 1.45-3.64; p<0.001) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "HAS_RISK_FACTOR",
      "object": "postpartum hemorrhage",
      "attributes": {
        "evidence": "Postpartum hemorrhage (aOR: 2.10; 95% CI: 1.30-3.38; p=0.002) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "HAS_RISK_FACTOR",
      "object": "preterm birth",
      "attributes": {
        "evidence": "Preterm birth (aOR: 1.85; 95% CI: 1.20-2.85; p=0.004) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational diabetes mellitus (GDM)",
      "attributes": {
        "evidence": "GDM (aOR: 1.55; 95% CI: 1.00-2.40; p=0.049) were significantly associated with increased risk of postpartum psychiatric disorders.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "postpartum depression",
      "predicate": "DIAGNOSED_BY",
      "object": "DSM-5 criteria",
      "attributes": {
        "evidence": "Cases included women aged 18-45 years diagnosed with PPD or PPP within six months postpartum based on DSM-5 criteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "postpartum psychosis",
      "predicate": "DIAGNOSED_BY",
      "object": "DSM-5 criteria",
      "attributes": {
        "evidence": "Cases included women aged 18-45 years diagnosed with PPD or PPP within six months postpartum based on DSM-5 criteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "postpartum psychiatric disorders",
      "predicate": "CAN_CAUSE",
      "object": "adverse child outcomes",
      "attributes": {
        "evidence": "Postpartum psychiatric disorders, including postpartum depression (PPD) and postpartum psychosis (PPP), are major contributors to maternal morbidity and adverse child outcomes globally.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "IS_A",
      "object": "pregnancy complications",
      "attributes": {
        "evidence": "Preeclampsia and gestational diabetes mellitus (GDM) are common pregnancy complications associated with significant maternal and neonatal morbidity.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "IS_A",
      "object": "pregnancy complications",
      "attributes": {
        "evidence": "Preeclampsia and gestational diabetes mellitus (GDM) are common pregnancy complications associated with significant maternal and neonatal morbidity.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "cesarean section",
      "attributes": {
        "evidence": "The coexistence of preeclampsia and GDM was associated with the highest rates of cesarean section (82.7%, n = 62).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "preterm birth",
      "attributes": {
        "evidence": "The coexistence of preeclampsia and GDM was associated with the highest rates of preterm birth (46.7%, n = 35).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "neonatal intensive care unit (NICU) admission",
      "attributes": {
        "evidence": "The coexistence of preeclampsia and GDM was associated with the highest rates of neonatal intensive care unit (NICU) admission (49.3%, n = 37).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "neonatal hypoglycemia",
      "attributes": {
        "evidence": "The coexistence of preeclampsia and GDM was associated with the highest rates of neonatal hypoglycemia (18.7%, n = 14).",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "intensive care unit (ICU) admission",
      "attributes": {
        "evidence": "Maternal complications, including intensive care unit (ICU) admission (10.7%, n = 8) and postpartum hemorrhage (9.3%, n = 7), were also more frequent in this group.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational Diabetes Mellitus",
      "predicate": "CAN_CAUSE",
      "object": "postpartum hemorrhage",
      "attributes": {
        "evidence": "Maternal complications, including intensive care unit (ICU) admission (10.7%, n = 8) and postpartum hemorrhage (9.3%, n = 7), were also more frequent in this group.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "multidisciplinary management",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "Early diagnosis, multidisciplinary management, and targeted interventions are crucial to mitigating these risks and improving perinatal care.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "targeted interventions",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "Early diagnosis, multidisciplinary management, and targeted interventions are crucial to mitigating these risks and improving perinatal care.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "early diagnosis",
      "predicate": "RECOMMENDED_FOR",
      "object": "Gestational Diabetes Mellitus",
      "attributes": {
        "evidence": "Early diagnosis, multidisciplinary management, and targeted interventions are crucial to mitigating these risks and improving perinatal care.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "pregnancy complications",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) and preeclampsia are prevalent pregnancy complications",
        "confidence": "high",
        "strength": "strong",
        "source": "Introduction section"
      }
    },
    {
      "subject": "preeclampsia",
      "predicate": "IS_A",
      "object": "pregnancy complications",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) and preeclampsia are prevalent pregnancy complications",
        "confidence": "high",
        "strength": "strong",
        "source": "Introduction section"
      }
    },
    {
      "subject": "preeclampsia with gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "autophagy-related gene expression alterations",
      "attributes": {
        "evidence": "This study aimed to examine alterations in autophagy-related gene expression in preeclampsia combined with GDM",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Introduction section"
      }
    },
    {
      "subject": "preeclampsia with gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "autophagy-related biomarkers",
      "attributes": {
        "evidence": "Our findings identified potential biomarkers and molecular mechanisms underlying preeclampsia with GDM",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "preeclampsia with gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "precision medicine strategies",
      "attributes": {
        "evidence": "The integration of multi-omics approaches advances precision medicine strategies for these comorbid conditions",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Discussion section"
      }
    },
    {
      "subject": "gene expression profiling",
      "predicate": "DIAGNOSED_BY",
      "object": "preeclampsia with gestational diabetes mellitus",
      "attributes": {
        "evidence": "We conducted bioinformatics analyses including gene expression profiling, weighted gene co-expression network analysis (WGCNA), gene ontology (GO) and KEGG enrichment analyses, machine learning modeling, immune infiltration analyses, and single-cell RNA sequencing",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Methods section"
      }
    },
    {
      "subject": "reverse transcription quantitative polymerase chain reaction",
      "predicate": "DIAGNOSED_BY",
      "object": "preeclampsia with gestational diabetes mellitus",
      "attributes": {
        "evidence": "Expression levels of four key genes were validated in placental samples using reverse transcription quantitative polymerase chain reaction (RT-qPCR)",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods section"
      }
    },
    {
      "subject": "single-cell RNA sequencing",
      "predicate": "DIAGNOSED_BY",
      "object": "preeclampsia with gestational diabetes mellitus",
      "attributes": {
        "evidence": "Single-cell analysis corroborated these results, revealing distinct autophagy-related gene signatures and enhancing understanding of the pathophysiology",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose tolerance test",
      "attributes": {
        "evidence": "Universal screening for gestational diabetes mellitus (GDM) using the oral glucose tolerance test (OGTT) has been recommended.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "fasting plasma glucose",
      "attributes": {
        "evidence": "Fasting plasma glucose performs better than glycated hemoglobin and glycated albumin for diagnosing gestational diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "In countries such as South Africa, where female obesity is common, this translates into high numbers of tests.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "glycated hemoglobin",
      "attributes": {
        "evidence": "We therefore investigated glycated hemoglobin (HbA1c), glycated albumin (GA) and fasting plasma glucose (FPG) as OGTT alternatives.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "glycated albumin",
      "attributes": {
        "evidence": "We therefore investigated glycated hemoglobin (HbA1c), glycated albumin (GA) and fasting plasma glucose (FPG) as OGTT alternatives.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "fasting plasma glucose",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "FPG is a viable method for GDM diagnosis that when used in a two-tiered modality reduces the number of required OGTTs by 77%.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion"
      }
    },
    {
      "subject": "two-tiered modality",
      "predicate": "RECOMMENDED_FOR",
      "object": "gestational diabetes mellitus",
      "attributes": {
        "evidence": "FPG is a viable method for GDM diagnosis that when used in a two-tiered modality reduces the number of required OGTTs by 77%.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "Gestational Diabetes-Screening, Prevalence and Postpartum Diabetes: Population-Based Cohort Study.",
        "confidence": "high",
        "strength": "strong",
        "source": "Title of the study"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose challenge test",
      "attributes": {
        "evidence": "GDM screening followed a two-step approach: a 50-g 1-h oral glucose challenge test (OGCT), followed by a 100-g 3-h oral glucose tolerance test (OGTT) using Carpenter-Coustan criteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "Materials and Methods section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "DIAGNOSED_BY",
      "object": "oral glucose tolerance test",
      "attributes": {
        "evidence": "GDM screening followed a two-step approach: a 50-g 1-h oral glucose challenge test (OGCT), followed by a 100-g 3-h oral glucose tolerance test (OGTT) using Carpenter-Coustan criteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "Materials and Methods section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "maternal age",
      "attributes": {
        "evidence": "Older age, lower SES, and Arab or Bedouin ethnicity were linked to higher GDM and postpartum DM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "socioeconomic status",
      "attributes": {
        "evidence": "Older age, lower SES, and Arab or Bedouin ethnicity were linked to higher GDM and postpartum DM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "ethnicity",
      "attributes": {
        "evidence": "Older age, lower SES, and Arab or Bedouin ethnicity were linked to higher GDM and postpartum DM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "CAN_CAUSE",
      "object": "postpartum diabetes mellitus",
      "attributes": {
        "evidence": "Gestational glucose intolerance and screening gaps were strong predictors of postpartum DM.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusions section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "CAN_CAUSE",
      "object": "impaired glucose tolerance",
      "attributes": {
        "evidence": "Postpartum DM incidence was 8.6% in women with GDM, 3.1% with unknown GDM status, and 2.1% with impaired glucose tolerance (IGT).",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "CAN_CAUSE",
      "object": "child birth weight",
      "attributes": {
        "evidence": "Data included age, socioeconomic status (SES), results of OGCT and OGTT tests, child birth weight, and gestational age.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Materials and Methods section"
      }
    },
    {
      "subject": "Gestational Diabetes",
      "predicate": "CAN_CAUSE",
      "object": "gestational age",
      "attributes": {
        "evidence": "Data included age, socioeconomic status (SES), results of OGCT and OGTT tests, child birth weight, and gestational age.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Materials and Methods section"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "endocrine disease",
      "attributes": {
        "evidence": "pregnant individuals with pregestational diabetes mellitus",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "hypoglycemia",
      "attributes": {
        "evidence": "composite neonatal morbidity: hypoglycemia",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "hyperbilirubinemia",
      "attributes": {
        "evidence": "composite neonatal morbidity: hyperbilirubinemia",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "shoulder dystocia",
      "attributes": {
        "evidence": "composite neonatal morbidity: shoulder dystocia",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_SYMPTOM",
      "object": "perinatal death",
      "attributes": {
        "evidence": "composite neonatal morbidity: perinatal death",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "glycemic control",
      "attributes": {
        "evidence": "based on glycemic control and vascular complications",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "vascular complications",
      "attributes": {
        "evidence": "based on glycemic control and vascular complications",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "SMFM",
      "predicate": "RECOMMENDS",
      "object": "delivery at 36-39 6/7 weeks",
      "attributes": {
        "evidence": "SMFM and ACOG recommend delivery of gravidae with pregestational diabetes at 36-39 6/7 weeks",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "ACOG",
      "predicate": "RECOMMENDS",
      "object": "delivery at 36-39 6/7 weeks",
      "attributes": {
        "evidence": "SMFM and ACOG recommend delivery of gravidae with pregestational diabetes at 36-39 6/7 weeks",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "LGA",
      "attributes": {
        "evidence": "Secondary outcomes included composite components, composite severe neonatal morbidity, LGA",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "SGA",
      "attributes": {
        "evidence": "Secondary outcomes included composite components, composite severe neonatal morbidity, SGA",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "NICU admission",
      "attributes": {
        "evidence": "Secondary outcomes included composite components, composite severe neonatal morbidity, NICU admission",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "pregestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "cesarean",
      "attributes": {
        "evidence": "Secondary outcomes included composite components, composite severe neonatal morbidity, cesarean",
        "confidence": "high",
        "strength": "moderate",
        "source": "text context"
      }
    },
    {
      "subject": "elective delivery",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "pregestational diabetes mellitus",
      "attributes": {
        "evidence": "elective delivery at 36 weeks should be avoided unless necessary",
        "confidence": "high",
        "strength": "strong",
        "source": "text context"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "IS_A",
      "object": "hypertensive disorder in pregnancy",
      "attributes": {
        "evidence": "Preeclampsia (PE) is a hypertensive disorder in pregnancy involving multiple organ systems",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "HAS_RISK_FACTOR",
      "object": "prior PE",
      "attributes": {
        "evidence": "Risk factors such as prior PE (P = 0.01), diabetes mellitus (P = 0.03), and gestational hypertension (P = 0.02) were more frequent in the PE group",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "HAS_RISK_FACTOR",
      "object": "diabetes mellitus",
      "attributes": {
        "evidence": "Risk factors such as prior PE (P = 0.01), diabetes mellitus (P = 0.03), and gestational hypertension (P = 0.02) were more frequent in the PE group",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational hypertension",
      "attributes": {
        "evidence": "Risk factors such as prior PE (P = 0.01), diabetes mellitus (P = 0.03), and gestational hypertension (P = 0.02) were more frequent in the PE group",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Preeclampsia",
      "predicate": "DIAGNOSED_BY",
      "object": "GlyFn/PlGF ratio",
      "attributes": {
        "evidence": "The GlyFn/PlGF ratio outperforms individual biomarkers in predicting preeclampsia in high-risk pregnancies, offering a valuable tool for early risk identification and timely intervention",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "GlyFn/PlGF ratio",
      "predicate": "RECOMMENDED_FOR",
      "object": "high-risk pregnancies",
      "attributes": {
        "evidence": "Combining these biomarkers into a ratio may enhance PE prediction in high-risk pregnancies",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Placenta Growth Factor (PlGF)",
      "predicate": "CAN_CAUSE",
      "object": "Preeclampsia",
      "attributes": {
        "evidence": "Reduced Placenta Growth Factor (PlGF) and elevated Glycosylated Fibronectin (GlyFn) levels reflect these pathological changes",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Glycosylated Fibronectin (GlyFn)",
      "predicate": "CAN_CAUSE",
      "object": "Preeclampsia",
      "attributes": {
        "evidence": "Reduced Placenta Growth Factor (PlGF) and elevated Glycosylated Fibronectin (GlyFn) levels reflect these pathological changes",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Letrozole ovulation regimen",
      "predicate": "TREATED_BY",
      "object": "single-drug luteal support",
      "attributes": {
        "evidence": "more patients in the letrozole group received single-drug luteal support (53.16% vs. 16.67%, P < 0.05)",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Biol Endocrinol. 2025 Jul 17;23(1):103"
      }
    },
    {
      "subject": "Polycystic ovary syndrome",
      "predicate": "TREATED_BY",
      "object": "Letrozole ovulation regimen",
      "attributes": {
        "evidence": "The letrozole ovulation regimen demonstrated comparable clinical pregnancy rates to the programmed regimen in PCOS patients undergoing FET",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Biol Endocrinol. 2025 Jul 17;23(1):103"
      }
    },
    {
      "subject": "Letrozole ovulation regimen",
      "predicate": "RECOMMENDED_FOR",
      "object": "Polycystic ovary syndrome",
      "attributes": {
        "evidence": "These findings suggest that the letrozole regimen may be a favourable alternative for endometrial preparation in this population.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Reprod Biol Endocrinol. 2025 Jul 17;23(1):103"
      }
    },
    {
      "subject": "Frozen-thawed embryo transfer",
      "predicate": "HAS_RISK_FACTOR",
      "object": "Polycystic ovary syndrome",
      "attributes": {
        "evidence": "Polycystic ovary syndrome (PCOS) patients typically undergo either an ovulation induction regimen or a programmed regimen for endometrial preparation before frozen embryo transfer (FET).",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Biol Endocrinol. 2025 Jul 17;23(1):103"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "long-term child health outcomes",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) significantly impacts long-term child health outcomes.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "neonatologists",
      "predicate": "HAS_SYMPTOM",
      "object": "knowledge, attitudes, and practices (KAP)",
      "attributes": {
        "evidence": "This study assessed neonatologists' knowledge, attitudes, and practices (KAP) regarding GDM-related complications in offspring.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "neonatologists",
      "predicate": "TREATED_BY",
      "object": "follow-up protocols",
      "attributes": {
        "evidence": "implementation gaps exist in follow-up protocols and specialist referrals.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "neonatologists",
      "predicate": "TREATED_BY",
      "object": "specialist referrals",
      "attributes": {
        "evidence": "implementation gaps exist in follow-up protocols and specialist referrals.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "standardized protocols",
      "predicate": "RECOMMENDED_FOR",
      "object": "neonatologists",
      "attributes": {
        "evidence": "Practice setting significantly influences care delivery, suggesting the need for standardized protocols across healthcare tiers.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "mild neonatal hyperthyrotropinemia",
      "predicate": "TREATED_BY",
      "object": "levothyroxine",
      "attributes": {
        "evidence": "six received levothyroxine (3-5µg/kg/day)",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "mild neonatal hyperthyrotropinemia",
      "predicate": "HAS_SYMPTOM",
      "object": "development delay",
      "attributes": {
        "evidence": "only one child (1/81, 1.2%) exhibited development delay in personal-social development",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "mild neonatal hyperthyrotropinemia",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gestational diabetes",
      "attributes": {
        "evidence": "Infants of mothers with gestational diabetes scored lower in the personal-social domain",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "mild neonatal hyperthyrotropinemia",
      "predicate": "CAN_CAUSE",
      "object": "persistent hyperthyrotropinemia",
      "attributes": {
        "evidence": "Persistent hyperthyrotropinemia occurs in 5.7% of mild cases",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "persistent hyperthyrotropinemia",
      "predicate": "HAS_RISK_FACTOR",
      "object": "higher initial TSH",
      "attributes": {
        "evidence": "Five neonates (5.7%) exhibited persistent hyperthyrotropinemia and had significantly higher initial TSH",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "metabolic complication",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM), a prevalent metabolic complication during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "insulin resistance",
      "attributes": {
        "evidence": "Its onset is closely associated with insulin resistance",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "insufficient compensatory function of β-cells",
      "attributes": {
        "evidence": "Its onset is closely associated with insufficient compensatory function of β - cells",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "abnormal placental function",
      "attributes": {
        "evidence": "Its onset is closely associated with abnormal placental function",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "breast cancer",
      "attributes": {
        "evidence": "Epidemiological studies have indicated that type 2 diabetes is an independent risk factor for breast cancer",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "breast cancer",
      "attributes": {
        "evidence": "North American results showed an association between GDM and a reduced breast cancer risk (HR=0.89, 95%CI: 0.84-0.95), whereas Asian findings suggested an association with an increased risk (HR=1.23, 95%CI: 1.15-1.31)",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Newcastle-Ottawa Scale",
      "predicate": "DIAGNOSED_BY",
      "object": "study quality",
      "attributes": {
        "evidence": "Two researchers extracted relevant data and assessed the quality of included studies using the Newcastle-Ottawa Scale",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "myocardial hypertrophy",
      "attributes": {
        "evidence": "Gestational diabetes mellitus (GDM) can negatively impact newborn cardiac health, particularly causing myocardial hypertrophy.",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "poor glycaemic control",
      "attributes": {
        "evidence": "The incidence of myocardial hypertrophy in the GDM group was 19.6%, significantly higher than 0% in the control group, and increased to 27.3% in neonates of mothers with GDM and poor glycaemic control.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "ANGPTL7",
      "predicate": "DIAGNOSED_BY",
      "object": "ELISA",
      "attributes": {
        "evidence": "Measure the interventricular septum (IVS) thickness through cardiac ultrasound and evaluate the level of ANGPTL7 in umbilical cord blood using the ELISA method.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "myocardial hypertrophy",
      "predicate": "DIAGNOSED_BY",
      "object": "cardiac ultrasound",
      "attributes": {
        "evidence": "Measure the interventricular septum (IVS) thickness through cardiac ultrasound and evaluate the level of ANGPTL7 in umbilical cord blood using the ELISA method.",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "ANGPTL7",
      "predicate": "CAN_CAUSE",
      "object": "insulin resistance",
      "attributes": {
        "evidence": "ANGPTL7 may contribute to myocardial hypertrophy in GDM neonates by promoting insulin resistance.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Conclusion"
      }
    },
    {
      "subject": "ANGPTL7",
      "predicate": "HAS_SYMPTOM",
      "object": "interventricular septum thickness",
      "attributes": {
        "evidence": "Furthermore, these levels were positively correlated with IVS thickness.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "poor glycaemic control",
      "predicate": "CAN_CAUSE",
      "object": "IVS/LVPW ratio",
      "attributes": {
        "evidence": "In the poorly-controlled GDM subgroup (GDM-A), neonates had significantly higher ANGPTL7 levels and IVS/LVPW ratio (1.19 vs. 1.03), indicating more severe myocardial abnormalities.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "TREATED_BY",
      "object": "glycaemic control",
      "attributes": {
        "evidence": "Monitoring ANGPTL7 levels in umbilical cord blood could help identify high-risk neonates and guide optimal glycaemic management during pregnancy.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Conclusion"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "IS_A",
      "object": "acute kidney injury (AKI)",
      "attributes": {
        "evidence": "Acute kidney injury (AKI) during pregnancy and the postpartum period, known as pregnancy-associated AKI (PrAKI)",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "maternal comorbidities",
      "attributes": {
        "evidence": "Common risk factors include maternal comorbidities and use of nephrotoxic medications.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "nephrotoxic medications",
      "attributes": {
        "evidence": "Common risk factors include maternal comorbidities and use of nephrotoxic medications.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "CAN_CAUSE",
      "object": "maternal mortality",
      "attributes": {
        "evidence": "PrAKI accounts for a substantial proportion of maternal mortality and morbidity",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "CAN_CAUSE",
      "object": "premature birth",
      "attributes": {
        "evidence": "PrAKI may also adversely affect the fetus, resulting in death, premature birth and small for gestational age.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "CAN_CAUSE",
      "object": "small for gestational age",
      "attributes": {
        "evidence": "PrAKI may also adversely affect the fetus, resulting in death, premature birth and small for gestational age.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hypertensive disorders",
      "attributes": {
        "evidence": "Causes of PrAKI include sepsis, autoimmune disorders and pregnancy-specific pathologies such as hypertensive disorders.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "sepsis",
      "attributes": {
        "evidence": "Causes of PrAKI include sepsis, autoimmune disorders and pregnancy-specific pathologies such as hypertensive disorders.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "pregnancy-associated AKI (PrAKI)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "autoimmune disorders",
      "attributes": {
        "evidence": "Causes of PrAKI include sepsis, autoimmune disorders and pregnancy-specific pathologies such as hypertensive disorders.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "Acute Disease Quality Initiative",
      "predicate": "RECOMMENDS",
      "object": "multidisciplinary management",
      "attributes": {
        "evidence": "The multidisciplinary management of these patients should be tailored to treat their specific causes of PrAKI to optimize short-term and long-term neonatal and maternal outcomes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Abstract"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "HbA1c",
      "attributes": {
        "evidence": "group I (clinically accessible tests like HbA1c, lipids)",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "insulin-like growth factor (IGF) axis markers",
      "attributes": {
        "evidence": "group II (clinically accessible biomarkers upon request like insulin-like growth factor (IGF) axis markers, adipokines)",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "adipokines",
      "attributes": {
        "evidence": "group II (clinically accessible biomarkers upon request like insulin-like growth factor (IGF) axis markers, adipokines)",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "amino acids (AAs)",
      "attributes": {
        "evidence": "group III (specialty lab-required targeted metabolomics: amino acids (AAs) and phospholipid fatty acids (FAs))",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "phospholipid fatty acids (FAs)",
      "attributes": {
        "evidence": "group III (specialty lab-required targeted metabolomics: amino acids (AAs) and phospholipid fatty acids (FAs))",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "early-pregnancy random plasma samples",
      "attributes": {
        "evidence": "This study suggested that a selected panel of cardiometabolic biomarkers using early-pregnancy random plasma samples predicted GDM comparably to those using mid-pregnancy fasting samples.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "mid-pregnancy fasting samples",
      "attributes": {
        "evidence": "This study suggested that a selected panel of cardiometabolic biomarkers using early-pregnancy random plasma samples predicted GDM comparably to those using mid-pregnancy fasting samples.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high-risk women",
      "attributes": {
        "evidence": "Early identification of high-risk women is critical for preventing gestational diabetes mellitus (GDM).",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "塑料增塑剂暴露",
      "predicate": "CAN_CAUSE",
      "object": "妊娠期糖尿病",
      "attributes": {
        "evidence": "Exposure to BPA and phthalates disrupts these epigenetic processes, leading to long-term reproductive health issues, including infertility, implantation failures, preterm birth, and pregnancy complications such as gestational diabetes and preeclampsia.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "塑料增塑剂暴露",
      "predicate": "CAN_CAUSE",
      "object": "子痫前期",
      "attributes": {
        "evidence": "Exposure to BPA and phthalates disrupts these epigenetic processes, leading to long-term reproductive health issues, including infertility, implantation failures, preterm birth, and pregnancy complications such as gestational diabetes and preeclampsia.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "塑料增塑剂暴露",
      "predicate": "CAN_CAUSE",
      "object": "早产",
      "attributes": {
        "evidence": "Exposure to BPA and phthalates disrupts these epigenetic processes, leading to long-term reproductive health issues, including infertility, implantation failures, preterm birth, and pregnancy complications such as gestational diabetes and preeclampsia.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "塑料增塑剂暴露",
      "predicate": "CAN_CAUSE",
      "object": "植入失败",
      "attributes": {
        "evidence": "Exposure to BPA and phthalates disrupts these epigenetic processes, leading to long-term reproductive health issues, including infertility, implantation failures, preterm birth, and pregnancy complications such as gestational diabetes and preeclampsia.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "无创生物标志物",
      "predicate": "DIAGNOSED_BY",
      "object": "子痫前期",
      "attributes": {
        "evidence": "Cell-free circulating nucleic acids are promising non-invasive biomarkers for the early detection of pregnancy complications, such as preeclampsia, with the potential to predict sensitivity and track gestational age and underlying pathophysiological processes.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "塑料增塑剂",
      "predicate": "IS_A",
      "object": "内分泌干扰物",
      "attributes": {
        "evidence": "Plasticizers, such as bisphenol A (BPA) and phthalates, are widely used to enhance the flexibility and durability of plastics; however, they are also recognized as endocrine-disrupting chemicals (EDCs) with severe health implications.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "塑料增塑剂暴露",
      "predicate": "CAN_CAUSE",
      "object": "表观遗传修饰",
      "attributes": {
        "evidence": "Recent research has highlighted the impact of plasticizers on irreversible epigenetic modifications, which influence abnormal gene expression patterns without altering the DNA sequence.",
        "confidence": "high",
        "strength": "strong",
        "source": "Reprod Toxicol. 2025 Jul 18:109000"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "IS_A",
      "object": "glucose intolerance",
      "attributes": {
        "evidence": "Gestational diabetes mellitus is defined as any glucose intolerance that begins during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "HAS_RISK_FACTOR",
      "object": "pregnancy",
      "attributes": {
        "evidence": "Gestational diabetes mellitus is defined as any glucose intolerance that begins during pregnancy",
        "confidence": "high",
        "strength": "strong",
        "source": "Abstract"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "50 g glucose loading test (GCT)",
      "attributes": {
        "evidence": "a total of 89 pregnant women (44 GDM and 45 non-GDM) underwent a 50 g glucose loading test (GCT) between 24 and 28 weeks of gestation",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "DIAGNOSED_BY",
      "object": "3-hour glucose tolerance test (GTT)",
      "attributes": {
        "evidence": "Women with high GCT values underwent rapid diagnostic testing with a 3-hour glucose tolerance test (GTT)",
        "confidence": "high",
        "strength": "strong",
        "source": "Methods"
      }
    },
    {
      "subject": "Gestational diabetes mellitus",
      "predicate": "CAN_CAUSE",
      "object": "placental changes",
      "attributes": {
        "evidence": "The observed differences suggest a potential association between the immunohistochemical expression of FKN and the presence of GDM, placental changes, and adverse outcomes of pregnancy",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Conclusions"
      }
    },
    {
      "subject": "fractalkine (FKN)",
      "predicate": "HAS_SYMPTOM",
      "object": "fetal macrosomia",
      "attributes": {
        "evidence": "FKN expression in HUVECs was found to be associated with fetal macrosomia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "fractalkine (FKN)",
      "predicate": "HAS_SYMPTOM",
      "object": "neonatal hypoglycemia",
      "attributes": {
        "evidence": "FKN expression in HUVECs was found to be associated with neonatal hypoglycemia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "fractalkine (FKN)",
      "predicate": "HAS_SYMPTOM",
      "object": "preeclampsia",
      "attributes": {
        "evidence": "FKN expression in the capillary endothelium was found to be associated with preeclampsia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Results"
      }
    },
    {
      "subject": "kangaroo care",
      "predicate": "IS_A",
      "object": "neonatal care",
      "attributes": {
        "evidence": "kangaroo care was available in 14/22",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "HAS_SYMPTOM",
      "object": "severe illness",
      "attributes": {
        "evidence": "A median score of 0 out of 3 for symptoms of severe illness (IQR 0–3) and a median score of 6 out of 8 for signs of severe illness (IQR 4–7) were documented",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "HAS_RISK_FACTOR",
      "object": "maternal HIV status",
      "attributes": {
        "evidence": "Maternal HIV status was documented in 674/1249 (54%, 95% CI 41.9% to 66.1%) cases",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "DIAGNOSED_BY",
      "object": "standard neonatal admission form",
      "attributes": {
        "evidence": "Out of 1249 records, 56.9% (95% CI 36.2% to 77.6%) had a standard neonatal admission form",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "TREATED_BY",
      "object": "phototherapy",
      "attributes": {
        "evidence": "19/22 had resuscitation and phototherapy equipment",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "TREATED_BY",
      "object": "resuscitation equipment",
      "attributes": {
        "evidence": "19/22 had resuscitation and phototherapy equipment",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "TREATED_BY",
      "object": "benzylpenicillin",
      "attributes": {
        "evidence": "Benzylpenicillin22 (100)",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "TREATED_BY",
      "object": "gentamicin",
      "attributes": {
        "evidence": "Gentamicin18 (82)",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "neonatal care",
      "predicate": "CAN_CAUSE",
      "object": "neonatal deaths",
      "attributes": {
        "evidence": "In Kenya, 60% of infant deaths and 40% of all under-5 deaths occur in the neonatal period",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "Ministry of Health",
      "predicate": "RECOMMENDS",
      "object": "essential newborn care package",
      "attributes": {
        "evidence": "The Ministry of Health has, therefore, started to prioritise interventions and investments to promote newborn (and maternal) health,3 basing its strategy on the essential newborn care package, including a number of low-cost, high-impact interventions",
        "confidence": "high",
        "strength": "strong",
        "source": "Assessment of neonatal care in clinical training facilities in Kenya"
      }
    },
    {
      "subject": "kangaroo care",
      "predicate": "RECOMMENDED_FOR",
      "object": "prematurity/low birth weight",
      "attributes": {
        "evidence": "There was only low availability of alcohol hand rub or an area designated for kangaroo care.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "survey data"
      }
    },
    {
      "subject": "HIV positive mothers",
      "predicate": "HAS_RISK_FACTOR",
      "object": "HIV exposure in neonates",
      "attributes": {
        "evidence": "12% of mothers were HIV positive (82/674, 95% CI 7.5% to 19.6%) but only two-thirds of their babies (54/82, 65.9%, 95% CI 46.9% to 80.8%) had a prescription for antiretroviral drugs in the case notes.",
        "confidence": "high",
        "strength": "strong",
        "source": "survey data"
      }
    },
    {
      "subject": "antiretroviral drugs",
      "predicate": "TREATED_BY",
      "object": "HIV exposure in neonates",
      "attributes": {
        "evidence": "only two-thirds of their babies (54/82, 65.9%, 95% CI 46.9% to 80.8%) had a prescription for antiretroviral drugs in the case notes.",
        "confidence": "high",
        "strength": "strong",
        "source": "survey data"
      }
    },
    {
      "subject": "birth asphyxia",
      "predicate": "HAS_SYMPTOM",
      "object": "respiratory distress",
      "attributes": {
        "evidence": "Signs of severe illness were better documented with an overall median of 6/8 signs documented (IQR 4–7).",
        "confidence": "medium",
        "strength": "moderate",
        "source": "survey data"
      }
    },
    {
      "subject": "neonatal sepsis",
      "predicate": "TREATED_BY",
      "object": "antibiotics",
      "attributes": {
        "evidence": "Antibiotic prescription Benzylpenicillin dosage (n=778) Appropriate 649 8366 to 93930–100 Overdose 90 123.4 to 334.20–100** Gentamicin dosage (n=761) Appropriate 473 6251 to 73677.7–91 Overdose 141 1913 to 25201.9–67",
        "confidence": "high",
        "strength": "strong",
        "source": "survey data"
      }
    },
    {
      "subject": "extremely low birth weight",
      "predicate": "HAS_RISK_FACTOR",
      "object": "high case fatality",
      "attributes": {
        "evidence": "the highest case fatality was in the extremely low birthweight category (<1000 g) at 88%",
        "confidence": "high",
        "strength": "strong",
        "source": "table 4"
      }
    },
    {
      "subject": "gentamicin",
      "predicate": "HAS_RISK_FACTOR",
      "object": "overdose",
      "attributes": {
        "evidence": "almost one in five (18.5%, 141/761, 95% CI 13.4% to 25%) for gentamicin",
        "confidence": "high",
        "strength": "moderate",
        "source": "table 3"
      }
    },
    {
      "subject": "gentamicin",
      "predicate": "CAN_CAUSE",
      "object": "ototoxicity",
      "attributes": {
        "evidence": "Gentamicin is potentially ototoxic and nephrotoxic",
        "confidence": "high",
        "strength": "moderate",
        "source": "discussion section"
      }
    },
    {
      "subject": "gentamicin",
      "predicate": "CAN_CAUSE",
      "object": "nephrotoxicity",
      "attributes": {
        "evidence": "Gentamicin is potentially ototoxic and nephrotoxic",
        "confidence": "high",
        "strength": "moderate",
        "source": "discussion section"
      }
    },
    {
      "subject": "Kangaroo Mother Care",
      "predicate": "RECOMMENDED_FOR",
      "object": "stable babies",
      "attributes": {
        "evidence": "KMC is recommended for stable babies in national guidelines as it may reduce mortality and risk of sepsis and hypothermia",
        "confidence": "high",
        "strength": "strong",
        "source": "discussion section"
      }
    },
    {
      "subject": "Kangaroo Mother Care",
      "predicate": "CAN_CAUSE",
      "object": "reduced mortality",
      "attributes": {
        "evidence": "KMC is recommended for stable babies in national guidelines as it may reduce mortality and risk of sepsis and hypothermia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "discussion section"
      }
    },
    {
      "subject": "Kangaroo Mother Care",
      "predicate": "CAN_CAUSE",
      "object": "reduced risk of sepsis",
      "attributes": {
        "evidence": "KMC is recommended for stable babies in national guidelines as it may reduce mortality and risk of sepsis and hypothermia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "discussion section"
      }
    },
    {
      "subject": "Kangaroo Mother Care",
      "predicate": "CAN_CAUSE",
      "object": "reduced risk of hypothermia",
      "attributes": {
        "evidence": "KMC is recommended for stable babies in national guidelines as it may reduce mortality and risk of sepsis and hypothermia",
        "confidence": "medium",
        "strength": "moderate",
        "source": "discussion section"
      }
    },
    {
      "subject": "low birth weight",
      "predicate": "HAS_RISK_FACTOR",
      "object": "gentamicin overdose",
      "attributes": {
        "evidence": "the majority (68/78, 87.2%) were low birth weight (<2500 g)",
        "confidence": "high",
        "strength": "moderate",
        "source": "results section"
      }
    },
    {
      "subject": "Vitamin K",
      "predicate": "TREATED_BY",
      "object": "neonates",
      "attributes": {
        "evidence": "70% (843/1213, 95% CI 56.9% to 79.7%) had Vitamin K prescribed",
        "confidence": "high",
        "strength": "strong",
        "source": "table 3"
      }
    },
    {
      "subject": "nutrition therapy",
      "predicate": "IS_A",
      "object": "treatment",
      "attributes": {
        "evidence": "The National Academy of Medicine (formerly the Institute of Medicine) broadly defines nutrition therapy as the treatment of a disease or condition through the modification of nutrient or whole-food intake",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "diabetes",
      "predicate": "TREATED_BY",
      "object": "nutrition therapy",
      "attributes": {
        "evidence": "Strong evidence supports the efficacy and cost-effectiveness of nutrition therapy as a component of quality diabetes care, including its integration into the medical management of diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "nutrition therapy",
      "predicate": "RECOMMENDED_FOR",
      "object": "adults with diabetes or prediabetes",
      "attributes": {
        "evidence": "Nutrition counseling that works toward improving or maintaining glycemic targets, achieving weight management goals, and improving cardiovascular risk factors (e.g., blood pressure, lipids, etc.) within individualized treatment goals is recommended for all adults with diabetes and prediabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "ADA",
      "predicate": "RECOMMENDS",
      "object": "medical nutrition therapy (MNT)",
      "attributes": {
        "evidence": "The American Diabetes Association (ADA) emphasizes that medical nutrition therapy (MNT) is fundamental in the overall diabetes management plan",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "registered dietitian nutritionist/registered dietitian (RDN)",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes-focused MNT",
      "attributes": {
        "evidence": "Diabetes-focused MNT is provided by a registered dietitian nutritionist/registered dietitian (RDN), preferably one who has comprehensive knowledge and experience in diabetes care",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "intensive lifestyle intervention program",
      "predicate": "RECOMMENDED_FOR",
      "object": "people with prediabetes and overweight/obesity",
      "attributes": {
        "evidence": "Refer people with prediabetes and overweight/obesity to an intensive lifestyle intervention program that includes individualized goal-setting components, such as the Diabetes Prevention Program (DPP) and/or to individualized MNT",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "diabetes MNT",
      "predicate": "RECOMMENDED_FOR",
      "object": "Medicare benefit",
      "attributes": {
        "evidence": "Diabetes MNT is a covered Medicare benefit and should be adequately reimbursed by insurance and other payers or bundled in evolving value-based care and payment models",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "DPP-modeled intensive lifestyle interventions",
      "predicate": "RECOMMENDED_FOR",
      "object": "prediabetes",
      "attributes": {
        "evidence": "DPP-modeled intensive lifestyle interventions and individualized MNT for prediabetes should be covered by third-party payers or bundled in evolving value-based care and payment models",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus Report"
      }
    },
    {
      "subject": "MNT",
      "predicate": "TREATED_BY",
      "object": "RDN",
      "attributes": {
        "evidence": "The RDN should implement three to six MNT encounters during the first 6 months following diagnosis and determine if additional MNT encounters are needed based on an individualized assessment.",
        "confidence": "high",
        "strength": "strong",
        "source": "Academy of Nutrition and Dietetics evidence-based nutrition practice guidelines"
      }
    },
    {
      "subject": "MNT",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Strong evidence supports the effectiveness of MNT interventions provided by RDNs for improving A1C, with absolute decreases up to 2.0% (in type 2 diabetes) and up to 1.9% (in type 1 diabetes) at 3–6 months.",
        "confidence": "high",
        "strength": "strong",
        "source": "Academy of Nutrition and Dietetics evidence-based nutrition practice guidelines"
      }
    },
    {
      "subject": "MNT",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 1 diabetes",
      "attributes": {
        "evidence": "Strong evidence supports the effectiveness of MNT interventions provided by RDNs for improving A1C, with absolute decreases up to 2.0% (in type 2 diabetes) and up to 1.9% (in type 1 diabetes) at 3–6 months.",
        "confidence": "high",
        "strength": "strong",
        "source": "Academy of Nutrition and Dietetics evidence-based nutrition practice guidelines"
      }
    },
    {
      "subject": "DPP",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes prevention",
      "attributes": {
        "evidence": "The DPP demonstrated that an intensive lifestyle intervention resulting in weight loss could reduce the incidence of type 2 diabetes for adults with overweight/obesity and impaired glucose tolerance by 58% over 3 years.",
        "confidence": "high",
        "strength": "strong",
        "source": "Diabetes Prevention Program (DPP)"
      }
    },
    {
      "subject": "intensive lifestyle intervention",
      "predicate": "RECOMMENDED_FOR",
      "object": "prediabetes",
      "attributes": {
        "evidence": "Substantial evidence indicates that individuals with prediabetes should be referred to an intensive behavioral lifestyle intervention program modeled on the DPP and/or to individualized MNT typically provided by an RDN with the goals of improving eating habits, increasing moderate-intensity physical activity to at least 150 min per week, and achieving and maintaining 7–10% loss of initial body weight if needed.",
        "confidence": "high",
        "strength": "strong",
        "source": "Diabetes Prevention Program (DPP)"
      }
    },
    {
      "subject": "dietary fiber",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "People with diabetes and those at risk for diabetes are encouraged to consume at least the amount of dietary fiber recommended for the general public; increasing fiber intake, preferably through food (vegetables, pulses [beans, peas, and lentils], fruits, and whole intact grains) or through dietary supplement, may help in modestly lowering A1C.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Consensus recommendations"
      }
    },
    {
      "subject": "Mediterranean-style diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "Emphasizes plant-based food (vegetables, beans, nuts and seeds, fruits, and whole intact grains); fish and other seafood; olive oil as the principal source of dietary fat; dairy products (mainly yogurt and cheese) in low to moderate amounts; typically fewer than 4 eggs/week; red meat in low frequency and amounts; wine in low to moderate amounts; and concentrated sugars or honey rarely.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Consensus recommendations"
      }
    },
    {
      "subject": "Vegetarian or vegan diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Reduced risk of diabetes",
      "attributes": {
        "evidence": "Reduced risk of diabetes• A1C reduction• Lowered triglycerides• Reduced risk of major cardiovascular events",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Vegetarian or vegan diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "A1C reduction",
      "attributes": {
        "evidence": "Reduced risk of diabetes• A1C reduction• Lowered triglycerides• Reduced risk of major cardiovascular events",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Low-fat diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Reduced risk of diabetes",
      "attributes": {
        "evidence": "Reduced risk of diabetes• A1C reduction• Weight loss• Lowered LDL-C and non–HDL-C",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Low-fat diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "Reduced risk of diabetes• A1C reduction• Weight loss• Lowered LDL-C and non–HDL-C",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Very low-fat diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Reduced risk of diabetes",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Very low-fat diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Low-carbohydrate diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "Weight loss• Lowered blood pressure",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Low-carbohydrate diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Lowered blood pressure",
      "attributes": {
        "evidence": "Weight loss• Lowered blood pressure",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Very low-carbohydrate (VLC) diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "A1C reduction",
      "attributes": {
        "evidence": "A1C reduction• Weight loss• Lowered blood pressure• Increased HDL-C and lowered triglycerides",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Very low-carbohydrate (VLC) diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "A1C reduction• Weight loss• Lowered blood pressure• Increased HDL-C and lowered triglycerides",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Dietary Approaches to Stop Hypertension (DASH)",
      "predicate": "RECOMMENDED_FOR",
      "object": "Reduced risk of diabetes",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Dietary Approaches to Stop Hypertension (DASH)",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Dietary Approaches to Stop Hypertension (DASH)",
      "predicate": "RECOMMENDED_FOR",
      "object": "Lowered blood pressure",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Paleo diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Reduced risk of diabetes",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Paleo diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Paleo diet",
      "predicate": "RECOMMENDED_FOR",
      "object": "Lowered blood pressure",
      "attributes": {
        "evidence": "Reduced risk of diabetes• Weight loss• Lowered blood pressure",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "Dietary fiber",
      "predicate": "RECOMMENDED_FOR",
      "object": "Lower all-cause mortality",
      "attributes": {
        "evidence": "The regular intake of sufficient dietary fiber is associated with lower all-cause mortality in people with diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "High-protein eating plans",
      "predicate": "RECOMMENDED_FOR",
      "object": "Weight loss",
      "attributes": {
        "evidence": "A meta-analysis from 2013 of studies ranging from 4–24 weeks in duration reported that high-protein eating plans (25–32% of total energy vs. 15–20%) resulted in 2 kg greater weight loss and 0.5% greater improvement in A1C",
        "confidence": "medium",
        "strength": "moderate",
        "source": "RCTs, meta-analyses, observational studies, nonrandomized single-arm studies, cohort studies"
      }
    },
    {
      "subject": "polyunsaturated fat",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes prevention",
      "attributes": {
        "evidence": "Large epidemiologic studies have found that consumption of polyunsaturated fat or biomarkers of polyunsaturated fatty acids are associated with lower risk of type 2 diabetes",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "omega-3 fatty acids",
      "predicate": "RECOMMENDED_FOR",
      "object": "prediabetes",
      "attributes": {
        "evidence": "Supplementation with omega-3 fatty acids in prediabetes has demonstrated some efficacy in surrogate outcomes beyond serum triglyceride levels",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "Mediterranean-style eating pattern",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes prevention",
      "attributes": {
        "evidence": "The PREDIMED trial, a large RCT, compared a Mediterranean-style to a low-fat eating pattern for prevention of type 2 diabetes onset, with the Mediterranean-style eating pattern resulting in a 30% lower relative risk",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "Mediterranean-style eating pattern",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes management",
      "attributes": {
        "evidence": "In the Dietary Intervention Randomized Controlled Trial (DIRECT), obese adults with type 2 diabetes were randomized to a calorie-restricted Mediterranean-style, a calorie-restricted lower-fat, or a low-carbohydrate eating pattern (28% of calories from carbohydrate) without emphasis on calorie restriction. A1C was lowest in the low-carbohydrate group after 2 years, whereas fasting plasma glucose was lower in the Mediterranean-style group than in the lower-fat group",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "low-carbohydrate eating plan",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes management",
      "attributes": {
        "evidence": "Reducing overall carbohydrate intake for individuals with diabetes has demonstrated the most evidence for improving glycemia and may be applied in a variety of eating patterns that meet individual needs and preferences",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "vegetarian eating pattern",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes management",
      "attributes": {
        "evidence": "Two meta-analyses of controlled trials concluded that vegetarian and vegan eating plans can reduce A1C by an average of 0.3–0.4% in people with type 2 diabetes",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "low-fat eating pattern",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes prevention",
      "attributes": {
        "evidence": "Several large type 2 diabetes prevention RCTs used low-fat eating plans to achieve weight loss and improve glucose tolerance, and some demonstrated decreased incidence of diabetes",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "2型糖尿病",
      "predicate": "TREATED_BY",
      "object": "低碳水化合物饮食",
      "attributes": {
        "evidence": "Low-carbohydrate eating patterns, especially very low-carbohydrate (VLC) eating patterns, have been shown to reduce A1C and the need for antihyperglycemic medications.",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "2型糖尿病",
      "predicate": "TREATED_BY",
      "object": "DASH饮食模式",
      "attributes": {
        "evidence": "One small, 8-week study comparing the DASH eating pattern with a control group in people with type 2 diabetes indicated improved A1C, blood pressure, and cholesterol levels and weight loss with the DASH eating pattern.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "2型糖尿病",
      "predicate": "TREATED_BY",
      "object": "间歇性禁食",
      "attributes": {
        "evidence": "Four fasting studies of participants with type 2 diabetes were small (≤63 participants) and of short duration (≤20 weeks). Three of the studies (124–126) demonstrated that intermittent fasting, either in consecutive days of restriction or by fasting 16 h per day or more, may result in weight loss.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "低碳水化合物饮食",
      "predicate": "CAN_CAUSE",
      "object": "低血糖",
      "attributes": {
        "evidence": "Adopting a VLC eating plan can cause diuresis and swiftly reduce blood glucose; therefore, consultation with a knowledgeable practitioner at the onset is necessary to prevent dehydration and reduce insulin and hypoglycemic medications to prevent hypoglycemia.",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "间歇性禁食",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "妊娠期",
      "attributes": {
        "evidence": "The safety of intermittent fasting in people with special health situations, including pregnancy and disordered eating, has not been studied.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "低碳水化合物饮食",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "慢性肾病",
      "attributes": {
        "evidence": "Because of theoretical concerns regarding use of VLC eating plans in people with chronic kidney disease, disordered eating patterns, and women who are pregnant, further research is needed before recommendations can be made for these subgroups.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "VLC eating pattern",
      "predicate": "TREATED_BY",
      "object": "type 1 diabetes",
      "attributes": {
        "evidence": "Participants following the VLC eating pattern had less glycemic variability, spent more time in euglycemia and less time in hypoglycemia, and required less insulin (130).",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "VLC eating pattern",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 1 diabetes",
      "attributes": {
        "evidence": "This evidence suggests that a VLC eating pattern may have potential benefits for adults with type 1 diabetes, but clinical trials of sufficient size and duration are needed to confirm prior findings.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "CAN_CAUSE",
      "object": "improved A1C",
      "attributes": {
        "evidence": "To support weight loss and improve A1C, CVD risk factors, and quality of life in adults with overweight/obesity and prediabetes or diabetes, MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activity.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "CAN_CAUSE",
      "object": "improved CVD risk factors",
      "attributes": {
        "evidence": "To support weight loss and improve A1C, CVD risk factors, and quality of life in adults with overweight/obesity and prediabetes or diabetes, MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activity.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "CAN_CAUSE",
      "object": "improved quality of life",
      "attributes": {
        "evidence": "To support weight loss and improve A1C, CVD risk factors, and quality of life in adults with overweight/obesity and prediabetes or diabetes, MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activity.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "CAN_CAUSE",
      "object": "prevention of progression to type 2 diabetes",
      "attributes": {
        "evidence": "There is substantial evidence indicating that weight loss is highly effective in preventing progression from prediabetes to type 2 diabetes and in managing cardiometabolic health in type 2 diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "CAN_CAUSE",
      "object": "improved cardiometabolic health",
      "attributes": {
        "evidence": "There is substantial evidence indicating that weight loss is highly effective in preventing progression from prediabetes to type 2 diabetes and in managing cardiometabolic health in type 2 diabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "HAS_RISK_FACTOR",
      "object": "overweight/obesity",
      "attributes": {
        "evidence": "For adults with type 2 diabetes who are not taking insulin and who have limited health literacy or numeracy, or who are older and prone to hypoglycemia, a simple and effective approach to glycemia and weight management emphasizing appropriate portion sizes and healthy eating may be considered.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "TREATED_BY",
      "object": "individualized eating plan",
      "attributes": {
        "evidence": "MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activity.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "TREATED_BY",
      "object": "enhanced physical activity",
      "attributes": {
        "evidence": "MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activity.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "TREATED_BY",
      "object": "weight loss medications",
      "attributes": {
        "evidence": "In select individuals with type 2 diabetes, an overall healthy eating plan that results in energy deficit in conjunction with weight loss medications and/or metabolic surgery should be considered to help achieve weight loss and maintenance goals, lower A1C, and reduce CVD risk.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "weight loss",
      "predicate": "TREATED_BY",
      "object": "metabolic surgery",
      "attributes": {
        "evidence": "In select individuals with type 2 diabetes, an overall healthy eating plan that results in energy deficit in conjunction with weight loss medications and/or metabolic surgery should be considered to help achieve weight loss and maintenance goals, lower A1C, and reduce CVD risk.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "Mediterranean-style eating plan",
      "predicate": "RECOMMENDED_FOR",
      "object": "prediabetes",
      "attributes": {
        "evidence": "People with prediabetes at a healthy weight should be considered for lifestyle intervention involving both aerobic and resistance exercise and a healthy eating plan such as a Mediterranean-style eating plan.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "prediabetes",
      "predicate": "TREATED_BY",
      "object": "nutrition therapy",
      "attributes": {
        "evidence": "nutrition therapy to support a 7–10% weight loss is the appropriate goal in treating people with prediabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "prediabetes",
      "predicate": "TREATED_BY",
      "object": "lifestyle intervention program",
      "attributes": {
        "evidence": "Nutrition therapy can be a component of a lifestyle intervention program or used in conjunction with antiobesity medications and/or metabolic surgery (153,154) in people with prediabetes.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "prediabetes",
      "attributes": {
        "evidence": "Regular physical activity by itself (155,156) or as part of a comprehensive lifestyle plan (26,74,83,151) can prevent progression to type 2 diabetes in high-risk individuals.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "TREATED_BY",
      "object": "weight loss",
      "attributes": {
        "evidence": "The Look AHEAD trial (177) and the Diabetes Remission Clinical Trial (DiRECT) (138) highlight the potential for type 2 diabetes remission—defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year (177,178)—in people undergoing weight loss treatment.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "type 1 diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "obesity",
      "attributes": {
        "evidence": "Obesity prevalence among people with type 1 diabetes has been significantly increasing (180–182). Currently, over 50% of people with type 1 diabetes have overweight or obesity (180–182).",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "type 1 diabetes",
      "predicate": "TREATED_BY",
      "object": "weight management",
      "attributes": {
        "evidence": "Therefore, weight management has been recommended as an essential component of care for people with type 1 diabetes who have overweight or obesity (189–192).",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "SSBs",
      "predicate": "CAN_CAUSE",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "SSB consumption in the general population contributes to a significantly increased risk of type 2 diabetes, weight gain, heart disease, kidney disease, nonalcoholic liver disease, and tooth decay (207).",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "water",
      "predicate": "RECOMMENDED_FOR",
      "object": "SSBs replacement",
      "attributes": {
        "evidence": "Replace sugar-sweetened beverages (SSBs) with water as often as possible.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "sugar substitutes",
      "predicate": "RECOMMENDED_FOR",
      "object": "reducing calorie and carbohydrate intake",
      "attributes": {
        "evidence": "When sugar substitutes are used to reduce overall calorie and carbohydrate intake, people should be counseled to avoid compensating with intake of additional calories from other food sources.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "sugar substitutes",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "If sugar substitutes are used to replace caloric sweeteners, without caloric compensation, they may be useful in reducing caloric and carbohydrate intake",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "alcohol consumption",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hypoglycemia",
      "attributes": {
        "evidence": "alcohol intake may place people with diabetes at increased risk for delayed hypoglycemia",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "alcohol consumption",
      "predicate": "CAN_CAUSE",
      "object": "hyperglycemia",
      "attributes": {
        "evidence": "Excessive amounts of alcohol (>3 drinks per day or 21 drinks per week for men and >2 drinks per day or 14 drinks per week for women) consumed on a consistent basis may contribute to hyperglycemia",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "moderate alcohol intake",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "Moderate alcohol intake ranging from 6–48 g/day (0.5–3.4 drinks) was associated with a 30–56% lower incidence of type 2 diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "wine consumption",
      "predicate": "RECOMMENDED_FOR",
      "object": "type 2 diabetes",
      "attributes": {
        "evidence": "wine consumption was associated with significantly lower diabetes risk",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "multivitamins",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "Without underlying deficiency, the benefits of multivitamins or mineral supplements on glycemia for people with diabetes or prediabetes have not been supported by evidence, and therefore routine use is not recommended",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "chromium supplementation",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "the routine use of chromium or vitamin D micronutrient supplements or any herbal supplements, including cinnamon, curcumin, or aloe vera, for improving glycemia in people with diabetes is not supported by evidence and is therefore not recommended",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "metformin",
      "predicate": "CAN_CAUSE",
      "object": "vitamin B12 deficiency",
      "attributes": {
        "evidence": "Metformin is associated with vitamin B12 deficiency, with a recent systematic review recommending that annual blood testing of vitamin B12 levels be considered in metformin-treated people, especially in those with anemia or peripheral neuropathy",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "metformin",
      "predicate": "TREATED_BY",
      "object": "B12 injections",
      "attributes": {
        "evidence": "The standard of treatment has been B12 injections, but new research suggest that high-dose oral supplementation may be as effective",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "metformin",
      "predicate": "TREATED_BY",
      "object": "high-dose oral supplementation",
      "attributes": {
        "evidence": "The standard of treatment has been B12 injections, but new research suggest that high-dose oral supplementation may be as effective",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "type 1 diabetes",
      "predicate": "TREATED_BY",
      "object": "intensive insulin therapy",
      "attributes": {
        "evidence": "For individuals with type 1 diabetes, intensive insulin therapy using the carbohydrate counting approach can result in improved glycemia and is recommended",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "fixed daily insulin doses",
      "predicate": "RECOMMENDED_FOR",
      "object": "consistent carbohydrate intake",
      "attributes": {
        "evidence": "For adults using fixed daily insulin doses, consistent carbohydrate intake with respect to time and amount, while considering the insulin action time, can result in improved glycemia and reduce the risk for hypoglycemia",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "high-fat and/or high-protein mixed meals",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "sole carbohydrate counting for insulin dosing",
      "attributes": {
        "evidence": "When consuming a mixed meal that contains carbohydrate and is high in fat and/or protein, insulin dosing should not be based solely on carbohydrate counting",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "saturated fat",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "CVD risk",
      "attributes": {
        "evidence": "The scientific rationale for decreasing saturated fat in the diet is based on the effect of saturated fat in raising LDL-C, a contributing factor in atherosclerosis",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "unsaturated fats",
      "predicate": "RECOMMENDED_FOR",
      "object": "CVD risk reduction",
      "attributes": {
        "evidence": "In a Presidential Advisory on dietary fat and CVD, the American Heart Association concluded that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "地中海式饮食模式",
      "predicate": "RECOMMENDED_FOR",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "A recent meta-analysis of nine RCTs showed that, compared with control, the Mediterranean-style eating pattern, which is high in monounsaturated fats from plant sources such as olive oil and nuts, improved outcomes of glycemia, body weight, and cardiovascular risk factors in participants with type 2 diabetes",
        "confidence": "high",
        "strength": "strong",
        "source": "301"
      }
    },
    {
      "subject": "高单不饱和脂肪饮食计划",
      "predicate": "TREATED_BY",
      "object": "2型糖尿病",
      "attributes": {
        "evidence": "The eating plans high in monounsaturated fat showed significant reductions in fasting glucose, triglycerides, body weight, and systolic blood pressure along with significant increases in HDL-C.",
        "confidence": "high",
        "strength": "strong",
        "source": "63"
      }
    },
    {
      "subject": "omega-3脂肪酸",
      "predicate": "RECOMMENDED_FOR",
      "object": "糖尿病",
      "attributes": {
        "evidence": "an increase in foods containing the long-chain omega-3 fatty acids EPA and docosahexaenoic acid (DHA), such as are found in fatty fish, is recommended for individuals with diabetes because of their beneficial effects on lipoproteins, prevention of heart disease, and associations with positive health outcomes in observational studies",
        "confidence": "high",
        "strength": "strong",
        "source": "302,303"
      }
    },
    {
      "subject": "omega-3脂肪酸补充剂",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "心血管疾病预防",
      "attributes": {
        "evidence": "Evidence does not conclusively support recommending omega-3 (EPA and DHA) supplements for all people with diabetes for the prevention or treatment of cardiovascular events.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "68a, 304-305"
      }
    },
    {
      "subject": "反式脂肪",
      "predicate": "HAS_RISK_FACTOR",
      "object": "全因死亡率",
      "attributes": {
        "evidence": "Trans fats also have been associated with all-cause mortality, total CHD, and CHD mortality",
        "confidence": "high",
        "strength": "strong",
        "source": "297"
      }
    },
    {
      "subject": "低钠饮食",
      "predicate": "RECOMMENDED_FOR",
      "object": "高血压",
      "attributes": {
        "evidence": "Many health groups acknowledge the current average intake of sodium, which is >3,500 mg daily (308), should be reduced (8,309–312) to prevent and manage hypertension.",
        "confidence": "high",
        "strength": "strong",
        "source": "308, 8,309-312"
      }
    },
    {
      "subject": "糖尿病肾病",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "低蛋白饮食",
      "attributes": {
        "evidence": "In individuals with diabetes and non–dialysis-dependent diabetic kidney disease (DKD), reducing the amount of dietary protein below the recommended daily allowance (0.8 g/kg body weight/day) does not meaningfully alter glycemic measures, cardiovascular risk measures, or the course of glomerular filtration rate decline and may increase risk for malnutrition.",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus recommendation"
      }
    },
    {
      "subject": "胃轻瘫",
      "predicate": "TREATED_BY",
      "object": "小颗粒食物",
      "attributes": {
        "evidence": "Selection of small-particle-size foods may improve symptoms of diabetes-related gastroparesis.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Consensus recommendations"
      }
    },
    {
      "subject": "胃轻瘫",
      "predicate": "TREATED_BY",
      "object": "纠正高血糖",
      "attributes": {
        "evidence": "Correcting hyperglycemia is one strategy for the management of gastroparesis, as acute hyperglycemia delays gastric emptying.",
        "confidence": "high",
        "strength": "strong",
        "source": "Consensus recommendations"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "TREATED_BY",
      "object": "small, frequent meals",
      "attributes": {
        "evidence": "People with gastroparesis may find it helpful to eat small, frequent meals.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "TREATED_BY",
      "object": "liquid calories",
      "attributes": {
        "evidence": "Replacing solid food with a greater proportion of liquid calories to meet individualized nutrition requirements may be helpful because consuming solid food in large volumes is associated with longer gastric emptying times.",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "TREATED_BY",
      "object": "small-particle-size foods",
      "attributes": {
        "evidence": "Results from an RCT demonstrated eating plans that emphasize small-particle-size (<2 mm) foods may reduce severity of gastrointestinal symptoms.",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "CONTRAINDICATED_FOR",
      "object": "high-fiber foods",
      "attributes": {
        "evidence": "High-fiber foods, such as whole intact grains and foods with seeds, husks, stringy fibers, and membranes, should be excluded from the eating plan.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "TREATED_BY",
      "object": "insulin pump",
      "attributes": {
        "evidence": "The use of an insulin pump is another option for individuals with type 1 diabetes and insulin-requiring type 2 diabetes with gastroparesis.",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "HAS_SYMPTOM",
      "object": "gastric reflux",
      "attributes": {
        "evidence": "Large meals can also decrease the lower esophageal sphincter pressure, which may cause gastric reflux, providing further aggravation.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "HAS_RISK_FACTOR",
      "object": "hyperglycemia",
      "attributes": {
        "evidence": "Correcting hyperglycemia is one strategy for the management of gastroparesis, as acute hyperglycemia delays gastric emptying.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "diabetic gastroparesis",
      "predicate": "TREATED_BY",
      "object": "nutrition support",
      "attributes": {
        "evidence": "When an individual with gastroparesis falls below target weight, nutrition support in the form of oral (for acute exacerbation of symptoms), enteral, or parenteral nutrition should be considered.",
        "confidence": "high",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "type 2 diabetes",
      "predicate": "HAS_RISK_FACTOR",
      "object": "insulin resistance",
      "attributes": {
        "evidence": "Further, overall findings tend to support evidence from existing clinical trials and observational studies showing that people with markers indicating higher risk for diabetes, prediabetes, or insulin resistance have lower risk when they reduce calorie, carbohydrate, or saturated fat intake and/or increase fiber or protein intake compared with their peers.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "nutrition therapy",
      "predicate": "RECOMMENDED_FOR",
      "object": "diabetes",
      "attributes": {
        "evidence": "Ideally, an eating plan should be developed in collaboration with the person with prediabetes or diabetes and an RDN through participation in diabetes self-management education when the diagnosis of prediabetes or diabetes is made.",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "IS_A",
      "object": "chromatin-remodeling enzyme",
      "attributes": {
        "evidence": "MORC family CW-type zinc finger 2 (MORC2) is an oncogenic chromatin-remodeling enzyme with an emerging role in DNA repair.",
        "confidence": "high",
        "strength": "strong",
        "source": "TITLE and ABSTRACT"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "IS_A",
      "object": "DNA damage-responsive protein",
      "attributes": {
        "evidence": "we recently demonstrated that MORC2 is a DNA damage-responsive protein with an emerging role in DNA repair",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "HAS_SYMPTOM",
      "object": "hypersensitivity to DNA-damaging agents",
      "attributes": {
        "evidence": "Chemical inhibition or depletion of NAT10 or expression of an acetylation-defective MORC2 (K767R) forces cells to pass through G2 checkpoint, resulting in hypersensitivity to DNA-damaging agents.",
        "confidence": "high",
        "strength": "strong",
        "source": "ABSTRACT"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "TREATED_BY",
      "object": "NAT10 inhibitor Remodelin",
      "attributes": {
        "evidence": "motivate the combined use of NAT10 inhibitor Remodelin and conventional DNA-damaging chemotherapy and radiotherapy to optimize clinical outcome of patients with breast cancer.",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "CAN_CAUSE",
      "object": "DNA damage-induced G2 checkpoint activation",
      "attributes": {
        "evidence": "acetylated MORC2 binds to histone H3 phosphorylation at threonine 11 (H3T11P) and is essential for DNA damage-induced reduction of H3T11P and transcriptional repression of its downstream target genes CDK1 and Cyclin B1, thus contributing to DNA damage-induced G2 checkpoint activation.",
        "confidence": "high",
        "strength": "strong",
        "source": "ABSTRACT"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "IS_A",
      "object": "lysine acetyltransferase",
      "attributes": {
        "evidence": "N-acetyltransferase 10 (NAT10) is a member of the GNAT family of KATs",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "TREATED_BY",
      "object": "NAT10 inhibitor Remodelin",
      "attributes": {
        "evidence": "motivate the combined use of NAT10 inhibitor Remodelin and conventional DNA-damaging chemotherapy and radiotherapy to optimize clinical outcome of patients with breast cancer.",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "CAN_CAUSE",
      "object": "DNA damage-induced G2 checkpoint activation",
      "attributes": {
        "evidence": "acetylated MORC2 binds to histone H3 phosphorylation at threonine 11 (H3T11P) and is essential for DNA damage-induced reduction of H3T11P and transcriptional repression of its downstream target genes CDK1 and Cyclin B1, thus contributing to DNA damage-induced G2 checkpoint activation.",
        "confidence": "high",
        "strength": "strong",
        "source": "ABSTRACT"
      }
    },
    {
      "subject": "DNA damage-induced G2 checkpoint",
      "predicate": "HAS_RISK_FACTOR",
      "object": "dysfunctional G1/S checkpoint",
      "attributes": {
        "evidence": "As the p53 gene is frequently mutated or silenced in human cancer (5,6), most cancer cells have a dysfunctional G1/S checkpoint and therefore depend on the S and G2/M checkpoints for survival in response to genotoxic stress (7).",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "H3T11P",
      "predicate": "IS_A",
      "object": "chromatin mark for transcriptional activation",
      "attributes": {
        "evidence": "histone H3 threonine 11 phosphorylation (H3T11P), a novel chromatin mark for transcriptional activation",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "IS_A",
      "object": "key regulators for the G2/M transition and mitotic progression",
      "attributes": {
        "evidence": "Cyclin-dependent kinase 1 (CDK1) and its interactor Cyclin B1 are key regulators for the G2/M transition and mitotic progression",
        "confidence": "high",
        "strength": "strong",
        "source": "CONTENT"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "IS_A",
      "object": "protein",
      "attributes": {
        "evidence": "Myc-DDK-tagged MORC2 (#RC200518) and GFP-tagged NAT10 (#RG207082) cDNAs were obtained from Origene.",
        "confidence": "high",
        "strength": "strong",
        "source": "Origene"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "IS_A",
      "object": "protein",
      "attributes": {
        "evidence": "GFP-tagged NAT10 (#RG207082) cDNAs were obtained from Origene.",
        "confidence": "high",
        "strength": "strong",
        "source": "Origene"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "HAS_SYMPTOM",
      "object": "DNA damage-induced G2 checkpoint",
      "attributes": {
        "evidence": "Exponentially growing cells were irradiated with γ-rays using a 137Cs Gammacell-40 irradiator (Institute of Radiation Medicine, Fudan University) at room temperature. After incubation for the indicated times, cells were harvested for further experiments.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Institute of Radiation Medicine, Fudan University"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "TREATED_BY",
      "object": "siRNAs",
      "attributes": {
        "evidence": "The siRNAs targeting NAT10, SIRT2, and corresponding negative control siRNAs (siNC) were purchased from GenePharma (Shanghai, China).",
        "confidence": "high",
        "strength": "strong",
        "source": "GenePharma"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "DIAGNOSED_BY",
      "object": "immunoblotting",
      "attributes": {
        "evidence": "Immunoblotting analysis and IP assays were performed as described previously (26,53). The optical density of immunoblotting bands was quantified using ImageJ program and was normalized to the internal control Vinculin.",
        "confidence": "high",
        "strength": "strong",
        "source": "ImageJ program"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "CAN_CAUSE",
      "object": "H3T11P",
      "attributes": {
        "evidence": "The Biotin-labeled histone H3 phosphorylation at T11 peptide (biotin-ARTKQTARKS(pThr)GGKAPRKQLA) and the unmodified control peptide (biotin-ARTKQTARKSTGGKAPRKQLA) were chemically synthesized at Sangon Biotech (Shanghai, China).",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Sangon Biotech"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "IS_A",
      "object": "protein complex",
      "attributes": {
        "evidence": "All of the primary and secondary antibodies used in this study are summarized in Supplementary Table S7.",
        "confidence": "low",
        "strength": "weak",
        "source": "Supplementary Table S7"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "IS_A",
      "object": "acetylated protein",
      "attributes": {
        "evidence": "endogenous MORC2 was indeed acetylated",
        "confidence": "high",
        "strength": "strong",
        "source": "reciprocal IP assays using an anti-MORC2 or anti-acetylated lysine (Ac-K) antibody"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "IS_A",
      "object": "acetyltransferase",
      "attributes": {
        "evidence": "NAT10 acetylates MORC2 at K767",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "TREATED_BY",
      "object": "Remodelin",
      "attributes": {
        "evidence": "cells were pretreated with or without 5 μM Remodelin for 3 h prior to NAM treatment",
        "confidence": "medium",
        "strength": "moderate",
        "source": "immunoblotting analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "TREATED_BY",
      "object": "NAM",
      "attributes": {
        "evidence": "treatment with NAM, but not TSA, enhanced exogenous and endogenous MORC2 acetylation",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "TREATED_BY",
      "object": "TSA",
      "attributes": {
        "evidence": "treatment with NAM, but not TSA, enhanced exogenous and endogenous MORC2 acetylation",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "IS_A",
      "object": "acetylated protein",
      "attributes": {
        "evidence": "MORC2 K767Ac levels were normalized to those of total MORC2 protein",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "CAN_CAUSE",
      "object": "MORC2 acetylation",
      "attributes": {
        "evidence": "NAT10 acetylates MORC2 at K767",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "DIAGNOSED_BY",
      "object": "IP assays",
      "attributes": {
        "evidence": "lysates were subjected to IP assays with control IgG, an anti-MORC2 or anti-Ac-K antibody",
        "confidence": "high",
        "strength": "strong",
        "source": "IP and immunoblotting analysis"
      }
    },
    {
      "subject": "SIRT2",
      "predicate": "IS_A",
      "object": "deacetylase",
      "attributes": {
        "evidence": "SIRT2 is the primary deacetylase for MORC2 deacetylation",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "TREATED_BY",
      "object": "MORC2",
      "attributes": {
        "evidence": "NAT10 directly interacts with MORC2 and acetylates it at K767",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "SIRT2",
      "predicate": "TREATED_BY",
      "object": "MORC2",
      "attributes": {
        "evidence": "SIRT2 is the primary deacetylase for MORC2 deacetylation",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "HAS_SYMPTOM",
      "object": "K767 acetylation",
      "attributes": {
        "evidence": "the K767 is the major acetylation site of MORC2",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "CAN_CAUSE",
      "object": "MORC2 K767 acetylation",
      "attributes": {
        "evidence": "NAT10 directly interacts with MORC2 and acetylates it at K767",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "SIRT2",
      "predicate": "CAN_CAUSE",
      "object": "MORC2 deacetylation",
      "attributes": {
        "evidence": "SIRT2 is the primary deacetylase for MORC2 deacetylation",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "DNA-damaging agents",
      "predicate": "CAN_CAUSE",
      "object": "MORC2 K767Ac",
      "attributes": {
        "evidence": "DNA-damaging agents stimulate MORC2 K767Ac in a NAT10-dependent manner",
        "confidence": "high",
        "strength": "strong",
        "source": "Figure 3A"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "HAS_SYMPTOM",
      "object": "enhanced interaction with NAT10",
      "attributes": {
        "evidence": "DNA damage enhances the interaction between NAT10 and MORC2",
        "confidence": "high",
        "strength": "strong",
        "source": "Figure 3H-M"
      }
    },
    {
      "subject": "DNA damage",
      "predicate": "CAN_CAUSE",
      "object": "NAT10 nucleoplasm translocation",
      "attributes": {
        "evidence": "treatment of MMS and IR resulted in a translocation of NAT10 from the nucleolus to the nucleoplasm",
        "confidence": "high",
        "strength": "strong",
        "source": "Figure 3N"
      }
    },
    {
      "subject": "H3T11P",
      "predicate": "IS_A",
      "object": "histone modification",
      "attributes": {
        "evidence": "H3T11P is described as a phosphorylation-modified histone H3 peptide, indicating it is a histone modification.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "CDK1",
      "predicate": "IS_A",
      "object": "protein",
      "attributes": {
        "evidence": "CDK1 is referred to as a target gene of MORC2 and is involved in transcriptional repression, indicating it is a protein.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "Cyclin B1",
      "predicate": "IS_A",
      "object": "protein",
      "attributes": {
        "evidence": "Cyclin B1 is referred to as a target gene of MORC2 and is involved in transcriptional repression, indicating it is a protein.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "CAN_CAUSE",
      "object": "DNA damage-induced reduction of H3T11P",
      "attributes": {
        "evidence": "The text states that MORC2 mediates DNA damage-induced reduction of H3T11P.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "CAN_CAUSE",
      "object": "transcriptional repression of CDK1 and Cyclin B1",
      "attributes": {
        "evidence": "The text states that MORC2 mediates transcriptional repression of CDK1 and Cyclin B1 in response to DNA damage.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "CAN_CAUSE",
      "object": "DNA damage-induced downregulation of H3T11P",
      "attributes": {
        "evidence": "The text states that MORC2 K767Ac is required for DNA damage-induced downregulation of H3T11P.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "CAN_CAUSE",
      "object": "transcriptional repression of CDK1 and Cyclin B1",
      "attributes": {
        "evidence": "The text states that MORC2 K767Ac contributes to transcriptional repression of CDK1 and Cyclin B1.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "CAN_CAUSE",
      "object": "regulation of H3T11P, CDK1, and Cyclin B1 expression",
      "attributes": {
        "evidence": "The text states that NAT10 regulates H3T11P, CDK1, and Cyclin B1 expression through MORC2 K767Ac.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "TREATED_BY",
      "object": "acetylation at K767",
      "attributes": {
        "evidence": "The text describes acetylation of MORC2 at K767 and its effects on binding to H3T11P and transcriptional repression.",
        "confidence": "high",
        "strength": "strong",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "DIAGNOSED_BY",
      "object": "immunoblotting analysis",
      "attributes": {
        "evidence": "The text describes using immunoblotting analysis to examine MORC2 and its mutants.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "H3T11P",
      "predicate": "DIAGNOSED_BY",
      "object": "immunoblotting analysis",
      "attributes": {
        "evidence": "The text describes using immunoblotting analysis to examine H3T11P levels.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "DIAGNOSED_BY",
      "object": "qPCR analysis",
      "attributes": {
        "evidence": "The text describes using qPCR analysis to examine CDK1 and Cyclin B1 mRNA levels.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2",
      "predicate": "HAS_RISK_FACTOR",
      "object": "DNA damage",
      "attributes": {
        "evidence": "The text discusses MORC2's role in response to DNA damage, indicating DNA damage as a risk factor for MORC2-related processes.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "H3T11P",
      "predicate": "HAS_RISK_FACTOR",
      "object": "DNA damage",
      "attributes": {
        "evidence": "The text discusses DNA damage-induced reduction of H3T11P, indicating DNA damage as a risk factor for H3T11P-related processes.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "HAS_RISK_FACTOR",
      "object": "DNA damage",
      "attributes": {
        "evidence": "The text discusses DNA damage-induced transcriptional repression of CDK1 and Cyclin B1, indicating DNA damage as a risk factor for their regulation.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "Text analysis"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "HAS_RISK_FACTOR",
      "object": "DNA damage",
      "attributes": {
        "evidence": "MORC2 K767Ac is required for G2 checkpoint arrest in response to genotoxic stress",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "CAN_CAUSE",
      "object": "mitotic catastrophe",
      "attributes": {
        "evidence": "Without functional G2 blockade, damaged cells may not be able to repair DNA damage before entering mitosis, leading to mitotic catastrophe",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "TREATED_BY",
      "object": "NAT10 inhibitor Remodelin",
      "attributes": {
        "evidence": "treatment with NAT10 inhibitor Remodelin enhanced the sensitivity of cells expressing WT MORC2, but not K767R mutant MORC2, to MMS and IR",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "HAS_RISK_FACTOR",
      "object": "DNA damage",
      "attributes": {
        "evidence": "NAT10 KO cells were more sensitive to MMS and IR",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "IS_A",
      "object": "cell cycle regulators",
      "attributes": {
        "evidence": "CDK1 and Cyclin B1 are key regulators for transition though the G2 phase and entry into mitosis during normal cell cycle",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "CDK1 and Cyclin B1",
      "predicate": "CAN_CAUSE",
      "object": "G2/M cell cycle arrest",
      "attributes": {
        "evidence": "Transcriptional repression of CDK1 and Cyclin B1 or inactivation of CDK1 and Cyclin B1 activity during DNA damage induces G2/M cell cycle arrest",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "DNA damage-induced G2 checkpoint",
      "predicate": "IS_A",
      "object": "cell cycle checkpoint",
      "attributes": {
        "evidence": "MORC2 K767Ac is required for G2 checkpoint arrest in response to genotoxic stress",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "DNA damage-induced G2 checkpoint",
      "predicate": "HAS_RISK_FACTOR",
      "object": "genotoxic stress",
      "attributes": {
        "evidence": "MORC2 K767Ac is required for G2 checkpoint arrest in response to genotoxic stress",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "HAS_SYMPTOM",
      "object": "DNA damage-induced G2 checkpoint activation",
      "attributes": {
        "evidence": "MORC2 K767Ac mediates DNA damage-induced reduction of H3T11P and transcriptional repression of its downstream target genes CDK1 and Cyclin B1, thus contributing to DNA damage-induced G2 checkpoint activation",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "CAN_CAUSE",
      "object": "resistance to DNA-damaging therapeutic agents",
      "attributes": {
        "evidence": "acetylated MORC2 contributes to G2 DNA damage checkpoint activation and facilitates cell survival following DNA damage",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "MORC2 K767Ac",
      "predicate": "DIAGNOSED_BY",
      "object": "immunohistochemical staining",
      "attributes": {
        "evidence": "We found that anti-MORC2 K767Ac antibody could detect strong signals in paraffin-embedded breast cancer tissues that were specifically blocked by the acetyl-K767 antigen peptide",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "NAT10",
      "predicate": "HAS_RISK_FACTOR",
      "object": "breast cancer",
      "attributes": {
        "evidence": "The expression levels of MORC2 K767Ac and NAT10 were upregulated in breast tumor specimens as compared with the corresponding normal tissues",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "antimicrobial activity",
      "attributes": {
        "evidence": "Good antimicrobial activity can be correlated with the presence of xanthene and imidazole units into the main structure of PIs.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "polyimide/HBP-modified SiO2 composite",
      "predicate": "HAS_SYMPTOM",
      "object": "increased heat resistance",
      "attributes": {
        "evidence": "The data obtained from examining the properties of the prepared BTDA-PIb/HBP@SiO2 demonstrated increased heat resistance, photoluminescence intensity, and antimicrobial inhibition compared to pure PI.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "polyimide/HBP-modified SiO2 composite",
      "predicate": "HAS_SYMPTOM",
      "object": "increased photoluminescence intensity",
      "attributes": {
        "evidence": "The data obtained from examining the properties of the prepared BTDA-PIb/HBP@SiO2 demonstrated increased heat resistance, photoluminescence intensity, and antimicrobial inhibition compared to pure PI.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "polyimide/HBP-modified SiO2 composite",
      "predicate": "HAS_SYMPTOM",
      "object": "increased antimicrobial inhibition",
      "attributes": {
        "evidence": "The data obtained from examining the properties of the prepared BTDA-PIb/HBP@SiO2 demonstrated increased heat resistance, photoluminescence intensity, and antimicrobial inhibition compared to pure PI.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "TREATED_BY",
      "object": "heavy metal ions (Hg2+ and Co2+) removal",
      "attributes": {
        "evidence": "Also, in this article, the polymeric samples as adsorbents were evaluated for extraction of heavy metal ions (Hg2+ and Co2+) from water sources.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "HAS_RISK_FACTOR",
      "object": "rigid structure characteristics",
      "attributes": {
        "evidence": "The rigid structure characteristics of PIs have a close relationship with the formation of charge transfer complexes (CTCs) in polymer chains; as such, the application and processability of traditional aromatic PIs are very limited.",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text content"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "TREATED_BY",
      "object": "structural modifications",
      "attributes": {
        "evidence": "Hence, structural modifications to polyimides for overcoming these drawbacks have been widely investigated.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "high thermal stability",
      "attributes": {
        "evidence": "These PIs showed glass transition temperatures ranging from 273 to 306 °C, and 10% mass loss temperatures within the range of 478–504 °C in a N2 atmosphere.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "imidazole-based polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "high transparency",
      "attributes": {
        "evidence": "High transparency with a UV-visible absorption cut-off wavelength was found to range between 285 and 300 nm.",
        "confidence": "high",
        "strength": "strong",
        "source": "text content"
      }
    },
    {
      "subject": "gentamicin",
      "predicate": "TREATED_BY",
      "object": "antibacterial agent",
      "attributes": {
        "evidence": "gentamicin (antibacterial agent) and fluconazole (antifungal agent) were used",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "fluconazole",
      "predicate": "TREATED_BY",
      "object": "antifungal agent",
      "attributes": {
        "evidence": "gentamicin (antibacterial agent) and fluconazole (antifungal agent) were used",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "SiO2 nanoparticles",
      "predicate": "IS_A",
      "object": "nanoparticles",
      "attributes": {
        "evidence": "SiO2 NPs, SiO2–NH2 NPs, SiO2–NH2@HBP, and BTDA-PIb/HBP@SiO2",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "IS_A",
      "object": "polymer nanocomposites (PNCs)",
      "attributes": {
        "evidence": "BTDA-PIb/HBP@SiO2",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "antimicrobial activity",
      "attributes": {
        "evidence": "bacterial and fungi cultures for antimicrobial activity were prepared",
        "confidence": "medium",
        "strength": "moderate",
        "source": "text"
      }
    },
    {
      "subject": "heavy metal ions (Hg2+ and Co2+)",
      "predicate": "CAN_CAUSE",
      "object": "environmental contamination",
      "attributes": {
        "evidence": "The solid–liquid extraction of Co2+ as its chloride salts and Hg2+ as its nitrate salt was carried out from aqueous the solutions at pH = 7–8",
        "confidence": "low",
        "strength": "weak",
        "source": "text"
      }
    },
    {
      "subject": "SiO2–NH2 NPs",
      "predicate": "IS_A",
      "object": "SiO2 NPs",
      "attributes": {
        "evidence": "The emergence of the new peaks at 2822 and 2929 cm−1 in the FT-IR spectrum of SiO2–NH2 NPs as compared with the FT-IR spectrum of SiO2 NPs",
        "confidence": "high",
        "strength": "strong",
        "source": "FT-IR spectrum analysis"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "amorphous nature",
      "attributes": {
        "evidence": "The BTDA-PIb/HBP@SiO2 showed an amorphous nature similar to BTDA-PIb with a wide peak at 2θ = 21.47°",
        "confidence": "high",
        "strength": "strong",
        "source": "XRD analysis"
      }
    },
    {
      "subject": "BTDA-PIb",
      "predicate": "HAS_SYMPTOM",
      "object": "amorphous pattern",
      "attributes": {
        "evidence": "The BTDA-PIb had an amorphous pattern and it could be related to disturbed the packing of polymers chains by the imidazole-based pendant groups",
        "confidence": "high",
        "strength": "strong",
        "source": "XRD analysis"
      }
    },
    {
      "subject": "SiO2–NH2@HBP NPs",
      "predicate": "HAS_SYMPTOM",
      "object": "non-crystalline structure",
      "attributes": {
        "evidence": "Due to the amorphous structure of SiO2 NPs, SiO2–NH2@HBP NPs will also have a non-crystalline structure",
        "confidence": "high",
        "strength": "strong",
        "source": "XRD analysis"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "uniform surface morphology",
      "attributes": {
        "evidence": "The outcome of FE-SEM demonstrated PI was successfully grafted onto SiO2 NPs",
        "confidence": "high",
        "strength": "strong",
        "source": "FE-SEM analysis"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "good solubility in polar aprotic solvents",
      "attributes": {
        "evidence": "All PIs have shown good solubility in polar aprotic solvents such as DMAc, DMF, DMSO, and NMP at ambient temperature",
        "confidence": "high",
        "strength": "strong",
        "source": "Solubility test"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "high-quality optical properties",
      "attributes": {
        "evidence": "The prepared polyimides (BTDA-PIa, 6FDA-PIa, BTDA-PIb, 6FDA-PIb) in this work show high-quality optical properties due to the presence of xanthene and imidazole group",
        "confidence": "high",
        "strength": "strong",
        "source": "Optical properties analysis"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "higher fluorescence intensity",
      "attributes": {
        "evidence": "The derived-(BTDA-PIb) polymeric nanocomposite exhibited emission at λem = 471 nm, absorption at λab = 290 nm. It has more fluorescence intensity compared to pure BTDA-PIb",
        "confidence": "high",
        "strength": "strong",
        "source": "Fluorescence spectroscopy"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "higher glass transition temperature (Tg)",
      "attributes": {
        "evidence": "The glass transition temperature (Tg) of the PIs was found at 273–306 °C",
        "confidence": "high",
        "strength": "strong",
        "source": "DSC analysis"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "lower Tg values",
      "attributes": {
        "evidence": "these polyimides demonstrated relatively lower Tg values when compared with PIs without methoxy groups",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "6FDA-based PIs",
      "predicate": "HAS_SYMPTOM",
      "object": "higher Tg values",
      "attributes": {
        "evidence": "The Tg values of 6FDA-based PIs were higher than those of BTDA-based PIs",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "excellent thermal consistency",
      "attributes": {
        "evidence": "The Td,10 values in nitrogen atmospheres were overstepped from 478 °C and the char yield was found within the range of 39.5–45.5%, which offered excellent thermal consistency of PIs",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "non-flammable polymer",
      "attributes": {
        "evidence": "the LOI of polyimides and nanocomposite were above 26%, which corresponds to the attributes of non-flammable polymer",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "PIs-6FDA",
      "predicate": "HAS_SYMPTOM",
      "object": "higher thermal resistance",
      "attributes": {
        "evidence": "The increasing order of thermal resistance was as follows: PIs-6FDA > PIs-BTDA",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "higher T10 and CR values",
      "attributes": {
        "evidence": "Higher values of T10 and CR were perceived on BTDA-PIb/HBP@SiO2 compared to neat PI",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "HAS_SYMPTOM",
      "object": "good inhibition activities",
      "attributes": {
        "evidence": "all tested polymers demonstrated good inhibition activities, which is related to the presence of the xanthene group and the imidazole ring in their backbone",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "relatively more antimicrobial activity",
      "attributes": {
        "evidence": "polymeric nanocomposite demonstrated relatively more antimicrobial activity than native BTDA-PIb",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "SiO2 NPs",
      "predicate": "HAS_SYMPTOM",
      "object": "antimicrobial agents",
      "attributes": {
        "evidence": "SiO2 NPs act as antimicrobial agents due to their high surface area, porous structure, and adsorption attributes",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "polyimides (PIs)",
      "predicate": "CAN_CAUSE",
      "object": "adsorption of Co2+ and Hg2+ ions",
      "attributes": {
        "evidence": "synthesized polyimides and nanocomposite were used for eliminating Co2+ and Hg2+ ions from wastewater through adsorption",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "largest absorption percentage for both heavy metal ions",
      "attributes": {
        "evidence": "the largest absorption percentage for both heavy metal ions have been related to the BTDA-PIb/HBP@SiO2 compound",
        "confidence": "high",
        "strength": "strong",
        "source": "text"
      }
    },
    {
      "subject": "PIs",
      "predicate": "HAS_RISK_FACTOR",
      "object": "heavy metal ions (Hg2+ and Co2+)",
      "attributes": {
        "evidence": "The removal percentage and distribution coefficient parameters for Hg2+ and Co2+ solutions (20 ppm), on the sorbents",
        "confidence": "high",
        "strength": "strong",
        "source": "Scheme 3 and Fig. 10"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "TREATED_BY",
      "object": "SiO2 nanoparticles",
      "attributes": {
        "evidence": "To achieve uniform dispersion of SiO2 NPs in the PI phase, we carried out hyperbranched aromatic polyamide linking of SiO2 NPs.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "enhanced photoluminescence intensity",
      "attributes": {
        "evidence": "The photoluminescence intensity, heat resistance, and antimicrobial inhibition properties of the BTDA-PIb/HBP@SiO2 indicated an obvious enhancement compared to the pure PI.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "enhanced heat resistance",
      "attributes": {
        "evidence": "The photoluminescence intensity, heat resistance, and antimicrobial inhibition properties of the BTDA-PIb/HBP@SiO2 indicated an obvious enhancement compared to the pure PI.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "BTDA-PIb/HBP@SiO2",
      "predicate": "HAS_SYMPTOM",
      "object": "enhanced antimicrobial inhibition properties",
      "attributes": {
        "evidence": "The photoluminescence intensity, heat resistance, and antimicrobial inhibition properties of the BTDA-PIb/HBP@SiO2 indicated an obvious enhancement compared to the pure PI.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "PIs",
      "predicate": "HAS_SYMPTOM",
      "object": "antimicrobial activity",
      "attributes": {
        "evidence": "Meanwhile, it was well investigated that incorporation of xanthene and imidazole as antimicrobial agents in the PIs backbone induced good inhibition against fungus, Gram-negative and germ-positive bacteria.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "6FDA-PIs",
      "predicate": "IS_A",
      "object": "heat-resistant PIs",
      "attributes": {
        "evidence": "We successfully prepared heat-resistant PIs (6FDA-based PIs and BTDA-based PIs) containing imidazole and xanthene segments via two-step thermic imidization using NMP as a solvent.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "BTDA-PIs",
      "predicate": "IS_A",
      "object": "heat-resistant PIs",
      "attributes": {
        "evidence": "We successfully prepared heat-resistant PIs (6FDA-based PIs and BTDA-based PIs) containing imidazole and xanthene segments via two-step thermic imidization using NMP as a solvent.",
        "confidence": "high",
        "strength": "strong",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "6FDA-PIs",
      "predicate": "HAS_SYMPTOM",
      "object": "greater thermal stability",
      "attributes": {
        "evidence": "6FDA-PIs revealed greater thermal stability compared to BTDA-PIs, with respect to the presence of polar –CF3 groups in their main structure.",
        "confidence": "high",
        "strength": "moderate",
        "source": "Conclusion section"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "IS_A",
      "object": "糖代谢异常",
      "attributes": {
        "evidence": "妊娠期糖尿病（GDM）是指妊娠期间首次发现的糖代谢异常。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "多饮",
      "attributes": {
        "evidence": "患者可能出现多饮、多尿、体重减轻等症状。",
        "confidence": "high",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "HAS_SYMPTOM",
      "object": "体重减轻",
      "attributes": {
        "evidence": "患者可能出现多饮、多尿、体重减轻等症状。",
        "confidence": "high",
        "strength": "moderate",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "DIAGNOSED_BY",
      "object": "口服葡萄糖耐量试验",
      "attributes": {
        "evidence": "诊断通常通过口服葡萄糖耐量试验（OGTT）进行。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    },
    {
      "subject": "妊娠期糖尿病",
      "predicate": "RECOMMENDED_FOR",
      "object": "血糖监测",
      "attributes": {
        "evidence": "血糖监测对于妊娠期糖尿病管理至关重要。",
        "confidence": "high",
        "strength": "strong",
        "source": "文本内容"
      }
    }
  ],
  "extraction_summary": {
    "total_entities": 973,
    "total_relations": 854,
    "entity_types": {
      "Disease": 70,
      "MedicalConcept": 204,
      "Complication": 126,
      "RiskFactor": 72,
      "DiagnosticMethod": 122,
      "Treatment": 163,
      "Food": 78,
      "Question": 56,
      "Symptom": 21,
      "Guideline": 61
    },
    "relation_types": {
      "IS_A": 53,
      "HAS_SYMPTOM": 88,
      "HAS_RISK_FACTOR": 133,
      "DIAGNOSED_BY": 76,
      "TREATED_BY": 114,
      "CAN_CAUSE": 187,
      "RECOMMENDED_FOR": 124,
      "CONTRAINDICATED_FOR": 29,
      "ANSWERS": 15,
      "RECOMMENDS": 35
    },
    "extracted_at": "2025-07-25T23:55:31.474462"
  }
}
